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Abstract 
Type 2 diabetc mellitu,' account for more than 90% of ca e. of diabete, mellitu .. 
Cardio a cular di ea e' are the major cau. e of morbidity and monality in diabetic 
patients. A variety of dia tolic and y tolic dy function ha e been reported. The 
severity of the abnormalitie depend' on the patients' age and diabetes duration. The 
aim of the study \Va. to in eSligate the age-dependent, exerci e and pharmacological 
intef\.ention on electromechanical function of tbe heart in the OOlo-Kakizaki OK) type 
2 diabeti rat . rnR A e pre ion wa a e. ed in entricular mu cle with real-time RT­
PCR. Ventricular m ocyte bortening, intracellular Ca
2+ tran port and L-type Ca2+ 
current were mea ured with video edge detection, fluore cence photometry and whole 
cell patch clamp technique , re pectively. In vivo biotelemetry wa u ed to measure the 
electrocardiogram. In young OK (8-10 week) rat, rnRNA expre . ion of Atp1a3. 
Cacna111, Sen1 band Hen2 were upregulated and Slc9a1, Hen4, Kena214 and Kcnj2 
were do nregulated. Amplitude of entricular myocyte shortening and intracellular 
Ca
2+ transient were unaltered, time to peak hortening wa prolonged and time to half 
decay of the Ca
2+ tran ient wa . bortened in OK myocytes. Phy ical exerci e j. well 
e tabti hed a a valuable form of non-pharmacological therapy. Experiment were 
performed in OK and control (10-11 month) following 2 -3 month of treadrrlill 
exerci e training. Expre ion of mRNA encoding Tpm2, Gja4, Arp1 bI Caenal g 
Caenb2, Hen2, Kena3 and Kenei were upregulated and Gja1, Kenj2 and Kenk3 were 
downregulated in heart of edentary OK rat compared to edentary control . GjaI, 
Cad and KellkJ were upregulated and Hcn2 wa down-regulated in hearts of exerci e 
'Ill 
tramed GK compared to edentary GK control.. Amplitude of ventricular myocyte 
<;hortening. Ca
2+ tran ients and L-type Ca�+ current were not ignificantly altered. 
The effect. of the anti-diabetic drug Pioglitazone on ventricular myocyte hortening and 
Ca:!+ tran port in addition to electrocardiogram were also inve tigated. Pioglitazone 
(0. 1 - 1 0) 11M reduced the amplitude of shortening in ventricular myocyte from GK and 
control rat�. Pioglitazone reduced the amplitude of the Ca2+ tran ient and mode t 
reduction in L-type Ca
2+ current in GK and control myocytes. Heart rate in GK rat 
wa� reduced. Although Pioglitazone reduced blood gluco e in GK rat it had little effect 
on heart electrocardiogram. 
Keyword: Type 2 diabete , Exerci e, Pioglitazone, Hea11, Ventricular myocyte . 
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Chapter 1 :  I n t roduction 
1 . 1  Th heart 
The heart i �  a mu:cular organ contai n ing four chambers. The upper two chamber . 
left and right atria are eparated by the in teratrial eptum .  The lower two chamber . 
left and right ventric l  , are eparated by the i nterventricu lar eptum. Heart val e are 
located between ea h atr ium and entric 1e .  The tricu pid val e control ' blood flow 
between the left atri um and left entricle and the m itral al e control blood flow 
between the dght atri um and the light ventric le .  The aort ic  valve i located between 
the left ventric le  and the aorta. and the pulmonary valve i located between the dght 
ventricle and the pulmonary artery . B lood flow in and out of the heart i regulated by 
two c ircui t , namely .  the pulmonary c ircu i t  which carrie deoxygenated blood from 
the right ventri cle to the lung i a  the pulmonary arteri e and carrie oxygenated blood 
to the left atri um via pulmonary em and the sy temi c  c ircui t  which carries 
o ygenated blood from the left ventricle to the rest of the body via the aorta and 
return deoxygenated blood i n  to heart v ia  uperior and inferior vena cava (Figure 
1 . 1 ) . 
The heart wal l con i t of three layer , the outer layer cal led the epicard ium.  contai ns 
quamou cel l  and a network of fibro-elastic connective t is ue .  The middle layer 
cal led the myocard ium i the mu cu lar l ayer and i t  make up the va t majority of the 
heart th ickne s and consists of card iac mu cle cel l  ( cardiac myocyte ), connect ive 
t i  ue and blood vessels .  The i nner layer i the endocard ium which i s  a th in  layer 
which l i ne the heart chamber and is made up of quamous cel l  , col l agen and elastic 
fi ber and a layer of m oth mu cle o  The heart ti ue i t  e lf  i uppl ied with blood 
through the coronary anerie that ari e from the aortic inu . Paral lel to the coronary 
arlerie there are coronary e in . The vein are re pon ible for col lecting 
deoxygenated blood from heart t i  ue i nto a large ve el cal led the coronary inu  
\ hich emptie blood i nto the ri ght atri um.  The heart i an energet ic  organ that 
requ ire: large amount � of ATP to upport i t  mu  cular acti vity .  Under phy iological 
condit ions. optimal ardiac function depend, on the efficient matching of energy 
produ t ion to energy expendi ture .  Ox idation of long chain fatty acid  and glucose in 
the mi tochondria are the main ource for ATP production. 
The hean i under extri ns ic con trol by the autonomic nervous y tern. I t  i s  rich ly  
i nner ated by branche of ympathetic and para ympathetic fibers which mainly 
teml inate on the i noateri al ( SA )  node and atrioventricular (A V)  node . St imulation of 
ympathetic nerve cau e the re lease of norepinephri ne at ner e endings which 
i ncrea e membrane permeabi l i ty to calc ium ions (Ca:?+) by opening vol tage-gated L­
type Ca2+ channel and enhance pacemaker cunent  ( Ir). which i ncrea e the rate of 
i n u  rhyth m  and rate of conduction of i mpulse and resul t  in cardiac accelerat ion.  
On the other hand. activation of para ympathetic nerves l iberate acetylchol ine (ACh)  
a t  nerve endings and causes an  i ncrea e of  ce l l  membrane permeabi l i ty to  potas i um 
ion ( K+) and produce hyperpolarization by uppre s ing Ir. The e effects slow the 
firing rate in the SA node and decrease exci tation of the conduct ion system and resul t  
in  reduction i n  the rate and force of contraction of the heart [ I ] . Cardiac muscle 
contraction i s  a lso regu lated by i ntri ns ic mechanism . According to Frank and 
S tarl i ng law of the heart . a the heart fi l l  wi th  blood the wall of the heart i 
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. tretched. The greater the fi l l i ng olume and hence. the greater the tretch. the greater 
w i l l  be the force of cardiac muscle contraction [ 2 . 3 ] .  
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Figure 1 . 1 :  Structure of the heart . Adapted from http://www.artic le web.orglblog/wp­
conten t/ gal lery/dra w-bio logy-diagrarnJdra w-bio 10 gy-diagrarn - 1 3 .jp g 
1 . 1 . 1  Cardiac myocyte elect rophy iology 
The ' tructural un i t  of the m cardium i the cardiac myocyte. Cardiac myoc te are 
the mo�t phy icall energeti c  cell in  the body contract ing con tant ly  throughout their 
l i fe pan . n l i ke keletal mu cle cel l , typical human ventricular myocyte have 
variable branch ing morphology, they are approximately 1 00- ] 50 fl m  in length and 
about 20-35 fl m  in diameter. Card iac myoc te are urrounded by a unique plasma 
membrane known a the sarcolemma. The arcolemma i compo ed of a hydrophobic 
pho, pholipid b i layer and hydrophi l ic head group . A variety of ion channels, pumps 
and ion e changer' are embedded i n  the arcolemma, al l  of which regulate the 
movement of ion, i n  and out of the myocyte. The tran ver e tubule (T-tubule ) are 
fi nger- l ike invagi nations which extend from the sarcolemma to the i nterior of the celL 
Each T-tubule contain a l arge number of vol tage-gated L-type Ca:!+ channel . 
Cardiac myocyte are h ighly packed with mitochondria to provide a steady uppl y of 
adeno ine tripho phate (A TP) which i s  required as a source of energy for cardiac 
mu cle contract ion .  Cardiac myocyte contain contract i le protei n  cal led 
myofi lament which i nc lude act in ,  myo in and a sociated regulatory protein 
arranged i n  a regular aLTay of thick (myos in)  and th in  (act in )  fi laments. The 
arcomere i the fundamental un i t  of the myofi lament and i s  bordered by the Z l i ne . 
The in teraction between act in  and myosin generate mu c1e contraction [4 ,  5 ] .  The 
regulatory protei n  associated with act i n  and myosi n i nc lude u-opomyosin and the 
troponin complex . The troponin complex i made up of three ubuni ts, troponin T 
(TnT. or tropomyosin b inding subuni t ) ,  troponin C (TnC or the Ca
2+ b ind ing 
subuni t ) and troponin I (Tn l ,  i nh ib i tory ubun i t  which also bind act in ) .  
The �arcopla mic reti culum ( R) i an i ntracel lu lar network which urround the 
contract J l e  prote in . It store and relea e Ca2+ that i imp0l1an l i n  the regulation of 
cardiac muscle contract ion.  t mul tiple s i te wi th in thi network the membrane 
flatten and i '  t ight ly pre ed agai n t T-lubule to foml terminal ci ternae SR 
ci  temae) .  Ca
2+ i re lea ed  from the  S R  v ia the  Ca2+ channel cal led the  ryanodine 
receptor (RYR) .  Three different RYRs ha e been identified i n  mammal ian ti ue 
i ncluding RYR J .  RYR2 and RYR3.  RYR2 the  predominant form in cardiac 
m u  cleo  The relationsh ip between T-tubu le  and RYR2 receptor 
proce ' of excitation-contraction coupl i ng ( E-C coupl ing) [ 6 ] .  
cri t i  cal to the 
Adjacent myocyte are held together by pec ial i zed cell to ce l l  junction cal led 
i ntercalated d isc ( lCD) .  The ICDs provide mechanical and e lectrical connection 
between cardiac myocyte . A long the longi tudinal part of the ICD . the aJcolemma 
of adjacent myocyte come into c lose prox imi ty and fu e at valious place to form 
gap junction . which pro ide low-re i tance pathway to allow the pread of cardiac 
i mpul  es between myocyte [ 7 ] .  Gap j unctions in the heart are compo ed of connexin 
protei n . There are three major connexi n  i otypes in cardiac mu cle;  connex in  .+3 
(CX'+3) .  connexin  '+S and connexin -+0. CX.+3 i s  the most promi nent i n  mammal ian 
cardiac mu c le  [ 8- 1 1 ] . 
The contract i le capabi l i t ie  of myocytes have to be generated i n  a h ighly ynchronou 
fa hion to produce an efficient heartbeat . This requ ire both the i n i ti ation and orderly 
pread of the wave of e lectrical act i vation from one myocyte to the next, throughout 
the heart . The e lectrical acti vat ion of the myocyte i known a the action potent ial  
(AP).  The AP i mediated by equences of opening and c lo ing ion channels and 
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re�ult i n  hange. in the membrane potential ( Em) .  In the re t ing tate the membrane 
pOlen tial range' from -60 1 -90 m . Compared to the extracel l u lar compartment. the 
I ntracel lu lar compartment i negat ively charged. Thi i an e ential phy iologic 
condi t ion that fa i l i tale the diffusion of ion acro the membrane down their 
concentrat ion gradient and generate a potent ial d ifference that counteract the 
di ffu ion and determine the e lectrochemical equ i l i brium according to the ern t 
equati n [ 1 2 ] .  
P differ from one region o f  the heart t o  another depending o n  the cel l  type . I n  
general AP can be c I a  s iRed i nto two type : pacemaker and non-pacemaker APs. 
Pacemaker cell are primari ly located in the SA and A V nod of the heart and have 
pacemaker potent ial that depolarize pontaneously towards threshold .  Non­
pacemaker APs found throughout the heart except in the nodal region and are 
characteri zed by fa t respon e wi th fa t depolarizat ion rate. 
A typical entricu lar myocyte AP la ts for 200-300 m ( species dependent) and ha 5 
equential pha e 0-'+ ( Figure 1 .2 ) .  Phase -+ i s  where the rest ing membrane potentia l  i 
approximately -90 mY.  Th i i attributed main ly to the selective permeab i l i ty of the 
cell membrane to K+. e pecia l ly i nward rect ifying K+ ( K1R) ,  and the concentration 
gradient  for K+ that ex i st s  across the cell membrane clo e to the Nern t equ i l ibri um 
potential for K+ (EK) [3 ,  1 3 . 1 '+ ] .  Upon arrival of suprathre hold e lectrical t imu l i .  the 
membrane pem1eab i l i ty to K+ decrea es and vol tage-gated Na+ channel (VGSC ) 
open al lowing a l arge i nflux  of Na+ current ( I  a) i nto the cel l ,  driv ing the Em toward 
the aT equ i l ibri um potent ial ( ENa) and producing rapid depolarization from -90 m V 
to + 1 0 m V (Pha e 0) [ 1 5 ] .  Phase 1 i s  a brief repolarizat ion during which transient 
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outward K+ ( Ito) channel <,  are opened and there i an outv. ard flO\ of K� current OK). 
producIng a lran ient sh i ft of the Em to approx imate ly  0 mY [ 1 6] .  Pha e :2  la t for 
1 00-200 m'  and i i n i t iated by opening  of low L-type Ca::>+ channel to produce the 
plateau phase of the AP. Duri ng Pha e 3 Ca::>+ channel s are i nactivated. whi le the 
del a ed rect ifier K+ channel activate and conduct I K in the outward direct ion .  
Final l . K I R  channel .  re-open duri ng Pha e -+ of  the  AP [ 1 5 ] .  
There i '  a ·trong a sociation between the AP and cardiac mu c le  contraction . Rapid 
depolarization precedes the development of force whi le  peak force occur toward the 
end of repolarization . Relaxation of the muscle usual l y  occur during Pha e 4 .  The 
event of mu de contraction proceed in para l le l  to the event of the AP. 
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Figure 1 . 2 :  Ventricu lar act ion potent ial . The ventricu lar act ion potential i generated 
mai nl y  by i nward ( a+ and Ca::!+ ). and outward ( K+) tran membrane ion currents .  
umber (O-�) denote the d ifferent  pha e of the ventricu lar action potent ial . Phase 0 
i depolarizat ion. Pha e 1 i s  fa t repolari zat ion,  Phase 2 plateau . Phase 3 i 
repolarization and Pha e -+ i the re t i ng pha e of the act ion potential . The i ndividual 
ionic membrane currents  and their t ime course are i l 1 u strated . Modified from 
Hoek tra et  al. 20 1 2  [ 1 7 ] .  
1 . 1 .2.  Ionic  ba i of the action potential  
1 . 1 .2. 1 Voltage-ga ted a+ chann el 
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Hodgkin  and Hu  · Iey were the fir t to characteri ze the VGSC by record ing  k u i na  � 1'1; 3 b 
V I tage clamp  technique . The demon trated three key feature of VGSC ; vol tage-
dependent act ivation, rapid inacti ation and elective ion conductance [ 1 8 ] .  In the 
pa�t 60 year , the mea urement of ion flu , channel affi n i ty binding and protein 
puri fication of VG C ha e been progre i e ly analyzed and studied. The VGSC are 
re ponsible for the rapid depolari zation ( Pha e 0) of AP of the exci table cell , 
i nc luding nerve. mu de and neuroendocri ne cel l . It play a crucial role i n  the 
propagation of AP and al 0 help determ i ne the duration of the AP. For example i n  
cardiac myocyte . orne a,, 1 .5 channel ( subtype of  VGSC which i h ighly 
e ' pre ed i n  the heart) may reopen during the plateau phase generat ing late i nward 
current [ 1 9 ] .  
The VGSC tructure (Figure 1 .3 )  consist of a pore forming ubun i t  a ( 260 kDa) 
a ociated with an aux i l i ary � subuni t  ( 30-35 kDa). The a ubunit is requ ired for 
channel function ( current conductance) wh i le  the � subuni t  i responsible for k inetics 
and voltage dependence of channel gat ing.  and is i nvolved in channel local izat ion and 
i n teract ion w i th variou extracel lu lar and intrace l l u l ar components. Four � ubunits 
ha e been found encoded in the human genome . VGSC i n  adu l t  central nervous 
sy tern and heart contain � I through �4 ubuni t  . where as only �J ubuni t  i ex pres ed 
in adu l t  skeletal mu c1e [ 1 9, 20 ] .  The a subun i t  consi t of four homologou domai n 
( I - IV). each con i ts of s ix  tran membrane a helice egment (S 1 -S6) .  The S4 
segment in each domain have posi t ive ly charged amino acid  re i dues at every third 
1 0  
PO., i l ion .  The. e re�idue erve a gat ing charge ' to i n i t iate channel acti vat ion duri na to> 
membrane depolari zat ion . The i ntrace l l ular loop connect ing homologou domain I I I  
and I sen e a the i nacti vat ion gate fold ing i nto the channel tructure and blocking 
the pore from the inside. The p ubuni t  i s  one tran membrane egment protei n  with a 
l arge -term inal e tracel l u lar domai n and a hort C-terminal i ntracel lular egment 
[ 1 9 ] .  
m e  mammal ian VGSC have been ident i fied ( av 1 . 1 -Na 1 .9 ) .  The e are 
functionall expre 'ed with > 50� homology in  ammo acid equence m the 
tran. membrane and extracel lu lar domains [ 1 9, 2 1 ] . a\l 1 .5 ubtype i found i n  
card iac myocyte, [ 22 .  23 ] .  
GSC are a i te of act ion for d ifferent pharmacological agent . For example. 
antiarrhythmic  drug and local ane thetics act a VGSC blockers, whi le veratrid in .  
batrachotoxi n  and aconi t i ne act a VGSC acti vator [ 2 1 ] .  M utation i n  SeNSA , the 
gene that encode card iac a 1 .5 ha been hown to be i nvolved i n  many d ifferent 
cardiac e lectri cal d i sorders i nc lud ing ,  B rugada syndrome CBS) , long QT syndrome, 
i diopath ic  ventri cular fibri l lat ion and complex phenotype of venrtri cular 
arrhythmias and di lat ive cardiomyopathy [ 2.+-26] .  
1 1 
a-subuni t  I N av 1 .5 �-subunit 1 -4 
l i nker loop 3 eOOH 
l i nker loop 2 
l i nker loop 1 eOOH 
Figure 1 . 3 :  S tructure of vol tage-gated Na
+ channel . The a and � ubunits of the Na+ 
channel are i l lus trated . Roman numeral i ndicate the a ubuni t  domain ; egments 5 
and 6 are the pore- l i n i ng egment and the S4 hel ice make up the vol tage en or . 
Adapted from Abrie l  2007 [ 27 ] .  
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1 . 1 .2 .2  Vol tage-gated a2+ chan nel 
Voltage-gated Ca2+ channel (VGCC ) were fir t i dent ified by Fan and Katz in 1 953 
[ � ] .  G C �  are the key i gnal tran ducer of membrane potent ial .  They have the 
abi l i t  to  convert the  electri cal i gnal of  an  AP i nto an in tracel lu lar Ca2+ transient and 
thu i n i t iate and regu late man phy iological proces e . I n  many di fferent cel l type , 
VGCCs mediate entry of Ca2+ CUITent  ( lea) which i n  turn can in i t iate honnone 
.... ecret ion or ynapti lran mi s ion and al 0 regulate enzyme act iv ity. gene expre ion, 
and other b iochemical act iv i t ies [ 29-32 ] . Acti at ion of VGCC in cardiac myocytes 
i n i t i ate and regulate contract ion through the proce of E-C coupl ing [ 3 3 ] .  
GCC are c Ia  i fi ed according to  their pharmacological and biophy ical propertie 
(act i vation threshold . conductance. and i nact i vat ion t ime)  i n to everal functional 
channel t pe inc luding T-type. L-type. Ltype. P/Q-type, and R-type . T-type open at 
low membrane potential and i nactivate very rapid ly .  R-type open wi th i n termediate 
membrane potent ial whi le  L-type open at high membrane potent ials with low 
i nact i  vat ion [ 34, 3 5 ] .  The e ubtype are c Ia i fied as fol low . Cav I . I -Cav 1 A, 
Cav� . 1 -Cav2 .3  and Ca 3 . 1 -Ca 3.3 [ 36-38 ] .  
I n  cardiac muscle. both L-type Ca
2+ channels ( long l a  t ing/ subtypes Cav 1 . 1 ,  Cav ] .2 ,  
Cay 1 .3 and Cav I A ) and T-type Ca
:!+ channel ( transient/subtype Cav3 . 1 .  Ca 3 .2  
and Cav3 .3 )  play an  important role i n  cardiac myocyte contraction and automat ic i ty 
[ 1 5 ] .  I n  the heart. L-type Ca
:'+ currents and T-type Ca2
+ CUITents are mediated by 
Cay 1 .2 and Cav3 .2  type of the a 1  ubun i t ,  re pect i vely [ 39 . 40] .  
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VGCC'i are a complex of five ubunit  , named a 1 .  a2, p .  y. and 8 ( Fi gure 1 .4 ) .  The a 1  
... ubunit  con i t · of four repeated domai n ( I- IV )  Vv i th each contain ing l X  
tran'imembrane segment . The a l  ubunit  i a voltage e n  or which i re pon ible for 
the Ca2+ current conductance [ 35 ,  4 1 ] . 
n l ike VGSC , the p ubunit of VGCC i i ntracel l u lar a hel ices [ 42 ] .  The a2 and 8 
ubuni ts  form an extrace l l u lar di u lfi de-l i nked a28 dimer. Co-expre ion of the p 
subunit  and a28 dimer enhance the expres ion and modulates the vol tage 
dependence and k inetic of gat ing [ 38 . 43,  .:+4 ] .  The y ubunit i a glycoprote in with 
four trammembrane egment [-1-5 ] .  Puri fi cation of different VGCC howed that y 
'ubun i t '  were not e pre ed i n  some t i  ue  depending on the VGCC types. L-type 
Ca2+ channel in cardiac myocyte are a ociated with a I ,  p. and a28 but not y 
subunit  [ 46 1 .  Three d ifferent  a l  ubunits have been identified by cD A cloning and 
functional e pre ion in mammal ian cel l or Xenopoll oocyte [ 47 , 48 ] .  In addit ion, 
i ndiv idual a 1  subuni t  types are a ociated wi th mult iple types of p subun i ts or a28 
dimers produc ing different sh ifts in the k inetic , vol tage dependence of gating and/or 
level of functional expre ion of di fferent a l  ubuni ts .  
In the c l i n ical ett i ng.  numerou drug that are u ed i n  the therapy of cardiovascu lar 
d isea e act by mediati ng the function of L-type Ca2+ channels .  These drugs are 
thought to act at three eparate but al losterical l y  coupled receptor i te . 
Phenylalkylamine ( uch a verapami l )  b lock the L type Ca2+ channel by b inding to 
the receptor that are found i n  the S6 egments i n  domains I I I  and TV  [ 49, SO] . 
Dihydropyridines act as L-type Ca
::!+ channel act ivator or inh ib i tors by binding to the 
receptor in S5 segment of the domain I I I  and in S6 egments in domains I I I  and TV  
[ 5 1 ] .  A third receptor � i te VI, hich i targeted b the benzothiazepine 
overlap with the phen Ja lkylamine receptor [ -+6 ] .  
1 .+  
thought to 
L-type Ca2+ channelopalh ie are i nvoJ ed in the pathogene is of variou cardiac 
di ea ... e . .  Ti mothy syndrome (T ) i an i nheri ted arrhythmogenic di order that i 
l i nked to mutation of the cardiac L-type Ca2+ channel [ 5 2 ] .  Down regulation of L­
type Ca:!+ channel are found to be a contri butory factor for atria l  fibri l lation [ 5 3 ] .  
Mutation o f  the L-type Ca
:!+ channel and their p ubunit  have been reported in BS.  a 
d i�ea. e which i characterized by a horter QT- interval [ 5'+ ] .  




Figure I A :  Structure of the vol tage-gated Ca2+ channel .  The a, B, y and a:!b ubunit  
of the voltage gated Ca�+ channel i i l l u  trated. Roman numeral ( I - IV )  i ndicate the 
domain of a ubun i t :  segment 5 and 6 are the pore- l i n i ng egment and the S4 
hel ice make up the vol tage en or . Adapted from Lehmann-Horn & lurkat-Rott 
1 999 [ 5 5 ] .  
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1 . 1 .2.3 L-t. pe Ca2+ channel and exci tation con t raction cou pl ing 
�+ The L-lype Ca- channel and lea have a fundamental role i n  in i t iat i ng cardiac myocyte 
E-C coupl ing ( Figure 1 .5 ) . Thi. an be defi ned a the proce b which an electrical 
. li mulus i con erred i nto a mechan ical re pon 'e .  
Arrival of an AP au e conformational change that lead to the opening of the a l  
. 
f 
'+ '+ :ubunl t  pore 0 the L-type Ca- channel and Ca- cunent enter the cyto 01 down i t  
eleclroch mi  a l  gradient .  Thi  smal l  i nward flow of Ca2+ current bind to RYR2 and 
triggers a large relea e of Ca2+ from the SR in to the cyto 01 by a proce s known a 
calc ium- induced calc ium relea e (CICR)  [ 33 .  56 ] .  The concentrat ion of i ntracel l u lar 
free Ca2+ i ncrea e 1 O-fold from 1 00 nM at re t to about I � M  [ 33 .  -+6] .  Thi s  i ncrea e 
of i ntracel l u l ar Ca2+ i known as the Ca2+ tran ient .  The Ca2+ bind to TnC which 
au e confOImational change which i n  turn relea e TnI from act i n  and faci l i tate 
myo in and act in  cro s-bridge interaction to produce cardiac mu cle contract ion. For 
relaxation to occur. Ca2+ must be removed from the cyto 0 1 .  Ca2+ i s  taken up i nto the 
SR via the S R  Ca2+ -ATPa e (SERCA) [ 3 3 ,  57 ] and effluxed from the cell primari ly 
on the la+/Ca2+ exchange ( removes approx imately the ame amount of Ca2+ that 
'+ C 
'+ entered the cel l  through L-type Ca- channel ) [ 1 4, 58-60 ] .  To a smaller extent a-
rna al 0 be tran ported out of the cel l by the sarcolemmal Ca
2+ - ATPase and taken 
up i nto the m i tochondria by the Ca2+ un iporter [ 1 4 . 33 ,  5 8 ] .  
The ampl i tude and duration of the Ca
2+ tran ient and the e n  i t iv i ty o f  the 
myofilaments to Ca
2+ are known to be important regulators of muscle contract ion .  
The mo t i mportant detemli nants of the ampl i tude of the Ca
2+ transient are the Ca2+ 
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content of the S R  and the amount of Ca�'" that enter the cyto 01 via the L-type 
a2+ channe l .  
The Ca:!+ content of the R i dependent on the amount of Ca"+ that i pumbed from 
the c to 01 i n to the SR  duri ng relaxation. Therefore.  decrea ed uptake of Ca"+ by the 
SR decrea e the ampli tude of Ca"+ tran ient and mu cle contraction [ 6 1 . 62 ] .  
RyR 
SR l-type Sarcoplasmic 
Ca2+ Ca2
+ reticulum (SR) 
channel Cal. Slores 
ATP 
SERCA 
Ca2+ sparks T·tubule 
ca2• sgn t 
I Contraction I Rela xation 
Figure 1 .5 :  Excitat ion-contraction coupl ing.  Ca2+ entry v ia  L-type Ca2+ channels 
cau e the relea e of Ca2+ from the SR via rayanodine receptor ( RyR)  re ult ing in the 
generation of a Ca
1+ tran ient and mu cIe contract ion. Relaxation occur when the 
Ca2+ i s  pumped back i nto the SR by the S ERCA pump and effl uxed from the myocyte 
by the CX ( a+/Ca1+ exchanger) .  Adapted and modified from 
http ://www. rudyblue .com/note /note/n/chapter- 1 4-cardiova cular-
phy iology/deck/9845939 
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1 . 1 .2.4 Pota i u m  chan nel 
\ ariety of K+ channel ' function ei ther to maintain the re l ing potential near the EK 
or lO repolari ze the P [ 63 ] .  K+ channel are broadly  cIa i fied on the ba i of their 
function, molecu lar structure, and electrical propert ie , Wi th in  the heart .  the major 
la'>se, of vol tage-gated K+ channel ( VGPCs) are KIR and leak channels .  The aried 
expre 'sion of K+ channel contributes to the ariabi l i ty of AP morphology in different 
region of the heart [ 6--1. ] .  
The VGPCs i nc lude the rapidly act ivati ng and i nact ivat ing Ito and the delayed 
outward rect ifi er i nc lud ing the u l trarapid  ( IKur) , rapid ( l Kr) and low ( I K.,) K+ 
channel . Structural ly  VGPCs ( Figure 1 .6)  are very im i l ar to the VGSC , however. 
the channel pore ubunit  i a heteromult imeric complex of four a-subuni ts  (each a-
ubuni t  i composed of four domai n ( I - IV) .  each domain contain ing l X  
tran membrane egment ( S l -S6) i n  tead of  one i ngle a-subunit a s  i found 11l 
VGSC . The e channel pore ubuni t  are covalent ly attached to a regulatory �­
ubuni t .  
Ito i a brief tran ient  current  which i s  act i vated during the early pha e of AP 
repolarization [65 ] .  I t  wa fir t de  cribed a an early outward current  i n  heep 
purk i nje fiber [ 66 ] .  Sub  equent work ident ified the presence of Ito in most heart 
t i s  ue inc luding ventric le , atri a, and in SA and AV nodes. [67-70] . 
Several studies have classifi ed Ito according to their recovery kinetics i nto fa t Ito ( Ito.f) 
and slow Ito ( Ito.', )  [ 7 1 ] . Molecular tudie on cardi ac t issue have revealed di t i nct Ito 
ubfami l i e  . Kv4.2 and Kv4.3 encode ItoJ and Kv4. 1 encode Ito . ., channels .  [72-74] 
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I Kur• I Kr and J K, are involved i n  late pha e of repolari zation ( Pha e 3 ) . The channel 
open equenl ia l ly at membrane p tential near to + 1 0  to +20 mY. They differ from 
ea h other based on their act i vation/i nacti ation k inetic . phannacological en i t iv i t  
and conductance [ 6'+.  75 ] .  
I Ku, h a  a very rapid acti ation and i encoded b y  KCNA5. which i s  e pre ed in the 
atri um more than 1 11 the ventric le .  It i more electi ve to the K+ blocker .+_ 
ami nopy rid ine ( .+- P) than ei ther I Kr or I K,. howe er. i t  i relat ively i nsen i t ive to 
tetraeth larnmonium (TEA).  barium ( Ba+ ) and cIa s I I I  ant ianhythmics of the 
methanesulfonan i l ide group [ 76-80 ] .  
A ubuni t  o f  I Kr encoded b y  KC H2 i act ivated and i nactivated rapidly [ 8 1 ] .  ha  a 
l arge Ingle channel conductance . It i selectively blocked by cIa s I I I  ant iarrhythmic 
of the methane u lfonani l ide group. IK,  i s  the dominant repolar iz ing current .  It has a 
maIler channel conductance with low act ivation and inactivation kinet ic . A ubunit  
of IK i encoded by KCNQ l [ 82 ]  . 
Col lectively, the level of expre ion of the three ubtype of the delayed rect ifier K+ 
channel  i s  greater i n  atri um than the ventri cle and th is  i s  explai ned by the horter AP 
i n  atria compared to ventri cles.  
I n  physiological and pathological condit ion . consideration should be taken that the 
role of VGPCs on cardiac function mu t be i ntegrated in the context of the other ion 
channel . For example. i n  some heart d i  ea e there i s  a reduction i n  I to  den i ty and 
con equently a delay in the rate of early repoJari zation, which may lead to a reduction 
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I n  L-type Ca2-t- current and decrea e i n  relea e of Ca2+ from the SR which in  tum 
exacerbale� impaired Ca2+ homeo ta�i in the heart [ 65 ,  3 ] . 
The K'R hanneb including K-t- inward rect ifier (K , ) . acetylchol ine en i t i ve K+ 
channel (KACh) and ATP en i l ive K+ channel (KATP) contri bute to the late rage of 
reploraizat ion and pIa an i mportant role i n  etti ng the re t ing potential close to EK 
The tructure of K'R ontains t\ 0 tran membrane domain ( M l and M2) connected 
by a pore and i ntrace l lu lar - and C-termin i  [ 63 .  6-1-, 75 .  8-1-] ,  and KJ is expre sed 
more in ventric le than in atri um [ 85 ] .  
The I KAch channel regulates heart rate (HR)  and conduction i n  respon e to ACh wh ich 
i relea�ed from the cardiac para ympathetic nerves. Fol lowing the b ind ing of ACh to 
the mu carin ic  M 2  receptor. the GP8 ubunit  of G-protei n  receptor interact d irectly 
with the cytopla mic - and C- termin i  of KAch channel and activate the channel . 
When these channel are acti vated. the membrane of the myocyte i hyperpol ari zed. 
and thi i a re ult of the slow rate of spontaneou depolarization .  The KAch are 
distri buted primari ly i n  SA and A V nodes and atrial myocyte [ 64 ] .  
KATP channels respond to change 111 the metabol ic tate o f  the myocyte and 
i ntrace l lu lar A TP concentrat ion .  Ba  ed on their molecular propert ie , two di sti nct 
ubt pe have been de cri bed in the heart . One i s  local ized in the arcolemmal 
membrane, whi le the second is local ized in the mi tochondrial membrane .  The e 
channel are activated during cell stre s when the ATP/ ADP ratio i s  al tered and 
provide l arge conductance of IK. B lockers of the e channels, for example sulfonylurea 
agents are used i n  treatment of type two diabetes mel l i tu  (T2DM) .  
') ')  
The K+ ... elect i \  e channel are important i n  the gene is  of  everal atrial and ventricular 
alThythmia . Dy regulation of rIO ha a) 0 been po tu lated to play a pivotal role i n  BS .  
LQT t pe  1 and type 2 yndrome have been reported w i th  abnormal j t ie  I n  gene 
encodmg I I\., (KC Q l )  and T Kr ( KC H2) re pect ively. 
a 
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Figure 1 .6 :  S tructure of pota s ium channels. (a) Voltage-gated K+ channel . The a 
ubuni t  i a i x- transmembrane domain one-pare-region of a tetrameric complex four 
compri i ng ex. ubunit . (b) Inward-rectifyi ng K+ channel (KIR) .  The ex. ubunit  i two 
membrane domain one-pare-region of tetrameric complex of four ex. ubuni t . 
Modified from Tamargo et al . 200-1- [ 86 ] .  
1 . 1 .3 onducti ol1 y tern of the heart 
The heart ha a pecia J ized conduction y tern which fac i l i tate electrical excitation in 
an orderly and , equential manner during each cardiac cycle. AP generated in the SA 
node. ,pread i nto the atria and the A V node. via the A V bundle ( Bundle of Hi ). to 
the Bundle branche ( i nterventricular eptum).  to the Purkinje fiber and the 
ventricles .  The ,pread of conduction varie in d ifferent regions of the heart . The 
conduction i� ery low in the A V node and thi plays an important role in t iming 
atrial and ventricu lar y tole .  Conduction i very rapid i n  the A V bundle.  Bundle 
branche, and Purkinje fiber . the rapid conduction in the e fiber coordinate 
e lectrical acti at ion of the ventricle and therefore the synchrony needed for efficient 
entricu lar function [ 87 . 8 8 ] .  
The conduction o f  e lectrical acti i ty i n  the heart a l  0 depend o n  current flow 
between adjacent myocyte ( longitudinal conduct ion) .  Gap j unction proteins (main ly  
CX ) provide low re i tance electrical pathway between adjacent myocyte that are 
e 'ential for propagation of electrical impulse throughout the heart [ 87 ] .  Electrical 
act iv i ty of the heart i commonly recorded by an array of electrode placed on the 
body urface and the re u l t ing voltage trace is called an electrocardiogram ( ECG). 
The normal ECG repre ent a erie of waves i nc luding P. QRS and T and typical ly  
each ECG record l a  t for 800 m ( Figure 1 .7 ) .  The e wave i ni t ia l ly have been 
identified by the father of the ECG. E inthoven Wi l lem [ 89 ] .  The P-wave i the fir t 
upward deflection and indicates atrial depolari zation . The QRS complex normal ly 
begin with a downward deflect ion (Q) which represent depolari zat ion of the ba al 
port ion of i nterventricu lar eptum.  The l arge upward deflection (R )  represents 
depolari zation of the apical portion of the in terventricu lar eptum and ventricle and 
the do\\ nward ( S )  repre ent depolarization of the basal port ion of the ventricle . The 
QR comple col lecti vely repre, ent ventricular depolari zat ion . The T wave 
normall  a small  upward deOection and repre ent ventricu lar repolaJizat ion.  
The P-R i n terval i s  the durat ion between the on et of P wave and the on et of the Q 
v, ave. which i gn i fi e  atrial  depolari zation and conduct ion of impulse through the 
node. The Q-T in terval i the durat ion between the on et of the Q-wave and the 
end of the T-wave. Thi s  i nterval repre ent a ful l  ventri cle cycle i ncluding ventricular 
depolari zation and repolari zal ion .  
The ECG can al '0 pro ide ariou econdary measurement of heart function. For 
example heart rate ari abi l i ty ( H RV) ,  which i the ariat ion of beat to beat i nterval , 
can be mea ured from the ECG. Analy i s  of HRV can be u ed to a e 
ympatho\ agal funct ion .  
The c l in ical  ign ifi cance of the ECG recordi ng i i n  i t  use to d iagno e a variety of 
card iac pathologjes [ 90 ] ,  For example, when the ampl i tude of the P-wave i e levated 
th i  may repre ent right atrial hypertrophy. If  th is  i accompanied by a broad based P­
wave th i  may i nd icate left atrial hypertrophy or d i latat ion .  When the P-wave i 
ab ent or i nvel1ed th i  may ugge t atrial fibli l lation .  I n  Bundle branch block QRS is  
prolonged or deformed. I f  the T-wave is  ta l l  and broad ba ed with s l ight  asymmetry, 
thi may predict acute myocard ial i schemia .  The P-R in terval i prolonged i n  
bradycardi a  and first degree heart block. and shortened i n  tachychard ia. Prolonged Q­
T i nterval is a soci ated wi  th myocardial  infarction and atrial fi bri l lat ion [ 9 1 ] . 
26 
Abnormal i t ie  of HRV have been . hown to be a 0 ialed wi th an i ncreased ri k of 












Figure 1 . 7 :  om1al electrocardiogram. The P-wave repre ents atrial depolari zation, P­
R i nterval repre ent atrial repolarizat ion,  QRS complex represents ventricular 
depolari zat ion.  The period between S and T wave ( S -T egment) repre ent 
ventlicular repolarization . QT i nterval represents the t ime between ventricular 
depolari zation and repolarizt ion and the R-R interval repre ent heart rate ( t ime 
between beat ). Modified from A heley & iebauer 2004 [92 ]  
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1 .2 Diabete mel l i tu  
1 .2. 1 H i  torical backgrou nd of  d iabete mel l i tu  
Oiabete. meJ l i tu  (OM)  i a heterogeneou group of metabol ic di order re u l t ino- from I:> 
a fai l i ng  i n  i n  u l i n  ecret ion, i n  'u l i n  act ion,  or  both . In  u l i n  deficiency lead to  chronic 
hyperg1ycaemia wi th d i  turbance of carbohydrate . fat and protei n  metabol i m [ 93 ] .  
3500 lear ago an Egyptian phy i ci an de cribed a di ea e that cau ed pat ient to 10 e 
weight rapidl} and uri nate frequent ly .  Later the ancient Greek de cribed the di ease a 
"a melt ing down of the fle h and l imb i nto uri ne", By 1 798 John Rollo recognized 
exces ugar in the blood a well a the urine. Diabete come from the Greek word for 
" pipe- l ike or ' iphon" and de cribe pat ient who pa exce ive amount of uri ne. 
Mel l i tu  i Lat i n  for "honey- weet" and i a de cription of the weetness of the patient ' s  
urine. I n  the middle o f  the n i neteenth century the l i nk between the pancreas and DM 
was i dent ified.  I n  1 889 M ikow ki  and Von Meri ng showed that pancreatectomy i n  dog 
cau ed a tate of polyuri a .  As oon as the l i nk between the pancreas and diabetes was 
recognized. re earcher focu ed on treat ing diabete with pancreat ic  extracts .  Wi th in  a 
year of the first ucces ful pancreatic extract ion, i n  u l i n  was suffi ciently puri fied for 
therapeut ic admin i  trat ion to pat ient wi th DM . Chemical ident ification of i n  u l i n  was 
reported by Abel i n  1 926. At present ,  more than 300 i n  u l i n  analogue have been 
ident ified. inc luding about 70 animal .  80 chemical ly  modified. and 1 50 bio ynthetic 
in uEn preparation . As drug treatments were bei ng developed i t  was also i ncreasingly 
recognized that diet  had an i mportant role to play in DM. Oral hypoglycemic  agent , 
developed over the l ast 50 year . have been the primary mode of treatment for type 2 
d iabete mel l i tus  (T20M) .  
1 .2 .2  E pidemiology of diabete mel l i tu  
DM is  a . eriou global health problem. Currentl there are more than 300 mi l l ion 
people uffering  from DM worldwide. A further i ncrea e of almo t 50% of diabetj c  
cases i s  ant icipated by  the year 2025 [ 9-+-96 ] .  Worldwide rates of  DM are imi lar i n  
men  and \ omen. al though they are s l ight ly h igher i n  men < 60 year of  age and i n  
women > 65 year of age . DM i now recogn ized a one of the top ten leading cau e of 
death i n  adul t . In  �O l l  DM cau ed 4.6 mi l l ion deaths worldwide according to the 
In ternational Diabete Federat ion ( IDF) .  In  the Uni ted Arab Emirate (UAE) 
epidemiological tudie ha e hown that DM i a eriou and wor ening medical 
problem. The prevalence of DM i n  the UAE i among the h ighe t in the world .  The 
h ighe t prevalence is found in the population of the Pac ific  i land of auru [ 95 ] .  In  
2005 the reported prevalence of DM i n  UAE c i t izen was 25% ri ing to ..J.O% after the 
age of 55 [ 97 ] .  Limi ted UAE regional data ugge t that the prevalence of DM in 1 995 
wa only 6% [ 98 ] .  
1 .2.3 Diagnostic criteria for d iabetes mel l i tus 
The diagno t ic criteria and cIa i fication of diabete was fir t propo ed by the World 
Health Organization ( WHO) in 1 965 . Thereafter, frequent modification were appl ied 
by different national and i nternat ional organizat ion and expert group inc luding the 
National Diabetes Data Group (NDDG) .  IDF  and the American Diabete A ociation 
(ADA).  The current  WHO gu idel i nes are based on one of three cri teria: fa t i ng blood 
g lucose. abnormal oral g luco e tolerance test (OGTT) and hemoglobi n A l  C (HbA 1 C )  
(Table ! . ! ) . The c l a  i c  feature of  DM i nc lude polyuria, polyphagia, polydipsia and 
unexplained weight 10 however. other features may also exist i ncluding fat igue. 
blurred v i  ion, frequent infections, poor wound heal i ng .  dry i tchy k in  and numbne � 
and t i ng l ing i n  hand . leg and feet .  In 2003, the ADA. expert commi ttee on the 
d iae:no i. and cIa ifi cation of DM recommended loweri ng the thre hold for fa t in a � � e 
blood gluco e from 6. 1 mM ( 1 1 0  mg/d l )  lo 5 .6 mM ( 1 00 mgldl ) .  
Table 1 . 1 :  Diabete d iagno t i c  criteria 
Cond it ion 2 hou r gluco e Fa t i n g  glucose H bA l c  % 
m M  ( m g/dO mM ( mg/d] )  
Normal � 7 . 8  (� 1 40) �6. 1 (� 1 1 0) �6.0 
Impai red fa t ing � 7 . 8  (� 1 40) � 6 . 1 ( � 1 1 0)  & � 6.0-6.4 
glycaemia 7 .0 ( � 1 26 )  
Impai red gluco e �7.8 (� 1 40) �7 .0(� 1 26) 6.0-6.4 
tolerance &� I I . l  (�200) 
Diabete mel l i tu � 1 1 . 1  (�200) �7 .0(� 1 26) �6.5  
Defi n i t ion and d iagno i of diabete mel l i tus  and i ntermediate hyperglycemia:  Report of 
WHO/IDF con u l tat ion. 2006, Geneva 
1 .2.4 Pre-d iabete tage ( i ntermed iate hypergJ caemi a)  
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The HO defi ne impai red fa t ing gluco e a a fa t ing pIa rna gluco'e l evel of 2: 6 . 1 
m M  and :s 7 m M  and impaired gluco e tolerance a 2 hour plasma gluco e, po t gluco e 
chal lenge of 2: 7 .8  to :s 1 J . 1  mM .  If the g lu  0 e Ie el do not meet the criteria for 
diabete , yet are h igher than tho e considered normal , those people would be cIa i fied 
a pre-diabetic [ 99 .  1 00 ] .  Th i tate i nd icate the relat ively high ri k for future 
development of T2DM.  Ac ording to the ADA expert paneL 70% of individuals with 
pre-diabete. w i l l  progre ' to diabete wi th in  1 0  years of on et [ 1 0 1 . 1 02 ] .  Pre-diabete 
i a sociated wi th  the s imul taneou pre ence of in u l i n  re i tance and pancreatic beta 
cel l  dy function that tart before gl uco e level change are detectable .  Pre-diabetes 
begin wi th  an accumulation of exce free fatty acid in adipose t i  ue. as well a non­
adipo'e t i  'ue uch a I i  er. mu  cle o  and pancreas (v i  ceral fat accumulation ) .  The 
depo�i tion of vi ceral fat i nduce the rel ease of pro- inflammatory adipocytokine such 
a tumor necro i s  factor-a (TNFa) ,  in terleuki n-6 ( I L-6). lept in  and macrophage 
migration i nh ib i tor factor. which i n  tum lead to decreased insul i n  en i t iv i ty [ 1 03 ] .  As 
indicated from large randomized c 1 in ical tria ls .  appropriate l i fe tyle modification and 
pharmacologic i ntervent ion i n  i nd iv iduals with pre-diabete have the potential to delay 
or even pre ent development of T2D M .  
1 .2.5 Class ification o f  d iabetes mel l i t us 
1 .2.5. 1 Type 1 Diabetes mel l i t us 
Type 1 Diabete Mel l i tu  (T I  DM ) accounts for approximate ly  5% to  1 0% of a l l  case 
of diabetes . The inc idence rate i ncreases wi th ha i ng a first degree relative with T l  DM 
[ 1 O.+] .  Earl ier the di  ease wa known a in u l in  dependent diabetes mel l i tu  which i an 
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autoimmune d l  ea e cau i ng de<;truction of pancreat ic beta cel l  and an ab olute i n  ul in 
defi c iency [ 1 0 ) .  The beta cel l  mediated autoimmune de truction i thought to be 
triggered b an envir nmental event. uch as a v iral i nfection [ 1 06 ]  and genet ical ly 
deternl ined ,u cept ibi l i ty factor increase the ri k of u h autoimmune phenomena. The 
peak incidenc of T I  D occur i n  chi ldhood and adole cence . The on et general ly 
occur� before the age of 30 years , but may be diagno ed at  any age [ 1 07 ] .  
Epidemiological studie h a  e reported n o  ignifi cant gender difference i n  i ncidence 
among i ndi idual ' diagno ed before age I S  years. however, after the age of 25 year , 
there i a male exce i n  i ncidence [ 1 08 ] .  Type 1 diabetic i ndi iduals are 
characteri t ical ly of normal weight or th in  i n  tature. T I DM pat ients are absolutely 
dependent on e ogenou ly  admin i  tered i n  u l i n  for surv ival . In  the ab ence of insu l in  
treatment people with T I DM are h igh ly  prone to diabet ic ketoacido i ( DKA) [ J  09 ] .  
1 .2.5.2 Type 2 diabetes mel l i tus 
T2DM.  previou ly  cal led non-in ul in dependent diabetes mel l i tu  account for roughly 
90% of al l  affected i ndiv idual . The pathogene j of th i  form of diabetes i 
characterized by the fol lowing three pathologje : ( 1 )  peripheral re i tance to i n  u l i n :  (2)  
i ncrea ed production of glucose by the l i ver and (3)  al tered pancreatic insu l in  secretion 
[ 1 1 0, 1 1 1 ] . T2DM i often a ociated with a strong fami l ial ,  probably genetic 
predi po i t ion .  The major ri ks for developing T2DM are i ncreasing age, edentary l i fe 
style and obe i ty  [95 ,  1 09 .  1 1 2- 1 1 '+ ]  and of great concern i s  the recent i ncrease i n  
T2DM in  ch i ldren [ 1 1 5 ] .  80% to 90% o f  ca e are obese [ 1 1 6 ]  and obe i ty i tsel f add 
addi tional i n  u l i n  res i  tance which might  be alleviated by weight reduction. 
Furthermore, people with an i ncrea ed percentage of body fat d i stributed predomjnantly 
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in the abdominal region al 0 have an increa ed ri k for development of T2DM [ 1 1 2 . 
1 1 3 ] .  Hypertension and h igh blood chole terol are pathologlcal cond i t ions which al so 
can potent ial l )  i ncrea e the i nc iden e of T2DM [ 1 1 7 ] .  n l ike T l  DM.  type 2 diabetic 
pat ient do not requ ire e ogenou in u l i n  for urv ival i nce they t i l l  produce in u l i n .  A 
variel of oral pharmacological agent are u ed to maintain the blood gluco e level .  The 
mechani ms f act i  ne of the e pharmacological agent include reduction of insu l in  
re · j tance i n  the periphery. decrea ed hepatic gluco e product ion, decrea ed gut 
carboh drale ab orpt ion and promotion of pancreat ic  beta cell in u l i n  production . 
1 .2.5.3 Other peei fle types of d iabete mel l i tus 
Gee lational diabete mel l i tu (GDM account for about 3% to 1 0% of d iabetes which 
resemble' T2DM in man i fe rat ion and etiology. As i t s  name suggest , GDM first 
appear during pregnancy, commonly between 24 and 28 week of ge tat ion . It i 
propo ed that. homlone secreted by the placenta i ncluding e trogen ,  proge terone. 
growth homlone. cort i cotroph in -relea ing hormone and prolact in  decrease the function 
of in u l i n .  re u l t ing in h igh blood gluco e level . Treatment with dietary changes andlor 
drug ( u  ual ly  i n  u l i n )  can reduce the potent ial of perinatal compl ications. Al though 
b lood gluco e level u ual 1y  normal i ze after birth .  700/£ of women with GDM 
eventual l y  develop T2D M  [ 1 1 8 ] .  
Many genet ic  abnormal i t ies  are associated with an i ncreased i ncidence of DM. The e 
inc lude Wolfram' s  Syndrome (WS)  which i s  an autosomal rece ive di order. 
Polymorphi  m i n  W S  associated wi th T2DM i characterized by i n  u l i n  defic iency and 
ab ence of in u l i n  ecret ing cel l s  [ 1 1 9 , 1 20 ] .  Maturity-on et diabete of the young 
(MODY) refer to a monogenetic di order of beta cel l  dysfunction leading to 
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hyperglycemia  v.. h ich c ur before the age of 25 year . I t  i characterized by a low 
on. et of �ymptom inc luding keto i and i mpaired in u l i n  ecret ion [ 1 2 1 - 1 23 ] .  
Leprechaun i ..,m and the Rab on-Mendenhal l yndrome are two early on et d i  ease that 
have mutation i n  the i n  u l i n  receptor gene cau ing alterat ion i n  in  u l i n  receptor 
function and eventual ly  di turbance ' i n  blood gluco e homeo tas is  [ 1 2-1- .  1 25 ] .  I n  
addi t ion.  D 1 could be  econdary to  other pathological condi t ion uch a pancreat i t i  
or trauma. V i ru e a l  0 have a role in  caw; ing diabete by direct ly i nfect ing and 
de troying pancreatic beta cel l . Congen i tal rubel l a. cytomegaloviru or adenoviru e 
are mo:-t l i ke ly  to be i nvolved i n  the pathogenesi of diabete [ 1 26- 1 28 ] .  
1 .2.6 Pat hophysiological mechanism o f  ty pe 2 d iabetes mel l i t u  
The pathogene 'i of T2DM a mentioned ear1 ier ( ection 1 . 2 . 5 . 2 )  i characterized by the 
fol lowing three di order : ( I )  peripheral resi stance to in u l i n .  e pecia l ly in muscle cel l  ; 
(2 ) i ncrea ed production of gluco e by the l i ver and ( 3 )  al tered pancreatic i n  u l i n  
ecret ion. Phy  iologically. i n  u l i n  e l i c i ts i t  act ion by b inding and act ivat ing a pecific  
pla�ma membrane receptor wi th tyro ine k ina e activ i ty which lead to tran location of 
gluco e tran porter to the cel l  surface and uptake of g luco e .  
Obe i ty .  phy  ical i nact iv i ty and h igh  c irculati ng level of  a number of  inflammatory 
element such as cytok i ne trongly modulate i nsu l in  act ion in various body organ 
inc lud ing adipo e ti ue .  keletal m u  cle and l iver and may adver e ly affect the 
re pon e of i n  u l i n  receptors to circulated i n  u l i n .  Thi may alter the in u l i n  ignahng 
which in turn may lead to chronic  hyperglycemia. Furthermore. the beta cel l  
abnormal i t ies i nclude both reduced beta cel l rna . di rupt ions of beta cel l  function and 
reduced abi l i ty to secrete suffic ient  i nsul i n  to main tain gluco e homeo ta i s .  
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Hyperg lycemia di rupt organ function b increa i ng ox idati ve tre which can cau e 
tox i c  effect: through the production of peroxides and free radical that damage all 
component of the cel l ,  i nc lud ing prote i ns. l ipid . and D A and t i s  ue i nj ury [ 1 29 ] .  
1 .2 .7 Genetic factor i n fluencing type 2 diabete mel l i tu 
There i �trong e idence that T2DM i '  an inheri ted d i  ea e .  Thi i nherent u ceptib i l i ty 
ha been attributed to a complex genetic orig in .  The ri k of developing T2DM i 
approx imately 3 -4 t ime h igher among fir t degree relat ive of diabet ic ubjects 
compared to 'ubject wi thout a fami l  h i  tory o f  diabete [ 1 30 ] .  I n  2007 genome tudie 
demon trated the pre ence of different T2DM u cept ib i l i ty loci i n  different ethnic 
group . bout 1 1  predi po i t ion gene /loci ha e been ident ified [ 1 3 1 ] . In tere t ingly. 
mo t of the i dent ified T2DM u cept ib i l i ty  genes exert their effect by affect ing beta cell 
funct ion. The genetic predi po i t ion of T2DM are clas i fi ed as e i ther monogenic or 
polygenic .  The monogenic foml of d iabete i nclude MODY . neonatal d iabetes. 
m i tochondrial d iabetes and other . MODY diabete re ult from mutation i n  any of at 
lea t e ight  d i fferent gene ( Table 1 . 2 ) .  
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Table 1 .2 :  Candidate gene. invol ved i n  MODY 
I y n d rome Gene loci Gene 
MODY I 20q 1 2-q J 3 . 1  Hepatoc te nuclear factor-.:I-u 
MODY 2 7p l S -p l 3  G lucokina e 
MODY 3 1 2q2.:1-.2 Hepatocyte nuclear factor- l u 
MODY -+ 1 3q2 1 . 1  In  u l i n  promoter factor- l 
MODY S J 7cen-q2 1 .3 Hepatocyte nuclear factor- l � 
MODY 6 2q32 N EU ROD- l 
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Genetic ,>tudie ( ummarized in Table 1 .3 )  ha e identi fied everal adipo e-expre ed 
gene l i ke ly to contribute to the ri k of T2DM [ 1 32 ] .  The gene variant wi th the greate t 
effect on the ri k of T2DM i s  peroxi orne prol iferator-acti vated receptor y (PP Ry).  
The pro ) � la polymorphi m found i n  PPARy i trongly a ociated with the ri k of 
in u l i n  res i stance producing T�DM.  KC III encode the i slet KATP- K i r6 .2 .  i located 
on I I  P 1 5 . 1  and mediates gluco 'e- t i mulated i nsu l i  n secretion . ,  It i al o in olved i n  
T� DM. where glutamate ( E) i ub ti luted for Iy  ine ( K) at pos i t ion 23 ( E23K)  [ 1 33 ] .  
More recently.  tudie ' reported ariant wi th in  a novel gene. TCF7L2. a a putat ive 
su'cept ib i l i t ) gene for type 2 d iabete . TCF7L2 encode tran cript ion factor 7- l ike 2 
and regu late pro-glucagon gene expre ion and thu i n fluence the production of 
glucagon- l i ke pept ide- l [ 1 3.:1-. 1 35 ] .  An addi t ional candidate l i nked to T2DM map to 
the region 3q. APM 1 gene. encod ing the d i fferent iated adipocyte- ecreted protein 
ACRP30/ad iponecti n .  an adipoki ne [ 1 36 ] .  M utation analyses have al 0 ident ifi ed the 
wide pread SNB 1 9 . '+3. 63 ariant of the calpain - l O  (CAP 1 0) which i located on 
chromo orne 2q37 and i ncrease the rj k of both in ul jn re i tance and i n  u J j n  ecret ion 
[ 1 37- 1 39 ]. 
Table 1 .3 :  Candidate genes and genetic polymorphisms and susceptibility for development of T2DM 
Gene Loci Variants implicated Encoded proteins Function of proteins 
TCF7L2 1 0.25 DG 1 0S478 Transcription-factor-7-1ike 2 Wnt-signalling, pancreas 
SNP7903 1 4  in intron 3 
PPARr 3p25 Pro 1 2Al Peroxisome-proliferator activated Nuclear receptor 
receptor y ( transcription factor) 
FTO 1 6 q l 2  lotron 2 Fat mass and obesity protein Nucleic acid 
demethylase 
KCNJIl I l p 1 5 . l  E23K Potassium-inward rectifier 6.2 Potassium channel, P 
cell 
ABCC8 I I  E23K Sulfonyle receptor 
IRS1 2q36 Gly972Arg Insulin receptor substrate Insulin receptor 
CDKAL l 6p22.3 Noncoding CDKS-regulatory-subunit- -----------... -
associated-protein l -like 1 
IGF2BP2 3q27 Insulin-like growtb factor 2 Transport IGF2 rnRNA 
mRNA binding protein 2 (translation) 
SLCJOA8 8q24 . 1 1  R325W Solute camer family 30, member linc transporter in p ceU 
8 
lDfEX 1 0  HaemopoieticaUy expressed ----.------
bomoeobox or insulin-degrading 
enzyme 
CAPN10 2q37 SAN 1 9,43,44 and63 Calpain- l 0 Calcium regulated 
cysteine protease 
Putative mechanism 
Insulin, glucagon secretion 
Adipose-tissue-relaled insulin 
resistance 
Obesity (via insulin resistance) 
p-cel1 dysfunction 
Insulin secretion 
Insulin signaling cascade 
p-ceU development, regeneration 
Insulin sensitivity 
p-cel1 dysfunction 
pancreas or liver development, 
IDE : insulin action , insulin-
release disturbance 





1 .2.8 Type 2 diabete meU i tu  and a ociated compl icat ion 
The major cau e of the h igh morbidi ty and mortal i ty rate as ociated with T:2DM i 
de\ elopment of a group of mi  rovascu lar and macro a cular compl ication affecting 
mult iple organ , y tems. The n et and progre ion of the e complication i strongly 
l i nked to the pre enc of u tai ned h perglycemia and may be accompanied by other 
di order such a hyperten ion and dy l i p idemia  which are commonly een i n  people 
v, i th T2DM . acrova cu lar complicat ion pri mari l y  affect large blood e els re u l t ing 
i n  ystemi di ease uch a coronary artery d i sease. stroke and peripheral va cular 
d i sea, e. M icrova cu lar compl icat ion are those affect ing ma] ]er blood ve el . 
primari l y  the k idne (nephropathy) which can resul t  i n  total kidney fai l ure. eye 
(reti nopath ) characterized by damage to the ret ina of the eye which can lead to v is ion 
10 ' and neural abnormal i t ie (neuropathy) which re u l t  i n  los of feel i ng and ul t imately 
may lead to u lceration and amputat ion of the toe . feet and lower l imb [ 1 09, 1 40 ] .  
1 .2.8. 1 Impact  of type 2 d iabetes mel l i tus  on  t h e  card iovascular system (diabetic 
cardiomyopath y )  
Data from epidemiological and c l i n i cal trial have confi rmed a h igher inc idence of 
card iova cular di ease i n  the type 2 d iabetic populat ion. independent of other potential 
et iological factor uch as hyperten ion or coronary artery di ea es [ 1 4 1 - 1 43 ] .  The ri sk 
of heart fai l ure i about -+ fold  i n  type 2 d iabet ic comparable to non-diabet ic patient and 
i more l i kely i n  people over the age of 64 year [ 1 44. 1 45 ] .  Diabet ic  cardiomyopathy 
(DCM) is defi ned as ventricu lar dysfunct ion secondary to DM associated with 
hypertrophy. fibrosi and ign ificant card iac dysfunction [ 1 46- 1 49 ] .  Al though the 
pathogene is of DCM is not completely under tood, the suggested mechan i sms of 
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development of DCM may inc lude reduced energy production due to decrea e i n  
mi tochondrial re, p iralion and pyru ate deh drogena e acti v i ty .  cardiac contract i le 
dy funct ion and impaired i ntracel lu lar Ca2+ homeo ta i [ 1 50. 1 5 1 ] . Structurall 
d iabet ic hearts may ha e i ncrea, ed i nterventricular eptum thickne s.  left atrial diameter 
and left ventricular ( L V )  mas,' i ndex l I 52 ] .  Myocardial fibrosi s wa in i t ia l ly de cribed 
b . Rubler el al i n  1 972  fol lowi ng anatomical d i s  ect ion of heart from --1- pat ients wi th 
d iabete and heart fai lure but wi thout arterial hyperten ion or coronary artery disea e .  
The. e heart showed LV hypertrophy and fibro i wi thout evidence of coronary artery 
atheroma or other ubstrate patholog [ 1 --1-6 ] .  These fi nding were confi rmed later by 
'everal hi tological and experi mental studies. Mo t of the resul ts  howed an i ncrease i n  
myocardial den i ty  i n  diabet i c  ubjects compared w i t h  control ubject [ 1 53 ] .  Spec ific 
biomarker for col l agen ynthe i or coJ 1agen degradat ion have been u ed i n  c l i n ical 
pract ice to detect myocardial fibro i and are found to be h igh i n  d iabet ic  patients. 
1 .2.8.2 I mpact of type 2 d i abetes mel l i tus  on mechanical function of the heart 
Pat ient w i th T2DM how a h igher i nc idence of cardiac arrhythmia . i nc l uding 
ventricu lar fibri l lat ion and udden death .  The ECG of type 2 diabetic pat ients may show 
everal al terations from normal pattern . many of them related to the QT i nterval [ 1 43 .  
1 5--1- ] .  Doppler i magi ng, echocardiography. radionucl ide angiography and other 
technique have demon trated a variety of d ia tol i c  and sy tol i c  dy funct ions in type 2 
d iabetic pat ient  and the severi ty of the abnormal i t ie depend on the patients'  age and 
the durat ion of d iabete . Dia tol i c  dysfunction i the most prominent mechanical defect 
and is thought to be the earl i e  t detectable functional abnoffi1al i ty in DCM [ 1 55 .  1 56 ] .  
D iastol i c  dy function has been a ociated wi th  i ncrea es  i n  LV mass, decreased 
-1-0 
compl iance and �lower rate of m ocardial rela  ation [ 1 57 .  1 58 ] .  Hemodynamic  
abnormal i t ie<, i nclude reduc d LV ejection fract ion. impaired myocardial velocity at 
earl ) d iast Ie .  abnormal relaxation duri ng the earl fi l l i ng pha e. prolonged 
i o\olumetri rela at ion. lower peak y tol ic  and early d ia tol ic  ve loc i ty. impaired 
d ia. tol ic re laxat ion and fi l l i ng  and reduced peak fi l l ing rate [ 1 52 .  1 59- 1 65 ] .  
1 .2.8.3 Molecular b a  i of d iabetic cardiomyopathy 
The development of OCM and the cel l u lar and molecu lar perturbation a ociated with 
the patholog are comple and mul t i factOIia1 . Several experimental tudie have hown 
that gene, encodi ng prote in  that are in olved in Ca�+ tran port and cardiac mu c1e 
contraction are variou Iy al tered in DCM .  Some al teration in  the regulat ion of gene 
e pres ion may be a' ociated with cardiac muscle functional defect . whi l st others may 
be a ociated with compensatory mechani m . The �2 ubuni t  of the L-type Ca2+ 
channel ha been reported to play i mportant role i n  many functional a peets of the Ca�+ 
channel and in part icular i t  has a role  in modifying inact ivat ion k inet ics [ 1 66 ] .  In 
diabet ic rat heart. the L-type Ca2+ channel �2 subuni t  gene ( Cacnb2 ) wa found to be 
downregulated compared to control rat heart . M yo i n  l i ght chain 2 (My/2) and SERCA 1 
(A rp2a J )  were al 0 downregulated . Mutat ions i n  Myl2 have been shown to cau e 
hypertroph ic  cardiomyopathy. which i characteri zed by ventricular hypertrophy 
a ociated with reduced compl iance of the heart and myofibri l l ar di array [ 1 67 ] .  SR  
Ca2+ ATPa es (SERCA ) play a major role i n  the control o f  Ca
2+ i gnal i ng [ 1 68 ] .  
Previou experiments have demon trated that overexpre s ion of SERCA 1 i ncrea ed 
horten ing ampl i tude and enhanced relaxat ion k inet ics in fai l i ng human myocyte 
[ 1 69 ] .  Interest ingly,  SERCA I (A tp2a 1) was downregulated i n  diabetic animal models .  
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Gat ing of a\ 1 . 1 channel rna regu late Ca2+ influx and exci tab i l i t  i n  neuron . cardiac 
and arterial <,m oth mu cleo  pregulalion of Cacnaic. which encode the al ubunit  of 
the a\ 1 . 1 ion channel .  rna pro ide an earl compen atory mechani m [ 1 70 ] .  If 
upregulation of Caclla I C tran lated i nto upregu lat ion of the a l  ubuni t .  then thi might 
alter the vol tage em,iti ity and perhap the act i vation and/or i nacti ation properties of 
the L-type Ca2+ channel. which in turn m ight pro ide a compen atory mechan i m for 
the reduced den i ty and prolonged i nact ivati n of L-type Ca2+ current .  T-type Ca"+ 
channels are impl icated i n  cardiac automat ic i ty and cardiova cular remodel i ng. 
pregulation of Cacnaig and Cacna i h .  the two i oform of T-type Ca2+ channel gene 
in the heart . may contribute to changes in channel acti v i ty [ 1 7 1 .  1 72 ] .  Previou tudie 
have demon 'trated altered Ca2+ ensi t iv i ty in the regulation of the cardiac act in-myo i n  
fi lament i n  diabet ic  heart and t h i  m ight be  attributed i n  part t o  change i n  expre ion of 
contract i le prote in  [ 1 73 ] .  One factor that can affect myofi lament en i t iv i ty to Ca2+ i 
i n tracel l u lar pH [ 1 7-+ ] .  Decrea ed a+/H+ exchange act iv i ty which has been pre iou ly  
demon trated i n  diabet ic  rat heart . lead to  a decrea e in  pH and a a con equence, a 
decrease i n  myofi lament ens i t iv i ty to Ca2+ [ 1 75 ] .  Previous tudies have demon trated 
abnonnal SR  Ca
2+ tran port . i nc luding SR  Ca
2+ content  and reduced rate of Ca
2+ 
re lease and re eque trat ion i n  d iabeti c  heart and the e defect have been a ociated with 
decrea ed SR  Ca2+ -ATPa e and ryanodine receptor prote in s  [ 1 76 ] .  
1 .2.8.4 Diabetic heart a n d  impaired calc i u m  handl ing 
Ca2+ i a cri t ical regulator of card iac funct ion. because i t  l i nk electri cal depolari zation 
of the cardiomyocyte wi th contracti on [ 33 ] .  Several experimental tudies at the cel lu lar 
level have l i nked the alterat ion of i n tracel lu lar Ca
2+ homeo tas i s  and the i nc idence of 
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cardiac d; function in the diabet ic  heart [ 1 77 .  1 78 ] .  Cardiac Ca2+ i gnal ing in diabete 
ha-, been mo l e ten ively studied in m ocyte' i olated from the ventricles of variou 
d iabet ic rodent model . I t  wa. found that duri ng  diabetes there wa an impairment i n  SR 
Ca2+ tran port [ j  79 ] .  Decrea 'ed SR Ca2+ content and decreased pontaneou SR Ca2+ 
re lea e and/or decrea ed ERCA funct ion w i l l  re ult in a reduction in the ampl i t ude of 
the Ca2+ transient and prolonged Ca2+ tran ient decay during relaxation pha e [ 1 80 ] .  
The molecular mechani m for S ERCA depre ion may be part ly attributed to changes i n  
mR level (gene e pre , ion)  of  the  SERCA prote i n  which has been reported i n  
d iabeti heart . Moreo er. the arcolemma Ca2+ pump and Na+/Ca2+ exchange act iv i ty 
together wi th efflux  of Ca2+ through the plasma membrane are depre ed i n  the diabetic  
heart [ I  1 ] . Addi ti onal ly,  al teration i n  mi tochondrial Ca�+ tran port m ight have a role  i n  
d iabet ic rat heart [ 1 7  ] .  Cardiac �-adrenoceptor function i s  a l  0 al tered i n  diabet ic 
ani mal . The e alterat ion i nc lude depres ed �-receptor number. a reduced re pon e to 
�-adrenergic agoni t and a s ign ificant alteration in the re ponse and ensi t iv i ty to 
perfu ate Ca2+ t imulation [ 1 82- 1 8.+] .  These resu l ts collect ively support the hypothe i 
that DM lead to an al teration i n  Ca2+ transport i n  the heart . 
1 .2.9 Experi mental models of d iabetes mel l i tus  
I n  1 890, when Von Merhri ng and M inkow k i  began studying the d ige t ive functions of 
the pancrea they d i  covered tbat the animal on which they had perfomled a 
pancreatectomy developed acute DM.  S i nce then a l arge number of experimental 
model have been developed to tudy diabetes and i t  compl ications. These i nclude 
chemical- i nduced models  which ut i l i ze diabetogen ic  agent such as epinephri ne. 
glucagon, growth hormone , treptozotocin and al loxan [ 1 85- 1 87 ] .  diet- i nduced model 
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which i m olve feeding animal with modified diet which may be enriched with fructo e 
or ucrose r 1 7  J and arious geneti c  model of diabete including the Zucker and Goto­
Kakizaki (GK)  rat l ]  88- 1 90 J .  Diabete ha been tudied in d ifferent pecie inc luding 
mouse, rat. rabbi l .  cat and dog. The general characteri t ic of DM found i n  different 
e peri mental model " ma i nclude hyperglycemia, hyper- or normo- or hypoin u l i nemia, 
polyuria, polydyp_ ia.  polyphagia. gluco uria and hyperl ipidemia [ J  9 1 ] . To varying 
degree these experi mental model e hibi t  diabet ic compl ication i nclud ing neuropathy. 
nephropathy. cardiomyopathy, athero clero i and hypertension.  
1 .2.9. 1 The Goto- Kakizaki  rat, an  a n i mal model of type 2 d iabetes mel l i tus  
The G K  rat . a polygeni c  model of T2DM. i one of the best characteri zed animal 
model used for tudyi ng T2DM and i t  related compl ication . The GK diabet ic  rat wa 
produced by Goto and h i  col l aborator through elect ive inbreeding of  Wi tar rat with 
abnormal glueo e tolerance repeated over several generation in Japan i n  1 973 [ 1 90 ] .  I t  
characterized by moderate but table fa t ing hyperglycaemia. hypoin  u l i naemia, 
normol i pidaemia. i mpaired glucose tolerance which appears at 2 week of age and an 
early on et of d iabetic comp l ications [ 1 92- 1 94 ] .  Impaired i n  u l i n  en i t iv i ty i n  the l i ver, 
keletal m uscle and adipo e ti ue has also been reported. Impaired i n  u l i n  ecretion 
and hepati c  glucose overproduction (hepat ic in u l i n  res i  tance) are ear ly event i n  
d iabet ic  G K  rat which contribute to the development of hyperglycaemia. In adu l t  G K  
rat the total pancreat ic  beta cel l  mas i decrea e d  by 60% and th i  i accompanied by a 
decrea e i n  pancreati c  i n  u l i n  stores and i n  u l i n  secretion, s imi lar characterist ics that are 
seen i n  human T2DM [ 1 95 ] .  Table I A shows the compari on of pancreatic beta cel l  
functional characteri t ics i n  GK rat and type 2 d iabet ic  human . 
Table 1 A: ompari on of pancreat ic  beta ce l l  i n  GK rat and human type 2 diabet ic 
Feature GK Rat Human T2DM 
In u Ii n re ... pon. e to gl liCO e Decrea ed Decrea ed 
Gluco. e o  idation DecreasedJ not Decrea ed 
changed 
In  "u l i n  r . pon e to GLP- l Not changed Not changed 
m- GPDH act iv i ty Decreased Decreased 
ATP/ADP ratio  Decrea ed Decrease 
1 .2.9.2 Genetic basi of diabetes mel l i tus  i n  the  Goto- Kakizaki rat 
The use of an animal model can fac i l i tate the search for genetic component i nvolved i n  
the onset and progre i on  of  T2DM.  The GK rat i a n  excel 1ent polygen ic  model for 
study ing genetic u cept ib i l i ty to T2DM and exhib i t  m i ld  fasti ng g luco e in tolerance 
a early a 2 week of age ( h i gh ba al pIa ma i n  u l i n  level ) and impaired glucose 
tolerance by ..J. week of age. Genetic tudie i n  human populat ion and G K  rat have 
i dent ified region of the human chromo orne and rat chromo ome showing evidence of 
ignificant l i nkage to d iabete -related phenotype . The earch for ident ifi cation of the 
morb id  gene in GK rat u i ng a quant i tat ive trai t locu (QTL) approach ha led to 
i dent ification of loci that regu late fa t i ng pIa rna glucose and in u l i n  levels, g luco e 
tolerance. i n  u l i n  ecret ion and adiposi ty (Table 1 .5 )  [ 1 96, 1 97 ] .  Niddm/i. recent ly  
i dent ified a a hort region locus of  Niddm l .  contri butes to  defect ive i n  u l i n  ecretion 
and i homologous to a region on human chromosome 1 0  that i associated with T2DM 
and inc lude TCF7L2 [ 1 98 .  1 99 ] .  IDE and SHIP2 gene loca l ized in chromo orne 1 i n  
G K  rat, encod ing i n  u l i n  degradi ng enzyme and phosphol ipi d  pho phatase respectively 
have also been impl icated in T2DM [ 200. 20 1 ] .  
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Table 1 .5 :  Candidate gene':> i nvol ved i n  pathogene�i of diabete mel l i tu i n  the GK rat 
Loci /gene  L i n kage phenotype 
Niddm l IGT + impaj red in  u l i n  ecretion + i n  u l i n  re i tance 
Sub l oci  
with age a sociated wi th obe i ty and dy l ip idemia 
iddm lb 
iddm l i 
idd/gk I 
Ide IGT + reduce l ipogene i i n  fat + blunted i n  u l i n  
t imulated glueo e tran membrane up  take 
InfJpll or Negat ive regulator of i n  ul i n  ignal i ng 
Ship2 
idd1l12 Fa t ing glucose + IGT 
Weight 1 Body weight and fasti ng insu l in  level 
Niddlgk5 I n  u l i n  ecret ion and pIa ma trig lyceride . 
pho phol ip id and H DL. LDL and total chole terol 
Nidd1l73 Fa t ing g lucose + IGT 
in u l i n  ecretion and  body weight 
1 .2.9.3 Goto-Kakizaki heart fu nct ion 
The GK model provide an opportun i ty to study the effect of T2DM on the heart 
wi thout other compl ication uch a obe i ty. It wa previously demon trated that the 
heart of G K  rat i i n  u l i n -re i s tant with a decreased i nsul i n-stimulated glucose uptake 
and an i mpaired i n  u l i n  s ignal i ng  pathway [ 202 ] .  Heart function in GK rats is frequent ly 
compromi ed. Several studie have revealed that the GK heart i bradycardic .  
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Biotelemetry data ha e demon trated that HR  and HRV were ignificantly reduced i n  
GK rat� 1 203 ] .  In add i t ion the GK heart action potential i mode t l  prolonged [ 1 92 ] .  
1agnetic re onance imagi ng ha� demon trated reduced myocardial blood now and 
redu ed ejection fra t ion.  main ly  a a re u l t  of a reduction i n  L longi tudi nal 
contract ion [ 204 ] .  The re u l t  obtai ned from entricu lar myocyte i olated from GK rat 
are controver�ial . ome ' tudie ha e 'hown that the amplitude of horteni ng and 
cOlTe�ponding ampl i tude of the Ca2+ tran i ent were unal tered [ 205 ] whi lst others have 
h \ n increa:-.ed ampl i tude of the intracel lu lar Ca2+ tran ient in ventri cular myocytes 
fr m I -month old GK rat [ J  92 ] .  
1 .2. 1 0  Type 2 d iabetes mel l i tus  management a n d  conseq uences for hea rt fu nction 
1 .2. 1 0. 1  Exerci  e and heart fu nction 
An abundance of evidence exi  t for pre crib ing exerci e therapy i n  the treatment of a 
variety of d i sease i ncluding metabol ic  yndrome-re lated di order (T2DM. 
dy l ip idemia. hyperten ion and obe i ty) .  heart, pu lmonary and mu cle di ea  es. 
depre ion and asthma. Epidemiological tudie have hown that regular phy i cal 
act iv i ty promote cardiore piratory fi tne and that d iabet ic ind iv iduals who maintai n a 
physical l y  act ive l i fe tyle are much Ie s l i ke ly  to develop cardiova cu lar di sea e 
related to d iabete . The po i t i ve phy iological adaptat ion of the nomlal heart during 
exerci e trai n i ng (EXT) i manifested a i ncrea ed del i very of blood to the peripheral 
va culature to meet the enhanced demands of the musculoskeletal and pulmonary 
sy tern . Thi i usual ly ach ieved wi th an i ncreased cardiac output (CO) through a 
comb ined i ncrease of H R. troke volume (SV ) .  and/or myocardial contracti l i ty [ 206. 
207 ] .  The mo t s ign ificant benefi ts  of phy ical EXT on the diabet ic  heart are due to 
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improvi ng g!uco e and l ip id metabol i  m and reduced i n  u l i n  re i tance however. the 
mechan i .  ms under! ing the e benefic ial effect are t i l l  unclear. In keletal mu cle . it 
� as propo ed that the benefi ial effect of EXT on gluco e homeo ta i could be 
attributed to an i ncrea e in cel l u lar gluco e transporter -+ GLUT+) i n  re pon e to i n  u l i n  
[ 20 -2 1 0] .  
A n  i ncrease i n  abdominal fat accumulation and los of m u  cle rna S are a ociated with 
the development of i n  u l i n  res i  tance . EXT re ul ts  i n  preferential 10 of fat from 
central regionc of the body lead ing  to a reduction of i n u l i n  resi stance. EXT can prevent 
mu cle atrophy and t imulate muscle development [ 2 1 1 ] . Several experimental tudie 
in diabet ic  animal have shown that EXT ha po i t ive effect on beta 1 adrenoceptor 
den i ty and the e benefic ial effects are due in part to normal i zation of the sympathetic 
outflow and improvement in the re pon i vene of the myocardi um to autonomic 
t imulation [ 2 1 2. 2 1 3 ] .  Moreo er, exercI e reduce c i rculat i ng level of ANG I T ,  
aldo terone. \'asopre i n .  neuropeptide y, A P and pro-i n flammatory mediators [ 2 1 -+ ] .  
EXT ign ificantly improve cardiac function by enhanc ing both fract ional shorten ing 
and ejection fract ion.  
1 .2. 1 0.2 Pharmacological therapy 
A n umber of oral pharmacological agent  developed during the la t 60 year have been 
ucce ful l y  used i n  the treatment of T2DM . The mechanism of actjon of these agent 
to lower blood gluco e are d i st inct .  Current ly, there are seven clas es of oral 
hypoglycemic agent approved by the FDA .  Sulfonylureas st imulate i n  u l i n  ecretion 
upon b ind ing to thei r receptor which are located in the beta cell of the pancrea . They 
block KATP channel . which i nduces depolarizat ion of the membrane.  Ca:1+ influx 
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1 .2. 1 0.3 Pero 'i orne prol iferator-act i  ated receptor 
Th PPAR belong to a fami l y  of nuclear receptor . cia i fied a tran cript ion factor . 
whi h have the abi l i t  to bind to D A and regulate the  expres ion of  variou gene . 
ome of the�e gene play di er e role i n  cel l  di fferentiat ion. development and 
metabol i �m [ :L2-2_-+ ] .  In mammal . three PPAR encoded by different gene have been 
ident ified thu · far. i nc lud ing PPARa. PP Ry and PPARW8. PPARs control the 
e pre. Ion of gene involved i n  numerou phy iological re pon e such as 
adipogene i . l i p id metabol i  m.  i n flammation and metabol ic  homeo tasi [ 225 ] .  
Each PPAR i ofoml ha  un Ique act ion which are attributable to  di t inct t i  ue 
expre IOn and d i fferent ial response to d ifferent l igands [ 223 .  _26 ] .  PPARa i 
expre ed i n  l i ver. k idney. heart and brown adipose t i  ue [ 227 ] and has a major role in 
� oxidation of faU acid .  Act ivation of PPARa induce ex pre sion of the fatty acid 
transport prote i n  ( FATP) and fatty ac id  transloca e ( FAT) both of which are re pon ib le 
for transport ing  fatty aci ds acro the cel l  membrane [ 228.  229 ] .  They al 0 enhance the 
e pre ion of enzyme i nvolved in fatty 0 idation uch a long chain fatty acid  acetyl 
eoA syntha e and other [ 228 ] .  Fibrate drug are the molecular target of PPARa and 
have been proven effecti e i n  the treatment of dy l i pi demia. PPAR�/8 share im i l ar 
function wi th PPARa and i expre sed i n  a wide range of bra in  and adipose t i s  ue. heart 
and keletal mu cle [225 ,  230] .  PPARy i widely expre ed in whi te adipo e ti sue 
and other t issue and i a regulator of adipogenesi and a modulator of whole body l ip id 
metabol i m and i nsul i n  en  i t i v i ty [ 23 1 ] . 
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1 .2. 1 0.4 The role of Pe roxi orne prol iferator-acti ated y receptor 
PAP R y L  P PAR y2 and PAPAR y3 i sofom1 have been identifi ed [ 232. 233 ] .  In 
�tructure PP Ry i. s imi l ar to other PPAR and compri e four functional domain 
i nc lud ing a h ighl  onserved D A binding domai n (DBD)  compo ed of two zinc 
fi nger . an -terminal tran acti vation domain (AF l ) .  a C-terminal l i oand bindino b b 
domai n ( LBO)  and a l igand-dependent tran activation function domai n (AF2)  [ 226 ] .  
After l i gand binding PPARy undergoe conformational change and fom1s a 
heterodimer with the ret i noid X receptor (nuclear receptor) ,  thi  heterodimer recognize 
a pecific 0 A re ponse element cal led PPAR respon e e lement ( PPRE) i n  the 
promoter region of target gene . which recru i t  cofactor protein i ncluding coacti ator 
or corepre 'or . 
e \'eral endogenoLl l igand for PPARy have been de cribed i nc luding fatty ac id and 
their deri ative . e ico anoids, I ophosphat id ic acid and ni trol ionol ic  acid [ 224, 234-
236 ] .  TZD are potent exogenou agonist  of PPARy. and have been used for the 
treatment of hyperglycemia in T2DM i nce 1 997 [ 237 , 238 ]  ( Figure 1 . 8 ) .  
The action mediated by PPARy modulate the  transcription of  a number of  gene 
re pon ib1e for improved in u l i n  en i t iv i ty. The e gene mai n ly regulate factor which 
are known to p lay an important role i n  the development of i n  u l i n resistance i n  T2DM 
uch a fatty acid .  adiponect in and i n flammatory markers. 
Act ivation of PPARy by TZDs promote fatty acid  uptake i nto adipose t is  ue, promote 
adipogenesi s  and i nduce adipocyte d ifferentiation to enhance torage of fat ,  thus reduce 
c irculat i ng fatty acid concentrat ion.  Activation of PPARy also enhance adiponecti n 
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production i n  adipo e cell and i ncrea, e adiponect i n  pIa ma concentrat ion. TZD 
binding to PP Ry are thought to reduce pIa ma Ie el of i nnammatory mediator uch 
as T JFu and pIa m in  gen acti  ator inh ibi tor- 1 ( PAl - I )  and IL-6 [ 232 , 239-2-1-2] .  
The role of PPARy in  gluco homeo ta i wa con fimled in human and an imal genetic 
tudies. Obe e mice with a mutation on eri ne 1 1 2 of PPARy howed a decrea e in 
PP Ry ph ,phor lation and an in rea e in PPARy acti v i ty, thu protecti ng mice from 
development of obe i ty  and a ociated i n  u l i n  re i stance [ 2.:\.3 ] .  On the other hand, mjce 
la k ing PPARy are predi po ed to developing insul i n  re i stance [ 244] .  S im i lar results 
were found i n  human . Dominant negative mutat ion in human PPARy cau e severe 
i n  u l i n  resi stance. whi le  carrier of Pro 1 2Ala pol ymorphi m in the PPARy gene reduce 
the risk of T2DM and improve gluco e homeo tasis [ 2.:\.5 . 2-1-6 ] .  
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Figure 1 . 8 :  Structure and molecu lar mechani m of action of peroxi orne prol iferator -
act i vated receptor y (PPARy) .  (a) PPARy tructure ha four functional domain : the 
tran activation domain (AF- I ) , D A binding domain ,  l igand binding domain ( LBD)  
and l i gand dependent tran acti ation AF-2 domain .  (b )  Thiazol idinedione (TZD ) 
b inds PPARy, the PPARy and ret i noid X receptor (RXR)  heterodimer bind to PPARy 
to PPAR re ponse element ( PPRE) recrui t  di verse cofactor that modulate the 
tran criptional acti v i ty of the target gene.  
1 .2. 1 0. - Thiazol id inedione: Piogl i tazone 
TZD h wed great promi e a PPARy receptor-mediated oral therap for the treatment 
of T2DM.  Cl in ical <,tudies have revealed their effecti vene at lowering fa t ing and 
po.,tprandial b lood gluco e and improv ing in u l i n  en i t iv i ty. The potency of the e 
agent i n  loweri ng glu ose i, trongly corre lated with receptor binding and agonism 
[ 2'+7 ] .  Trogl i lazone, the fir t TZD marketed i n  1 997 for the treatment T2DM. howed 
benefic ia l  effect ' on i n  u l i n  en i t i  it . b lood gluco e level and c irculat ing free fatty 
a id . In 2000. trogl i tazone wa wi thdrawn from the market due to eriou 
hepatotoxi ity [ 2'+8 ] .  Ro ig l i tazone \ a approved in 2000 for treatment of T2DM. 
However. l arge meta analy i of randomized c l i n ical trial that evaluated the glycemic 
control of ros igl i razone re ealed that ro ig l i tazone wa associated with a ignifi cant 
increa e i n  the ri k of myocardial i nfarct ion and death from cardiovascular di sea es 
[ 2c.\.9 ] .  In 20 1 0. the European Medic ine Agency recommended u pen ion of 
ro ig l i tazone, whi le  the FDA se erely re tricted it u e [ 250, 25 1 ] . In 20 1 3  the FDA 
removed thi  re trict ion on the ba i of the re u l t  of Rosigl i tazone Evaluated for 
Cardiova cular Outcome and regulat ion of G lycemia i n  diabetes ( RECORD) c l i nical 
trial which i ndicated no elevation of the risk of heart attack or death in pat ient treated 
w i th ro ig l i tazone [ 252 ] .  
Currently, piogli tazone (P IO)  i the on ly  TZD approved for second or  th ird l i ne 
treatment of T2DM [ 25 3 ] .  It can be admin i stered as a monotherapy or i n  combination 
wi th metformin ,  su lfonylurea , exenatide. d ipeptidyl peptida e c.\. inh ibi tors or in u l in  
[ 25-1- ] .  The c l i n ical pharmacology data fol lowing oral dose of 30 mg PIO howed a peak 
p Ia ma concentration ach ieved 2 hr after admin i  tration, whi le steady tate i s  ach ieved 
after 4-7 da) <, of do<,i ng. PIO undergoe hepat ic metaboli m ia cytochrome P'+50 2C 
I nto <,ix metabol i te (M- I  - M-V I ) .  Among them. M- l l .  M- I l I  and M- IV are act ive 
metab l i te . The efficac of metabol i te M - 1 l I  how imi lar to unchanged PIO efficacy, 
\\. hi le metabol ite M- I  :how three fold higher acti vi ty than unchanged P IO and M- l l  
ha� a min imal effica y .  The mean p I a  rna  e l imination half- l ife of  unchanged P IO  i n  
man i 5 -6  hr, and for total acti e metabol i te J 6-23 hr . 
Be ide it i n .  u l in  sen i t iz ing effect . PIO ha been reported to lower blood pre sure i n  
human and ex.perimental animal [ 255-25 8 ] .  In animal tudie PIO appear to improve 
\'a, cular tone and decrease endothel ial dy function by t imulat ing of n i tric 0 i de and 
reducing endothel in - l production. P IO compared wi th ros ig l i tazone has beneficial 
effect on trig lyceride . and total chole terol [ 259 ] .  P IO may also exert an anti­
inflammatory effect as wel l  a decreasing hepatic i nflammation i n  overweight rat on 
h igh chole terol and fructo e diet [ 260 ] .  C l i n ical and experi mental tudies have also 
hown that P IO ha atheroprotective effect i n  human and animal wi th athero clero i 
[ 26 1 .  262 ] .  
Data from c l in ical studie has re ealed that P I O  has other TZD side effects. A major 
ide effect of P IO i weight gain  which i s  due to expan ion of the subcutaneous fat 
depot and th is  may vary great ly depending on the i nd iv idual and on the treatment 
regimen employed . Another i mportant s ide effect i odium and water retent ion, which 
can provoke edema, anemia and even aggravate or reveal heart fai l ure [ 263, 264 ] .  
Cl in ical trial have hown that P IO  treatment i associated with reduction i n  bone 
formation and den ity and an i ncreased ri sk of fracture and/or 0 teoporo is part icularly 
in women [ 265 ] .  Furthermore. the use of PIO ha been a ociated with an i ncreased ri k 
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of bladder cancer 1 255 ] .  In 20 1 I ,  and based on the ri k of bladder cancer the FDA 
1 . ,>ued a v. arning. whi le  France uspended and Gemlany re tricted the u e of PIO. 
1 .2. 1 0.6 Piogl i tazone: H ea rt benefit or ri k? 
Fol lowing concern about the cardiova cular afety of ro ig l i tazone, greater caution i n  
the u e  of  TZD part icularly i n  pat ient w i th  a hi story of  heart fai l ure wa urged . 
everal meta anal i ,  and c l in ical and experimental tudie ha e been conducted to 
eyaluate the effect of PlO on cardiova cular outcome . Al though the ide effects of 
PIO i nclude sod ium and water retention, which can pro oke edema and aggravate or 
reveal heart fai l ure. e eral c l i n ical studies have ,hown that PlO exert cardiova cular 
benefi t . A randomized pro pect ive PIO c l i n ical trial i n  macrova cular events 
( PROact ive study) demon�trated that PIO wa associated wi th a reduction in mortali ty. 
non fatal M I  and �troke in patient wi th type 2 d iabetes compared w i th placebo [ 255 ] .  
The re u l t  of  a meta anal i conducted in 2007 which included 1 9  tria ls  and 1 6,390 
pat ient wi th drug durat ion ranging from 4 month to 3 .5  year howed a ignifi cant 
lower ri k of death. M I  or stroke among d iabet ic pat ient receiving PIO. However, PIO 
increa ed evere heart fai l ure with no i ncrea e in mortal i ty [ 266 ] .  Another c l in ical tudy 
ha hown that P IO does not affect heart function i n  diabet ic patient receiving PIO 
treatment [ 267 ] .  
I n  a ymptomat ic T2DM patients wi th L V  d iastol i c  dysfunction, adding P I O  does not 
i nduce any adver e or favorable changes in heart function, despite improvement i n  
glycemic controL i n  u l i n  sen i t iv i ty, l ipid profi le  and  blood pressure [ 268 ] .  A rudy 
conducted in T2DM pat ients hav ing ystol ic  dy function demonstrated an exces of 
overnight ho p i tal i zation for revi sable heart fai lure for patients treated with PlO. 
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Vv i lhoUl an exce s of cardiova cu lar mortal i ty or aggravated cardiac function [ 269 ] .  
Other ..,tudie. have hown PlO attenuate conge t ive heart fai l ure-i nduced atrial 
..,tructural remode l ing and atri al fibri l lat ion in rabbi t  heart [ 270] and improve ' LV 
remodel ing and function in mice wi th po't-myocardial i nfarct ion heart fai l ure [ 27 1 ] . It 
aL 0 redu e angjoten in II induced cardiac h pertrophy in rats in 1'ifro and in l'i1'O 
[ 272 ] .  In another rudy, PIO amel iorated LV hypertrophy and fibro i in the heart of 
hyperten, ive rat [ 273 ] and attenuated cardiac hypertrophy and fibre i s  i n  angioten in 
I I - i nduced cardiac hypertrophy i n  m ice [ 27.:1- ] .  I n  addit ion,  PIO has been hown to 
protect again t i chemiaJreperfu ion i nj ury when admini tered prior to i chemia 111 
i �olated perfused rat heart [ 275 ] .  
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H) pothe i 
The progres�ion of electromechanical d function i n  diabetic heart might be delayed or 
normal ized by e erci e trai n ing or pharmacological ant i-diabet ic treatment. 
The main object ive of the project were to i nve t igate the effect of: 
I .  D M  on ventricular m ocyte contraction and i ntracel lu lar Ca�+ I n  young GK 
t pe  2 diabet ic rat . 
') DM on e pre ion of gene encoding variou cardiac muscle proteins i n  young 
GK type 2 diabetic rat . 
3.  E erci e train ing on ventlicu lar myocyte contraction. i ntracel lu lar Ca�+ tran pon 
i n  adult  GK type 2 d iabet ic rat . 
-t. Exerci  e train ing on ex pre ion of gene encoding various cardiac mu cle 
protein in adul t  GK type 2 diabetic ral . 
Exerci e train ing  on expre sion of variou cardiac protein in adul t  GK type 2 
diabet ic rat . 
6.  Exerci  e train i ng on the u l tra trucutre of ventri cu lar mu cle in adul t  GK type 2 
diabetic rats .  
7 .  PIO on ventri cu lar myocyte contraction, i ntracel l u lar Ca2+ tran port i n  adul t  GK 
type 2 diabet ic rat . 
8. P IO on cardiac electrical conduction i n  adul t  GK type 2 diabetic rat .  
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Chapte r  2 :  Materials and Met hods 
2. 1 Ethical approval 
1 1  experi mental procedure ere performed with appro al of the Animal Re earch 
Ethic ommi ttee of the Col lege of Medicine and Health sciences (CM H S ) , United 
Arab Emirates Uni ver. i t  ( AEU) .  Al Ain ,  UAE. 
2.2 Experimental an i mal 
Experiment \ ere conducted i n  male GK type 2 diabetic rats and age-matched male 
Wil>tar con trol '. GK rat were obtained from Taconic (Germantown. New York. USA) 
and age-matched W i  tar cont rol rat were bred at  our ani mal fac i l i ty. CMHS.  UAE 
The animal were a commodated in the animal fac i l i ty. i n  polypropylene cage ( .. n 
22 .5 20.5 cm;  fi ve rat s/cage) .  The temperature was maintai ned between 22-2'+ 0e, 
SOCk: humidi ty and animal were expo ed to 1 2  hr 1 1 2  hr day/night  cycle. The animals 
were fed a tandard mai ntenance diet ( Emirates Feed Factory, Abu Dhab i .  UAE) ad 
libitulIl with free acce to water. 
Body weight. fa t ing blood gl uco e and blood gluco e at l 20 mm after an 
i nteraperi toneal ( i .p )  i njection of glucose ( 2  g gluco e/kg body weight) were measured 
periodical ly .  G K  rat wi th  nom1al fa t ing blood gluco e and IGT were excl uded from 
the experiments. For ill \·itro studie . body weight .  heart weight and non-fast ing blood 
glucose were measured immediate ly prior to experiments .  
2.3 Experimental  design 
I n  one et  of experi ments, young GK rats at 8 week of age ( early onset d iabete ) were 
u ed. Ventricu lar myocyte contract i l i ty and i ntracel lu lar Ca
2+ concentrat ion were 
9 
measured and expre<,sion profi le of gene ' encoding a variety of cardiac mu cle prote in 
were e\ aluated. The effects of chronic diabele and the effect of different diabele 
treatment inten ention i nc luding exerci e trai n ing a non-phannacological and PIO a 
phannacological treatment were e al uated u i ng ani mal at 8- 1 0  month of age. Thi 
wa d ne by e aluati ng ventricu lar myocyte hortening. i ntracel lu lar Ca::+ 
concen trat ion. R a2+ transport. myofilament en i t iv i ty to Ca�+ and L-type Ca2+ 
current .  Furthermore. ventricu lar mu cle morphology and ex pre 'sian of gene encoding 
a yariety of cardiac muscle protein were e aluated i n  edentary and e erci e trai ned 
GK and control ani mal . The effect of PIO on horten ing and Ca�+ transport 111 
ventricular myocyte from G K  and control animal were investigated. Fi nal ly. an 111 
\ 'il'O biotelemetry tudy wa conducted to i nve t igate the effect of PIO on the ECG in  
GK and control animal . 
2 ... Methods 
2.4. 1 Ventricular myocyte isolat ion 
LV m ocyte were i alated u ing enzymatic and mechanical di per al technique 
according to previou Iy  de cribed method [ 276 ] .  Ani mals were euthan ized by 
decapi tation u ing a gu i l lot ine .  The abdomen was opened horizontal ly and the rib and 
sternum were femo ed to acce s the chest cavi ty .  The heart wa expo ed and e levated 
by crad l ing it gent ly (to avoid i njury) in the fi nger t ips .  Hearts were removed rapidly 
and i mmer ed in a cold perfu ate ( i n  m M :  1 30.0 NaCL 5 ..+ KCl .  1 . .+ MgCI2, 0.75 CaCh, 
0.-+ NaH::P04• 5 .0 H EPES , ] 0.0 glucose. 20.0 taurine and ] 0.0 creati ne; pH 7 .3 )  to l imi t  
any i chemic i nj ury duri ng the  period between exci  ion and the  re toration of  va cular 
perfu ion . The heart wa c leared of extraneou t i s  ue and debri s and with the aid of 
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forcep�, the aorta 'W s l ipped over the t ip of a cannula and mounted for retrograde 
perfu,>ion accord ing to the Langendorff method. Publi hed review by Skrz piec-Spring 
in 2007 and more recent ly by Bel l  in 20 1 1  de cribed the general pri nciple of thi 
technique [ 277. 27 ] .  The Langendorff apparatu ( Figure 2 . 1 )  con i t of a cannula 
attached to the outflow of a heal e changer. A peri tal t ic pump (M in ipu l  3 .  Gi l  on. 
France) v, a  set to deli ver i solat ion oIut ion at a con tant flow rate of 8 mllg heart/m in .  
1 1  perfusion procedure were performed with t i  ue  being maintained a t  37 °C and 
perfu ion olut ion' cont i nuou 1 aerated with 95% O2 and 5% Co2. Heru1 were 
perfuced \ ith cel l i olation solut ion conta in ing in m M :  1 30.0 aCl .  5 .4 KCl, 1 .4 
MgCI 2 • 0 .75 CaCh. 0.-1- aH2P04, 5 .0 H EPES, 1 0.0 gluco e, 20.0 tauri ne and 1 0.0 
creatine ;  pH 7 .3 ) .  When the heart contract ion had tabi l i zed perfu ion wa witched for 
-+ m in  to Ca2+-free cel l  i olation olution conta in ing 0. 1 mM ethylene glycol tetra acet ic 
aci d  (EGTA). The purpo e of the low Ca2+ olut ion i to loosen j unctions between 
cardiac myocyte . Solut ion wa then swi tched to cell i olat ion olut ion contai n ing 0.05 
m 1 Ca2+ . 0.60 mg/ml type 1 collagenase (Worth ington B iochemical Corp. Lakewood, 
J .  USA) and 0.075 mg/ml type X I V  protease ( S igma, Taufkjrchen. Germany) for 6 
m in .  The enzyme cocktai l 100 en col l agen and other l i nkage between cardiac 
myocyte . The heart wa then removed from the Langendorff ystem, the ventricle 
t i  ue exci ed from the heart, m i nced and gent ly  haken in col l agena e-contai n ing 
i olation olut ion upplemented wi th 1 17£  bov ine erum albumin  (BSA)  for -+ m in  at 37 
DC.  Cel l  were fi l tered from this solut ion through a 300 /-lm nylon me h. The fi l trate 
contain ing  ventricular myocytes was centri fuged at 400 rpm for 1 m in .  Sub equently,  
the upematant was removed and the cel l pel let wa re-su pended in cel l i solat ion 
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,>olution ontain ing 0.75 m M  Ca�+. Thi proce wa repeated four t ime u ing ti ue 
remai ning in the n Ion me h. Ventricular myocyte were col l ected from the econd. 
th ird and fourth . hakes and tored at � °c and u ed over a period of 1 -8 hr . Ventricular 
mJocyte� were fre h I  i olated on a dai l y  ba i . E periments were performed i n  
ventricu lar myocyte that di played normal rod- haped morphology w i th  clear triation 
( Figure 2 .2) .  
Body weight. heart weight and non-fast i ng blood gluco e were measured immediately 
prior to experiment . Heart were weighed before canulation . Immediately, fol lowing 
.acrifice of the arumal .  blood was col lected i n  tube contain ing ethylene­
diaminetetraacetic-ac id (EDT A) and then centrifuged at 3,000 rpm for 1 5  min .  The 
upernatant (plasma) wa tran felTed to eppendorf tubes and tared at -80
°C. 
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Figure 2 . 1 :  Langendorff apparatus. Arrangement of sy tem ( upper pane l ) .  (a) Solut ion 
reservoir , (b)  Heart exchanger, ( c )  Peri tal t ic  pump and (d )  Thermo circulator. 
Magnified picture of Heat exchanger and heart warm ing jacket ( lower left panel )  and 
Magnified picture of cannulated heart ( lower right panel ) .  
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Figure 2 .2 :  M icrograph of i solated myocyte . A collection of ventricu lar myocyte 
( upper panel ). ( a) V iable myocyte and (b)  on-viable myocytes. Si ngle ventricular 
m ocyte ( lower pane l ) .  
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2A.2 Exerci  e t ra i n i ng protocol 
Thi rty male GK and th i rty male Wi tar control rat aged 8 month were di vided i nto -+ 
�ubgroup"', each contai n ing 1 5  rats .  2 ubgroup of GK and control rat received 
exerci e trai n ing whi l 't the other 2 ubgroup of GK and control rat cont i nued a 
�edentar I l i fe, tyle .  E erci e train ing '> a performed on a treadmi l l  ( EXER-'+, Columbu 
Instruments ,  Columbu , OR, U A) ( Figure 2 . 3 )  according to previou Iy  de cribed 
protocol ' wi th minor modifi cation [ 279, 280 J .  Dai ly I hr  exerci e trai n ing ses ion 
v. ere repeated 5 day per week for a period of 2-3 month . Each exerci e trai n ing period 
began wi th a 1 0  min  \ arm-up dur ing which t ime the bel t  peed wa gradual ly  i ncrea ed 
from zero to train ing peed. During week 1 .  the train i ng bel t  peed wa 1 0  mimin, 
during week' 2-3 belt  peed wa i ncrea ed to 1 5  mimin  and during  week 4- bel t  speed 
wa mai ntained at 1 5  m/min  and the belt gradient wa i ncrea ed from 0
° to 1 0°. 
Thereafter, the e erci e train ing  belt peed was i ncrea ed to 20 m/min .  If rat topped 
running they would move backward on to an electrical grid where they would recei e a 
mall electrical hock ( 200 m pulse of 2 mA electric current) .  
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Figure 2 . 3 :  Treadmi l l  u ed for exerci e trai n i ng. (a) Control un i t ,  (b) Electric grid . and 
(c) Exerci e bel t .  
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2.4.3 E pre ion of m R  A 
Expre�, i n of gene encoding a range of cardiac mu cJe protein wa a e ed u i ng 
real - l ime re\'er<.;e tran cription polymera e chai n reaction ( Real t ime RT-PCR ) modified 
from pre\iou�1  de cribed method [ 2  I ] , 
2A.3. 1 ample  collect ion 
ample� of  left ventric le  t i s  ue were acquired from the apex of the heart in vil'o prior to 
removal of the heart for myocyte i olat ion ( Section 2 .· t  J ) . Sample of left ventricle 
li, 'ue were col lected and placed immediately i n  R Alater (AM702 1 ,  Life 
Technologie . Carl bad. CA. SA) and kept overnight at room temperature to al low 
thorough penetrat ion of the ti ue. Ti ue ample were then frozen at -80 °C pendi ng 
further proce i ng. 
2A.3.2 RNA ext raction and quant ification 
I olat ion of total R A from the ti sue wa performed u i ng the SV Total R A I olation 
Sy tem (Promega. Madi on, USA) according to the manufacturer' i nstruction . In 
brief. frozen LV amples were cut i nto small ect ions with a steri le razor blade. The 
t i  ue « 30 mg) wa homogenized i n  RNA Iy  i buffer contain ing p-mercaptoethanol 
( B M P) to di  fupt cel l . precipi tate cel l u l ar prote i n  and relea e the RNA into o lut ion,  
Pha e eparation was done with the addi tion of RNA d i l ut ion buffer to the homogenized 
ample . The lysates were i ncubated for 3 min  at 70 DC and cel l  debri wa collected by 
centrifugation ( 1 0 m in :  1 2 .000 rpm ;  25 °C) .  The upernatant (contain ing RNA) wa 
m ixed i n  a fre h Eppendorf tube with 95% ethanol and tran ferred onto a pm 
column .  After centri fugat ion (1 mm;  1 2 ,000 rpm ;  25 °C) ,  the elute wa d iscarded and 
the column wa wa hed with wash buffer. After an addi t ional centrifugation tep ( l  
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min :  1 2 .000 rpm: 25 ° ). D a e I mi a. appl ied to the membrane of the column and 
,>ample were i ncubated for 1 5  min  at 25 0c .  Dige�tion wa topped by the addi tion of 
D a e I top m ix  and the column ", ere centrifuged ( 1  m in :  1 2.000 rpm :  25 °C ) . 
Fol lowing t�o  '> a�h . tep� wi th wa h buffer ( I  min and 2 min :  1 2 ,000 rpm : 25 0q, the 
column � a  tran fened to a teri le  Eppendorf tube and RNa e-free water was added. 
fter i n  ubation for I m in  at 25 °C, the R A wa el uted by centrifugation ( 2  min :  
1 2 .000 rpm :  _5 °C) .  The concentrat ion and purity of  the R A was determi ned by 
mea uri ng the ab orbance at 260 11m (A260) and the rat io of the ab orbance at 260 and 
2 0 nm ( D- 1 000. anoDrop) .  Sample were aJ iquoted and stored at -80 °C. pending 
further proce l llg. 
2.4.3.3 Reverse t ra nscri pt ion to cDNA 
A t o-step RT-PCR procedure wa u ed to generate complementary DNA (cDNA) .  
Total R A (500 ng) wa converted i nto cDNA in  a 25 /-1 ] PCR reaction with 1 0  x RT 
buffer 2 .0 /-1 1 .  25 x d TP Mix ( l 00 mM) 0 .8  /-1 1 ,  l O x RT random primer 2 .0 /-1 1 ,  
M u]t iScribe
ThI Rever e Tran cripta e 1 .0 /-1 1 .  R N a  e i nhibi tor 1 .0 /-1 1 ,  and uclea e free 
H20 ( High Capaci ty cD  A Re erse Tran cription Ki t  (4374966. Appl ied B io ystem . 
SA) .  Rever e tran cription wa carried out u ing the fol lowi ng parameter values: 25 
°c for 1 0  min ,  37 °C for 1 20 min .  and 85 °c for 5 min  on the Veri t i  thermal cycler 
( Applied B iosy tern . USA) .  
2.4.3A Real t i me reverse t ranscript ion polymerase c h a i n  reaction 
Gene expre ion was performed using cu tom Taqman Low Den i ty Anay ( Format 32 .  
4346799. Applied B iosy tems,  USA) .  The TaqMan as ay were pre-loaded i n  each 
react ion well  of the anay i n  trip l icate for each RNA sample. The target genes for rea]-
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l Ime RT-PCR analy e,' are , hown in Table 2 . 1 .  Rat glyceraldehyde-3-pho phate 
dehydrogena e ( Gapdh) wa used a an endogenou control .  1 00 ng of cD A ( RNA­
equ i \ alent) was loaded together with 2 x TaqMan Gene Expre ion Ma  ter Mix ( 0 
AmpEra e G. Appl ied Bio )" tern ' , SA) made up to 1 00 /-1 1 per port . Real-t ime RT­
P R was performed on a 7900HT Fa t A B I  Pri m 7900HT Sequence Detect ion Sy tem 
pplied B io y tem . A) .  The PCR thermal cycl ing parameter were run i n  tandard 
mode a. follow : 50 °C for 2 m in .  9-+.5 °c for 1 0  min .  fol lowed by 40 cycle of 97 °C 
for 30 sec and 59 .7  for 1 m in .  Re ul t  were i ni tia l ly analyzed u i ng ABI Pri m 7900HT 
D . \'� A.  All remain ing  calculation and tati t ical analy i were performed by the 
SDS RQ Manager 1 . 1 A  oftware u i ng the 2-�.0.Ct method with a relat ive quantifi cation 
RQminJRQmax confidence et at 95%.  
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Table 2 . 1 :  Target gene . alternat ive name and role of gene elected for real-t ime RT­
PCR analy'>e 
Gene Altemati Ye name Role 
Card iac mu de p rotei ns and a socia ted regulatory p rotein 
Myh6 M 0 i n .  hea polypeptide 6. cardiac Mu cle contraction 
mLl cleo alpha 
M\'h 7 I\lyo�i n. hea polypeptide 7. cardiac Muscle contraction 
mu cle. beta 
Myhpc3 Myosi n binding protein  C Mu  cle contraction 
A1YI I M yosi n .  l i ght chrun I Muscle contraction 
Myl3 Myosi n, l i ght chain 3 Muscle contraction 
A Clc J Actin ,  alpha. cardiac mu cle 1 Muscle contraction 
TlII1i3 Tropon in  I type 3 .  cardiac Regulation of mu cle 
contraction 
TlIl lf2 Troponin T2. cardi ac Regulation of muscle 
con tracti on 
Tpm J Tropomyo i n  1 ,  alpha Regulation of muscle 
contraction 
Tpm2 Tropomyo in 2 .  beta Regulation of mu c le  
contraction 
Tpm4 Tropomyo in 4- Regulation of mu cle 
contract ion 
Dbi Ti t in  protei n homolog Scaffoldi ng for 
arcomere a sembly 
I ntercel l u l a r  p rotei ns 
Gja J  Gap junction prote in ,  alpha- l I n tercel lu lar 
communication 
Gja4 Gap junction prote in ,  alpha 4- Intercel lu lar 
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communication 
Gja5 Gap jun tion prote in .  alpha 5 Intercel l u lar 
communication 
Gja 7  Gap junction prote in .  alpha 7 In tercel l  u lar 
communication 
Dsp De mopJakin In terce l lu lar junction 
Carl Caveol in  J Ca eolae membrane 
COI'3 Caveol in  3 Caveolae membrane 
I nt racel l u lar Ca
.l+ t ra nsport and regulat ion 
A TP2a J A TPa e. Ca-+ tran port i ng. card iac SR Ca-+ pump 
mu cleo fa t twi tch 1 ( SERCA 1 )  
A rp2a2 ATPa, e . Ca-+ tran port ing.  cardiac SR  Ca�+ pump 
mu cle .  slow twitch 2 (SERCA2 ) 
Rw2 Ryanodine receptor 2 .  card iac SR Ca-+ channel 
Casq2 Cal eque tri n 2 SR Ca-+ binding 
prote i n  
PIn Pho pholamban SR Ca-+ pump 
regu lation 
Calm2 Calmodul in  2 Regulation of ion 
channel 
Camk2d Calc ium/calmodu l in  Regulation of Ca-+ 
homeostasi 
Prkaa2 Prote in  kina e. A MP-acti vated, alpha 2 Regulation of cel l ul ar 
catalytic ubuni t  energy metaboli  m 
Cell membrane tra nsport 
A tp l a l  ATPase. alpha 1 polypept ide Na+/K+ pump 
A tp l a2 ATPase. alpha 2 polypeptide Na+/K
+ pump 
A rp J a3 ATPase, alpha 3 polypept ide Na
+/K+ pump 
7 1  
Alp l  bJ  AIP� e,  beta I polypept ide Na+/K+ pump 
SIc8a l Solute caITier fam i ly  8, member 1 Na + /Ca-+ exchange 
le8a3 ol ute caITier fami ly  8 .  member 3 a+/Ca-+ exchange 
le9a l Solute carrier fami ly  9. member I Na+/lr exchange 
Calci u m  chan nel 
CaCl7a i c Calcium channe l .  alpha I C ubun i t  L-type CaH channel 
Caena i g Calc ium channeL alpha I G ubunit  I-type Ca-+ channel 
Cacl/a i lz Calcium channe l .  alpha I H subun i t  T-type Ca-+ channel 
Caclla_ di Calcium channe l ,  alpha2/delta subun i t  Ca-+ channel 
I modulation 
Cacna2d2 Calcium channeL alpha 2/del ta suburut Ca-+ channel 
") modulation 
Cael/bi Calc ium channe l .  beta 1 ubunit  Ca-+ channel 
modulation 
Cacnb2 Calcium channe l .  beta 2 ubuni t  Ca-+ channel 
modulat ion 
Caenb3 Calc ium channe l .  beta 3 ubuni t  Cad channel 
modulation 
Caenb-l Calc ium channeL beta � ubuni t  Ca-+ channel 
modulation 
Sod i u m  channel 
Sen5a Sodium channel ,  type 5 ,  alpha Na+ channel 
Sen ] b Sodium channeL type 1 ,  beta Na+ channel 
Scn3b Sodium channel ,  type 3, beta Na+ channel 
Potassi u m  channel 
Hell 1 Hyperpolarization-acti vated cycl ic Pacemaker CUITent ( Ir) 
nucleotide-gated K+ channel 1 
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Hm2 Hyperpolari zation-acti vated cyc l ic  Pacemaker current ( Ir) 
nucleotide-gated K+ channel 2 
HCIl..f Hyperpolarization -acti vated cycl ic Pacemaker current ( If) 
I nu Ie  t ide-gated K'" channel -+ 
Kcno2 I Pota. i urn channel .  haker-related Delayed rectifier K+ 
ubfami ly, member 2 channel OK) 
Kcna3 Pota i um channel .  . haker-related Delayed rect ifier K+ 
'ubfami l  . member 3 channel ( IK ) 
Kcno..f Pota, s ium channe l .  haker-related Slow transient 
ubfami ly. member -+ outward K+ channel 
( 1\0.,) 
Kcno5 Pota ium channel ,  haker-re lated Ultra-rapidly 
'ubfami ly .  member 5 acti at i ng delayed 
rect ifier ( lKur) 
Kenol Pota�s ium channeL haker-related Ultra-rapid ly 
ubfami l  . member 7 act ivati ng delayed 
rect ifier ( IKur) 
Kenj2 Potassium channel . ubfami ly  J ,  I nwardly-rect ifyi ng 
member 2 K+ channel ( l K l )  
Kenj3 Pota i um channe l .  subfami l y  J .  Inwardly-rect ifyi ng 
member 3 K+ channel ( IKAch) 
Kellj5 Pota ! U rn channe l .  ubfami ly  J .  Inward ly-rect ifyi ng 
member 5 ( l K ,  Ach) K+ channel ( I KAch) 
Kcnj8 Pota i u m  channe l .  ubfami l y  J .  I nwardly-rec6fyi ng 
member 8 K+ channel  ( l KATP) 
KCllj]  1 Poras i um channel Inwardly-rect ifying 
K+ channel ( IKATP) 
Kellj l 2  Pota i um channe l .  ubfami ly  J ,  I nwardly-rectify ing 
member 1 2  K+ channel ( IK l )  
Kchip2 A-type potas ium channe l ,  protei n  2 Transient outward K+ 
channel ( Ito )  
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KCllabI I P ta i um vol tage-gated channel 
haker related ubfami l  beta, 
member 1 
KcnbI Pota, s ium voltage-gated channeL Dela ed rect ifier K+ 
Shab-re lated ubfami ly. member 1 channel ( l K I )  
KendI Pota . ium vol tage-gated channel .  
hal -re lated fami ly .  member 1 
Kcnd2 Pota ium vol tage-gated channeL Fa t tran ient outward 
hal-related fami ly. member 2 K+ channel ( ItoJ) 
Kcnd3 Potas ium ol tage-gated channe l ,  Fa t tran i en t  outward 
Shal -re lated fami ly. member 3 K+ channel ( IIOJ) 
KcneI Pota ium vol tage-gated channel .  S low delayed rect ifier 
Isk-related ubfamj ly, member I K+ channel ( l K',) 
KClle_ Pota� i um vol tage-gated channel .  S low delayed rect ifier 
I k-related ubfami l y. member 2 K+ channel ( IK,) 
Kcne3 Pota ium vol tage-gated channeL S low delayed rect ifier 
1 k-related ubfarrul y. member 3 K+ channel ( I K', )  
Kcne4 Potas i um ol tage-gated channel .  
Isk-re lated subfarn i l y. member 4 
Kcnq I  Pota i um vol tage-gated channel ,  S low delayed recti fier 
KQT-l i ke ubfamj ly. member I K+ channel ( IK,) 
Kcng2 Pota i um vol tage-gated channe l ,  
subfami l y  G. member 2 
Kcnh2 Pota i um voltage-gated channe l .  Rapid delayed 
subfami l y  H .  member 2 rect ifying K+ channel 
( IKr) 
Kcnk3 Pota i um  channel .  ubfami l y  K. 
member 3 
KCl1n2 Potas ium i ntermediate/ mal l 
conductance calc ium act ivated 
channe l ,  ubfami l y  N ,  member 2 
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2.-l.4 l\ J ea u rement of vent ricula r myoc te hortening 
The apparatu,>  u'>ed to mea ure ventricular myocyte hortening i i l l u  trated in Figure 
2.-1- and measurement were performed us ing pre iou Iy  de cribed techniques [ _  2 ] .  In  
brief. fre h l  I i '>olated entricu lar m cyte were al lowed to ettle on the gla bottom of 
a Perspe chamber mounted on the tage of an i nverted micro cope (Axiovert 35 .  Zei . 
Gott ingen .  Gemlan ) and ie\ ed with a lOX object ive len and with a h igh peed video 
camera ( M yotrac. Cry tal Biotech .  UT. SA) .  Myocyte were uperfused (3 -5 mllnt in )  
\ i tb nOI1TIal Tyrode ( T) conta in ing the fol lowing i n  mM:  1 40.0 aCL 5 .0 KCL ] .0 
Mg 1 2 . 1 0.0 g lu  0 e. 5 .0  H EPES. ] . 8 CaCh (pH 7 .-1-) .  Inflow of NT sol ution to the 
chamber was control led by two micro pump ( P07002-39/P07002-33. Cole-Parmer. 
SA) .  Outflow and the level of fl u id  in the chamber wa control led by a gla s tube 
dipp ing i nto the chamber and connected to a wa te bott le which wa connected to a 
vacuum l i ne .  The temperature of the chamber ol ut ion wa maintained at 35-37 °c by a 
temperature control ler (TC-20. NPI ,  GenTIany), which compri ed a heat ing coi l  wound 
around the i nflow l i ne and a thermo tart dipping i nto the chamber solut ion. Ventricular 
myocyte were t imulated at ] Hz  (SD-5 St imulator, Grass I n strument, USA)  us ing 2 
plat i num electrode posi tioned at e i ther ide of the chamber. Myocyte hortening was 
recorded wi th  a v ideo edge detection y tem (VED- 1 1 4. Cry tal B iotech. 
orthborough. MA,  USA) .  
M yocyte wi th  nOI111al rod- haped morphology and table horten ing duri ng electrical 
t imu lat ion were elected for experi ments .  Cur ors of the v ideo edge system were 
po i t ioned over the edges .  Re t ing cel l  length ( RCL),  t ime to peak (TPK) shortening,  
t ime to half (THALF) relaxat ion and ampl i tude of horten ing (expressed as a % of 
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re<,t ing cel l  length) were mea ured.  Data v. ere acquired and analyzed with S ignal 
A\ erage ,>oftware (v 6 .37 .  ambridge Electronic De ign . Cambridge. UK) .  
2.4.5 M ea u rement o f  i n t racel lu lar  Ca2+ concentrat ion 
The fluore ence photometr y'tem hown in Figure 2..+ was u ed to mea ure 
i ntracel l u lar Ca2+ concentration i n  m ocyte loaded with the fluore cent indicator fura-2 
AM ( F- 1 22 1 .  Molecular Probe . Eugene, OR. SA) .  
Myo te were loaded wi th the fluore cent indicator fura-2 AM according to pre iou ly  
de  cribed techn ique [ 282 ] .  In  brief. 6 . 25 )1 1 of a 1 .0 mM tock olut ion of fura-2 AM.  
di  solved i n  d imeth 1 u lpho ide  (DM SO) was added to  2 . 5  ml  of  cell to give a fi nal 
fura-2 concentration of 2.5 )1 M .  Myocytes were haken gently for 1 0  m in  at room 
temperature. After loading with fura-2 AM,  myocyte were centrifuged at ..+00 rpm, 
wa hed wi th T to remove extracel l u lar fura-2 and then left for 30 min  to en ure 
complete hydr01y i of the i nt race l lu lar e ter. To measure i ntrace l lu lar Ca2+ 
concentration. myocyte were al ternatel y  i l l um inated by 3..+0 and 380 nm l ight  using a 
monochromator (Cairn Research. Faver ham ,  UK)  which changed the exci tation l ight 
every 2 m . The re u l t ing fluore cence emi tted at 5 1 0 nm wa recorded by a 
photomul t ip l ier tube and the rat io of the emi tted fluore cence at the two excitation 
wavelength ( 3"+0/380 rat io) wa calculated to provide an i ndex of i ntracel lu lar Ca2+ 
concentrat ion . Re t ing fura-2 rat io,  TPK Ca2+ transient ,  THALF decay of the Ca2+ 
tran ient and the ampli tude of the Ca2+ transient were mea ured i n  e lectrical ly  
t imulated ( I  Hz)  myocyte mai ntai ned a t  35-36 0c . Data were acquired and analyzed 
wi th S ignal Averager software v 6 .37 (Cambridge Electronic De ign,  Cambridge, UK . )  
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Figure 2 .-1- :  Electrophy iology y tern . (a )  Ant i -v ibration table, ( b )  Farady cage. ( c )  
Inverted micro cope. (d )  Ce l l  perfu ion  y tern. (e )  Temperature control ystem, ( f) 
ideo edge detect ion y tern. ( g )  Flore cence photometry y tern and ( h )  Electrical 
t imulator. 
2.4.6 Mea u rement of arcopla rrUc reticu l u m  a2+ t ran  port 
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R Ca2+ was a e ed u i ng previou Jy  described technique [6 L 2 2 ] .  After 
e tabl ! .  h i ng teady tate Ca2+ tran ient i n  e lectrically t imulated ( I  Hz )  myocyte 
mai ntained at 35-36 °C and loaded with fura-2 .  ti mu lation wa paused for a period of 5 
ec. Caffeine ( 20 mM)  wa then appl ied for 1 0  ec u ing a olution switching device 
cu tomized for rapid olut ion exchange [ 283 ] .  Electrical t imu lation wa then re umed 
and the Ca2+ tran ient were al lowed to recover to teady state .  SR-relea able Ca2+ wa 
a .e sed by mea uring the ampl i tude of the caffeine-e oked Ca2+ tran ient .  Fractional 
relea e of R Ca2+ wa a e sed by compari ng the ampl i tude of the electrically-evoked 
teady tate Ca2+ tran ient  with that of the caffeine-evoked Ca
2+ transient .  Ca2+ refi l l ing 
of the SR  wa a e ed by mea uri ng the rate of recovery of electrical ly-evoked Ca2+ 
tran ient fol lo\ i ng appl ication of caffeine .  
2.4.7 Asse sment of myofi lament  sensi t i vi ty  to Ca2+ 
M ofi l ament en  i t i  i ty to Ca2+ wa asse sed us ing previou ly de cribed technique 
[ 2 8"+ ] .  I n  some cell hortening and fura-2 ratio were recorded s irnul taneou Iy. 
M yofi lament en i t i vi ty  to Ca1+ wa a e ed from phase-plane diagram of fura-2 rat io 
v . cel l  length by mea uring the gradient of the fura-2-cell length trajectory during  late 
rel axation of the twi tch contraction .  The posit ion of the trajectory reflect the relat ive 
myofi lament re ponse to Ca
1+ and hence. can be u ed as a measure of  myofi lament 
en  i t iv i ty to Ca1+ [ 285. 286 ] .  
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2.4.8 M ea u rement of L-t pe Ca2+ curr nt 
L-type 
' +  
a- current � a  mea. ured u i ng whole-cell patch -clamp according to 
pre\ iou,>l} de�cribed technique [2 I ] . Figure 2.5 how, the arrangement of the patch 
clamp �y tern . Cell � ere mounted on the tage of an in erted micro cope ( Nikon 
E LIP E Ti .  i kon Instrument Inc.  SA) .  L-type Ca�+ current was recorded with an 
A opatch 200B ampl i fier Molecular De ice . Sunnyvale, CA. SA) l i nked to an NO 
i n terface ( Digidata 1 200. Molecular Devic . USA)  connected to a computer. The analog 
s ignal W�L fi l tered u ing an eight-pole Be el fi l ter with a bandwidth of 5 kHz and 
digit ized at a .ampl ing rate of 1 0  kHz under software control (pClamp 8 .2 ,  Molecular 
Devices. Sunny ale. CA, USA) .  Patch pipette were fabricated from fi lamented BF 1 50-
6- 1 0  boro i l i cate gla (OD = 1 .5 mm, Sutter In trument. CA. USA) us ing a hori zontal 
pul ler ( Sutter I n  trument Co. CA, SA). Pipette t ip  were fire-pol i shed using a 
m icroforge (Zei I D03. Germany) .  The pipette was carefu l l y  moved to the cel l  urface 
by u ing a three-axi micromanipulator ( PatchStar. Scient ifi ca. U K). A tight eal 
(Giga eal ) between the membrane and the tip of the pipette was obtained by the 
appl ication of suction through the pipette. Further suction was appl ied in order to 
di rupt the membrane and ach ieve whole cel l configuration.  Cel l that had stable 
current  wi th in  the  thi rd to fifth min  after e tabl i sh ing  whole cel l  mode were used i n  the 
majority of our experiment . The whole cel l bath solution contained the fol lowing i n  
mM:  1 45 NaCI ,  2 MgCI 2, 2 CaCh, 10  H EPES and 10  glucose, pH  wa adj usted to  7 . 35 . 
The rate of olut ion flow to the recording chamber wa control led by two micropump 
( M i cropump. Inc . .  W A. USA) .  
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The pipette olution contained the fol lo\ ing in mM : 1 40 C CL 2 MgCI 2 • 1 0  TEACI .  1 0  
EGT . 1 0  HEPES. I g TP (pH 7 .25 ) .  Electrode re�i lance ranged from 3 to 5 MD. 
and ..,eal re i stance. � re 1 -5 GD. Serie re i tance were compen ated to > 75o/c of the 
uncompensated alue. Exp liment were performed at 34-36 0c. The current-vol tage 
relali n 'hip \ a obtained by applying  300 m te t pul e i n  the range -60 mV to +70 
m i n  1 0  mV . tep from a holding potentia1 of -50 mY.  The ampl i tude of current 
were normal ized 10 cel l  membrane capaci tance ( nAIPF). The teady-state inacti at ion 
of Ca2+ current a mea ured a the relationship of ampl i tude of the peak current at a 
te t pul e of 0 mY to ampl i tude of the peak current at 1 000 m long pre-pul e to 
\'ariou voltage between -50 and +30 mY.  Normal i zed peak current measured after 
the e pre-pu lse were plotted agai nst the re pect ive pre-pul se potential . Ti me course of 
recovery from i nacti vat ion wa i nve t i gated u i ng a two-pulse protocol . Two 1 00 m 
depolariz ing pul e to + 1 0 mY were eparated by in ter-pu lse i nterval with variable 
durat ion. Peak Ca2+ current  ampl i tude mea ured by the second pul e was normal i zed to 
that mea'ured by the fi r t pul e and their rat io wa plotted again t the i nter-pul e 
in terval . Data were acqu i red and analyzed wi th pClamp software v 8 .2 .  
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Figure 2 . 5 :  Patch clamp y tern . (a)  Patch pipette. (b )  M icromanipulator. (c)  I nverted 
l ight micro cope, Cd )  Ant i -v ibrat ion table. (e )  Faraday cage to hie ld the y tern from 
ambient elec trical noi e .  ( f)  Ampl i fier. (g )  Analogue to digital converter and (h )  
M icromanipulator contro l .  
2.4.9 \Ve tern blot 
2.4.9. 1 ample col lect ion,  prote in  e t raction and quant i fication 
amples of left ventric le t i s  'ue were acquired from the ape of the heart , frozen 
immediately in l iqu id ni trogen and tored at - 0 °c pending further proce ing. For 
proce i ng, frozen left ventricle t i  ue were allowed to thaw and were then weighed . 
wa�hed with ice-cold 0.9% normal al ine ,  mi nced and homogenized ( 25% wi ) i n  
i ,otonic 1 00 mM pota "ium pho ph ate buffer (pH 7"+) contai n ing I mM EDTA and 0. 1 
mM phen ImethyL u lfonyl florid (PMSF-protea e i nh ibi tor, S igma Aldrich) .  The 
homogenate wa centrifuged for 1 0  min at 6000 rpm at 4 °c and the upematant wa 
col lected. The protein content wa mea ured by Bradford assay according to previou Iy  
de, cribed technique [ 287 ] .  Sample were al iquoted and stored at -80 °C.  Al l  the 
procedure were perfonned on ice to prevent proteolysis of prote ins .  Protein content 
wa quant ified u i ng pectrophotometry (Beckman Du-70, A LT, EL USA) .  
2.4.9.2 Preparat ion of Sod i u m  dodecyl-sulphate polyacrylamide gel electrophoresis 
The apparatus u ed for preparation of the odium dodecyle-sulphate (SDS)  
Polyacrylamide gel electrophore i i ncl uded a vertical clamp tand, cassette plate , 
ca t ing tand, eparator and comb.  1 0% SDS poly acrylamide gel was prepared u i ng 
two different layers of acryJamide gel .  The eparating gel ( l 0 ml  gel contai n i ng. 2 .5 ml  
of 1 .5 M Tri -ba e pH  8 .8 ,  1 00 � J of 1 0% SDS, 3 .33  ml  of 30% acrylamidelbi . 50 � l  of  
l O% ammonium per u lfate (APS), 5 � J  of TEMED and 4.02 ml di  t j ] ]ed water) wa 
prepared and loaded i nto the apparatus .  Th i s  l ayer j re  ponsible for eparat ing the 
protei n by i ze .  
Oi t i l led water wa added onto the top of the eparati ng gel to prevent the gel from 
drying.  When the gel polymeri zed. ater was removed, and the tacking gel (5 ml gel 
contain i ng. 1 . 75 ml of 0.5 M Tri -HCL pH 6 . .  50 1-\ 1  of 1 0% SO , 650 1-\ 1  of 30% 
acr lamid Ibi �. 25 1-\ 1  of 1 0% P and ] O  1-\ 1  of TEMEO) wa loaded onto the top of the 
�eparat ing gel .  A comb \ a '  i n  erted i nto the tacking gel in order to form well . Once 
the gel \\ a · et. the comb wa removed and the SOS-PAGE was ready for load ing .  
2.4.9.3 Protein expre i on 
Prote in, equi valent to 25 -70 I-\g ( Table 2 .2)  from edentary controL exerci e trai ned 
control , edentary GK and exerci e trai ned GK rats were mixed with a ample buffer 
( l 2 .5o/c of 0.5 M Tri s-ba e pH 6 .8 .  1 0% glyceroL 20% of 1 00/£ (w/v) SOS, 5% 2-b­
mercaptoethanol and 2 .5% of 0.05% (wi ) bromophenol b lue)  to give a fi nal olume of 
30-ol0 ).1 1 . Samples were heated for 1 0  m in  at 95 DC fol lowed by a brief spin for ] 0 sec . 
About 1 5  1-\ 1  of sample m ixture and 5 ).1 1 of pre- tai ned tandard protei n-molecular 
weight marker ( Pre tained S OS-PAGE Standards. broad range B io-Rad Laboratorie , 
Hercules .  CA, USA) were loaded onto the prepared ] 0% S OS gel and electrophore ed 
at 1 00 V i n  runn ing buffer (25 mM Tri -ba e. 1 92 mM glycine and 0. 1 0/£  SOS,  pH 8 .3 ) .  
After the run .  the ge l  wa detached from the cas  ette plate and washed for 20 min  with 
tran fer buffer at room temperature. The separated prote in  were then tran ferred 
electrical l y  at 80 V on to a n i troce l l ulo  e membrane ( Schleicher & Schuel l ,  Protran) for 
2 hr at -+ °c i n  transfer buffer ( 1 1 9  mM Tri s-ba e, 1 92 mM glyc ine and 20% methanol ) 
a previou ly de cribed [288 .  289 ] .  A successfu l  prote i n  transfer wa ind icated by the 
complete tran fer of pre- tai ned molecular weight marker onto the n i trocel lu lo e 
membrane. on-specifi c  b inding s i te were then blocked by i ncubat ing the membrane 
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overnight i n  5o/c fat free mi lk  at 4 0c. wa hed twice with Tri -bufferd al i ne (TBS)  
con tain ing 0.059C Tween 20  (TB T) � r 1 0  min each.  and then probed with primary 
ant ibodie� a':> l i "ted in Table 2 . 2  for 2 hr' at room temperature .  Primary antibodie were 
d i luted in 59C fat free m i lk blocki ng agent .  The membrane wa wa hed in everal 
change of TB T and TB buffer . and then incubated with econdary antibody for I hr 
at room temperature .  Later. the membrane were wa hed twice for [ 0  min with TBST 
and twice with TBS buffer (TBS buffer wa prepared as a 1 0  tock solut ion and 
di l uted I :  1 0  to make I x working olut ion .  1 x TBS buffer contai ned 20 mM Tn -HCI 
and 1 50 mM NaCl .  pH 7 .4) .  
2A.9A Blot development and protei n detect ion 
The blot wa de eloped u ing Thermo Scient ific Pierce ECL 2 We tern Blotti ng 
Sub trate .  Each blot was i ncubated with 1 .23 ml working olut ion for 5 min at room 
temperature. The sub trate working olut ion wa prepared by mi ing ub trate A and 
ub trate B in a 40: 1 rat io .  The blot wa removed and dried u ing absorbent ti ue to 
remove exce l iqu id .  The blot wa placed on a Typhoon Imager (Typhoon FLA 9500) 
wi th the protein  ide faci ng down.  and canned u ing the 473 nm exci tation and LPB 
(5  1 OLP) emi  ion fi lter i n  fl uorescence mode to v i  ual i ze the  protein  band . The protein 
band were then quantified u i ng ImageQuant TL 7.0 oftware. To check for equal 
loading.  each of the blots were also incubated with tripping buffer contai n ing 62 .5  mM 
Tn -HCI ; pH 6 .7 .  1 00 mM �-mercaptoethanoL 2% S DS .  for I hr at 56 °C. Thi s  step wa 
es enti al to remove primary and secondary antibodie from the blot .  The blot was then 
blocked overnigh t  wi th  5% fat [Tee mi lk  blocking agent at 4 °c and i ncubated with 
i n ternal control ant ibody. �-acti n was u ed as an in ternal control . The densi ty of each 
band v. a� then normal i zed to the internal control . The i nten i ty of the band wa 
calculated and expre ed a a re lative i nten i ty compared to the control edentary 
protein . .  v" hich wa arbi trari l taken a 1 00%. The anal y e were representative data of 
three i ndependent experi ment�. 
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Table 2 .2 :  Characteri. t ics of protei n  and primary and econdary antibody 
Prote in Prote in Prote in Pri mar antibody Secondary 
i ze ( Il g )  anti bod -
(kDa) d i l ution 
Conne in 37 '+5-55 70 Connex in  37 ant ibody ( M - 1 9 ) . 1 : 2000 
Di lution 1 :  1 00 
Connex in  .+3 .+3 50 Connexi n  .+3 antibody ( D-7) .  ] : 2000 
Dil ut ion 1 : 200 
L-type Ca-+ 50-70 50 L-t pe Ca-+ CP 2 antibody ( F- 1 : 2000 
29). Di lution 1 : 200 
Tropomyo i n  3.+ 25 Tropomyosin  antibody (C-3) .  1 : 2000 
Di lution 1 : 200 
�- ct in .+2 SO �-Act in  antibody (C-4) .  1 : 3000 
I Di lut ion 1 :  1 00 
Primary and econdary antibodie were purcha ed from Santa Cruz B iotechnology, CA, 
SA .  
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2.4. 1 0  Drug prepa rat ion for ventricular m 'ocy te experi ments 
PlO ( E69 1 0. igma- Idrich ) wa di 0 1  ed in  1 00� DMSO to produce O.S . S and SO 
m M  toc,", solut ions which \\ ere tared at -20 °C. PlO olut ion were prepared b 
addit ion of , tock 'olut ion T to achieve 0. 1 .  I and 1 0  mM bath olut ion. Final 
DM 0 concentrat ion \Va 0.02% in all te t olut ion . Experimental olution were 
prepared from , tack , olut ion immediate ly prior to each e periment. Therefore. the ce l l s  
v. ere perfused wi th  the  fre h l y  made bath olut ion contai n ing the desired 
concentrat ions of the drug . 
2.4. 1 1 III vivo B iotelemetry 
Figure 2 .6a-e how the procedure and apparatus u ed i n  the biotelemetry tudy. Heart 
b iopotential wa moni tored with a biote lemetry system ( Data Science In ! . .  St PauL 
Ml . SA)  u ing pre jou Iy  de cribed technique [ 203. 290 ] .  The system compri ed the 
tran m i tter de ice (TA I 1 CTA-F-t.O. Data Science In t . ) .  the recei er ( RPC- I ,  Data 
Science I n t . )  a data exchange matri x ( 20CH,  Data Science In t )  and a per onnel 
computer for y tem configurat ion . control , acqui i tion.  torage and analy i . 
2 .4. 1 1 . 1  S u rgery 
The tran mi tter de Ice were urgica l ly  i mplanted in 7 male GK and 7 male Wi tar 
control rat . 6 month of age, under general ane the ia ( sodium pentobarbi tone. -t.5 
mglkg. i .p) .  Transmi tter device were i n  erted i nto the peri toneal cavity with the 
electrode protruding caudal ly  ( towards the tai l )  and arranged in Einthoven bipolar lead 
I I  configuration (right foreleg and left i de of che t at the level of the last rib ) .  
Tran mit ter were acti vated by use  of  a permanent magnet wi tch .  
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2.4. 1 1 .2 E peri mental protocol 
Before . urgical implan tation of the tTan mi tter device non-fa ti ng blood alucose and v e 
body \\ e ight were measured. After an overn ight  fa t a gluco e tolerance te t wa 
admin i .  teredo B lood gluco e wa. mea ured at t ime zero ( fa t ing blood gluco e) and 1 20 
m in  C l Iowing admin i ,trat ion of gluco e (2 g/kg body weight,  i .p) .  Surgical 
implantation of tran mi t ter was then performed. Data acqu i i t ion commenced one 
week after surgery and cont i nued throughout the tudy. Body weight and non-fa t ing 
blood gluco e a mea ured at the end of each PIO do e period and at the end of the 
experi ment .  An imal  recei ed tandard rat chow ad libitulll throughout the experiment .  
2A. l l .3 Treatment  p rotocol 
DUli ng the fi r t few week animal received normal dri nking water. Duri ng week 4-
ani mal recei ed WaterlDMSO (0. 1 9% v/v) .  week 5 -6 Water/DM SOIPIO 2 .5  mg. 
\\ eek 7- Waterl DMSOIPIO 5 mg, week 9- ] 0  WaterlDM SO/PIO 1 0  mg, week 1 1 - 1 2  
WaterlDMSOIPIO 20 m g  and week 1 3 - 1 4- back to Waterl DMSO. 
2A. 1 1 .4 Drug preparat ion for biotelemetry study 
PIO tablet (Actos - Takeda Pharmaceut ical ,  Tokyo. J apan) were u ed i n  th i  
experiment . A tablet wa cru hed i nto a fi ne powder. d i  olved i n  DMSO and d i luted 
w i th water to form a u pen ion .  The u pension wa u ed to prepare the requ ired 
concentrat ion of PIO ( accord ing to the treatment protocol i n  Section 2 .4 . 1 1 .3 )  and 
di olved i n  a small  volume of water. When the animals  had can umed the drug 
contain i ng water. the bottles were refi l led wi th water. Drug uspension was prepared 
fre h on a dai ly  ba i s .  Final DMSO concentrat ion wa 0 . 1 9  v/v throughout the tudy. 
2.4. 1 1 .5 Da t a  collection 
E G dala wa col lected for 5 mi nlhour/anima1l24 h .  From the col lected ECG data. 
econdar phy iological mea urement were detenni ned. i ncl uding the average 5 min 
HR and HRV.  
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Figure 2 .6 :  B iotelemetry tudy. (a) Surgical tools, (b )  Preparing animal for urgery, (c )  
Implant ing the tran miner i n  i ntraperi toneal cavi ty and (d) admin istration of antibiotic 
and (e)  Animal cage i tt ing on biotelemetry receiver . 
2.4. 1 2  Tran O1i ion electron micro copy 
2.4. 1 2 . 1  a m ple proce i ng 
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Fre.,h l)  i olated left ventricle ample from -1- group of animal were cut i n to -1- mm x -1-
nun pice, and tran ferred i nto Kamov ky fi ati e ( 2 .5% paraformaldehyde. 25% EM 
grade glutaraldehyde. 0. 1 M sodium pho phate buffer, pH 7.2) i n  gla vial . Sample 
were wa. hed in 0. 1 M phosphate buffer 3 t imes for 1 5  min each and stored at -1- °c unt i l  
further proce ' ing. Samples were then treated with 1 % 0 mium tetroxide buffered in  0. 1 
M pho�phate buffer for one hour at room temperature on a rotamixer. fol 1owed by 
v. a h i ng wi th d i  t i l led water and dehydrati on i n  graded ethanol a fol low : 1 5  m in  each 
i n  30%. 50%. 70%, 80%, 90%, ethanol . and 2 change in absolute ethanol and 
propylene 0 i de .  Ti sue were then treated wi th agar re in-propylene oxide mixture a 
1 :  1 ,  1 : 2 and 1 : 3 ratio  for 1 hour each . and transfeITed in to pure re i n  at -1- °c overnight .  
Re i n  wa compo ed of 23 g Agar 1 00 epoxy re in .  1 3  g Dodecenylsucc in ic  anhydride, 
1 -1- g Methylnadic anhydride. and 1 . 1  Tri Dimethylami nomethyl pheno1 .  
T i  'ue  were then embedded 1 11 fresh res in  u i ng flat molds. Polymeri zat ion was 
performed at 65 °C for 2-1- hr . ltrath i n  ections ( 90- I 00 nm) were cut wi th a Diatone 
kn ife (Agar Scient ifi c. E e . England) and mounted on 3 .0 mm 200 me h copper grids .  
The ect ion were tai ned wi th saturated uranyl acetate for 50 min  and lead c i trate 
olut ion for 25 m i n .  U l trath i n  sect ions were scanned and photographed u ing a Phi l l i p  
CM I 0  elec tron m icroscope (E indhoven, The etherland ) .  
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2.4. 1 2 .2 M orphometric anal 
number f electron micrograph �ectjon were taken per rat i n  each group. The 
number of mi tochondria i n  a given area wa counted manual ly .  The arcomere length 
and vv idth were mea ured u i ng Image J oftware . The average number of mi tochondria 
number and the a erage arcomere length and width were calculated. I ntercalated di c 
feature. were e aluated i ual l  and membrane convolut ionllength un i t  was mea ured. 
2.4. 1 3  Stati t ical a naly i 
Re ul ts  were expre ed a. the mean ± SEM of ' n '  observation . ' n '  refers to number of 
animal or number of ventri cular myocytes .  Data were analyzed by the I ndependent 
. ample He t .  Paired ample t-te t or ana]y i of variance ( A  OVA ) with Bonferroni 
post hoc a� appropriate, us ing I B M  SPSS S tati t ic for Window , Ver ion 20.0 ( IBM 
Corp. Armonk. Y ) .  P alue < 0.05 were considered i gnificant and P < 0.0 ] were 
con idered h igh ly  ign ificant .  
Chapter 3 :  Re u l ts and Discu sion 
3. 1 horterung and i n t racel lu lar  Ca2+ i n  ventricular myocyte and exp re ion of 
gene encod ing cardiac mu de p rotein in ea rly on et type 2 d iabetic Goto­
Kakizaki ra 
3. 1 . 1  I n t roduction 
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The total number of people with diabete j projected to ri e from 1 7 1  mi l l ion in 2000 
Lo 366 m i l l ion i n  2030 [ 95 ] .  The a ociation between type 2 diabete and obe ity is  
very trong and cardiovascular di ea e i the major cau e of morbidi ty and mortal i ty i n  
d iabetic patient [ 96. 29 1 ] . The GK rat i one of the be t characterized genetic animal 
model of type 2 d iabete . Thi train wa created by e lect ive breeding of an outbred 
colon. of Wi tar rat . wi th select ion for h igh gluco e levels i n  an oral gl uco e tolerance 
test [ 1 90] . Type 2 d iabete in the OK rat appear to be polygenic with at least three 
different  loci i nvolved in the di ease [ 1 97 ] .  General characteri t ics of the GK rat i nclude 
fa t ing hyperglycaemia.  i mpai red secretion of i n  u l i n  i n  respon e to glucose both in 
)'ivo and in i olated pancrea . rai ed HbA j hepatic and peripheral insu l in  resi tance and 
a variety of l ate compl i cation i ncludi ng nephropathy and neuropathy [ 1 90 ] .  The 
et iology of d iabete in O K  rat i ncludes a decrease of pancreat ic in u l i n  store and 
reduced beta-cel 1  mas and prol iferative capacity, reduced beta cell ensi t iv i ty to 
g lucose, i mpai red insu l in  rel ea e, under expre ion of GLUT2 in beta cel l s  and 
reduction in GLUT..f prote in  in G K  heart . Previou tudie , which have been general ly 
performed in adul t  ani mal , have demon tJ"ated a variety of contract i le  dysfunctions in 
GK rat heart inc luding decreased heart rate, decreased ejection fract ion, mai n ly a a 
resul t  of a 10 i n  LV longitudinal contract ion, and prolonged t ime-cour e of hortening 
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and/or relaxation i n  ventricu lar myocyte . The e contracti le d function have been 
part ly  attri buted to defect in Ca2- tran port and myofi lament en i t iv i t  to Ca2+ [ 1 92 .  
20-k 2 5 ] . Defecti e contraction and Ca2+ tran port rna i n  turn be attributed to change 
i n  the expression of gene, and remodel ing of protei n . Al tered expre ion of gene that 
encode ariou, L-type Ca2+ channel pr te i n  ( Cacna lc .  Cacnb2. Cacna2dl )  and cardiac 
m u, cle prote in  (Myh6. Myh 7. My12. TIlIlC 1) ha been reported in GK rat fed h igh fat 
diet and in Zucker type 2 diabetic fatty rat [ 28 1 .  284 ] .  
The a im  of  the current study wa  to  characteri ze the expre ion pattern of gene 
encoding cardiac mu 'cJe prote in  and myocyte hortening and i ntracel lu lar Ca2+ 
concentration i n  oung  ( 8- 1 0  week of  age ) type 2 diabet ic GK rat heart . 
3. 1 .2 Re u J ts 
3 . 1 .2. 1 General characteristic of t h e  a n i ma ls 
I n  order to characterize the diabetic state i n  the early tage of diabete of the GK and 
age matched control rat . blood gluco e and body weight were mea ured at a young age 
( 7  week ) .  Fa t ing blood gluco e wa signi ficant ly (P < 0.0 1 )  elevated i n  GK rats 
( 1 24 .-+0 ± 9 .86 mg/dl ) compared with control animals ( 73 . 1 0  ± 2 .48 mg/d l ) .  After an 
overn igh t  fa t and at 1 20 m in  fol lowing a glucose challenge ( 2  g gluco e/kg body 
weight. i .p ) .  b lood gluco e was ignificant ly  (P < 0.0 1 )  elevated i n  GK rat ( 2 1 8 . 50 ± 
23 .93 mg/d l )  compared wi th control animal (95 .60 ± 3 .65 mg/dl ) .  The e resul ts  
confi rmed the diabetic state of the GK rat . 
At 8- 1 0  weeks of age, the experi ments were tarted . The general characteri stic of GK 
and control rat obtained immediate ly  before the experiment are hown in  Table 3 . 1 .  
9.+ 
Bod) \\ eight wa not ign ifi cant ly ( P  > 0.05 ) al tered. non-fa r ing blood gluco e and 
heart weight were ign i ficamly (P < 0.0 I )  elevated and heart weight to body weight 
rat io was not ign i fi cant ly (P > 0.05 ) al tered i n  GK rat compared with age-matched 
control ani mal s .  
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Table 3 . 1 :  General characteri t ic of GK compared to control rat 
Control GK 
Body weight (g)  2 1 8 .50 ± 8 .65 2.+6.-+0 ± 1 1 .97 
Non-fa l ing blood gluco e (mgld J )  1 1 8 .40 ± 6.53 1 66 .-+0 ± 1 .+ .33** 
Heart weighl ( g) 0.96 ± 0.03 1 .05 ± 0.02* *  
Heart weight to body weight ratio .+ .43 ± 0. 1 1  4 .33 ± 0. 1 5  
( me/g) 
Animal were 8- 1 0  week of age .  Data are mean ± S .E .M.  tat i  t ical compari on were 
perfomled u i ng  i ndependent amples He t, n = 1 0  animal . **  P < 0.0 1 
3. 1 .2 .2  E pre ion of cardiac mu de m R N A  
Expre�"ion of  cardiac mu .  Ie  me�. enger R 
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(mR A) was a e ed in oung 8- 1 0  
\\ eek GK and age-matched control rat u i ng real t ime RT-PCR a ay a de cribed in 
-.ection 2 .-+ .3 .  Level '  o f  mR A reflecting the  expre ' ion of gene encodi ng a variety of 
cardiac mu cle and ion channel prote in are 'hown in Figure 3 . 1 -3 .7 .  Expre ion of 
gene, enc d ing cardiac muscle protein (Myh617, Mybpc3, Myll/3, Acre l .  Tnni3. Tnn2. 
Tpll1 !/2f..1. and Dbi) and int erce l lu lar protein ( Gja l/-I/5/7, Dsp and Cm'1I3) were not 
ignifi cantl (P > 0.0 ) al tered in GK compared wi th control entric le (Figure 3 . 1 and 
Figure 3 .2 .  re pect ively) .  Expres ion of gene encoding some membrane pump and 
exchange protein (Alp I  a 112, A rp l  b I  and Sle8a1 )  ( Fi gure 3 . 3 )  were not ign ificantly ( P  
> 0.05 ) altered, whi l  t others were ei ther ign ifi cantly (P  < 0.05 ) upregulated (Arp!  a3) 
or s ign i ficantly (P < 0.0 1 )  dO\ nregulated (Sle9a 1 ) .  Relat ive expression of A tp!  a3 wa 
_ .6 1 ± 0.69 ver u O .  -+ ± 0.23. and SIc9a 1 wa 0.62 ± 0.07 versu 1 .08 ± 0.08 in GK 
compared with control ventric le .  Expre ion of gene encoding some calc ium channel 
protei n  ( Caena I cl1 g, Cacna2d1l2d2 and Cacnb1/2) ,  odium channel prote in  (Sen5a) 
and pota i um channel protei ns (Kcna3/5, Kenj3/5/8/1 11I2, Kehip2, Kenab l ,  Kcnbl ,  
Kmd1l2/3. Kenel/4. Kcnq1 .  Kcng2, Kcnh2, Kellk3 and Kenll2) were not sign i ficantly 
(P > 0.05) al tered. wh i l  t other were ei ther s ignifi cant ly  (P < 0.05 ) upregulated 
CCaena 1 h, Sen 1 b and Hen2) or igni fi cantly ( P  < 0.05) downregulated (Hen4, Kena2/"/' 
and Kcnj2) ( Figure 3 .-+  and 3 .6 .  re pectively ) .  Relat ive expre sion of Caena 1  h was 0.95 
± 0. 1 6  ver us 0.-+7 ± 0.09. Sen 1 b wa 1 . 8"'- ± 0. 1 6  ver us 1 . 1 1 ± 0. 1 1 and Hen2 was 1 .55 
± 0. 1 5  versu 1 .03 ± 0.08 in GK compared w i th control ventricle .  Relative ex pre ion of 
Hen';' wa 0. 1 6  ± 0.03 ver us 0 .37 ± 0.08. Kena2 was 0.35 ± 0.03 ver us 0.80 ± 0. ] I .  
97 
Kcna4 \\ a� 0.79 ± 0.25 I'er Uj 1 .90 ± 0.26 and Kcnj2 \ a 0.52 ± 0.07 versus 0.7 ± 0.0 
in GK compared with control entricle .  Expre �ion of genes encoding Ca�+ tran port 
(Afp2a J/2 and Ryr2) and Ca:!+ regulatory protei n ( Casq2, PIn. Ca11712. Comk2d and 
Prkaa2)  v. ere not - ign i fi cant ly ( P > 0.05 ) altered ( Figure 3 .7) .  
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Figure 3 . 1 :  Expression of genes encoding anou mu c le  protei ns .  The relat ive 
quanti t ie  ver u Gapdh of gene encoding vanou muscle prote ins  i n  ventricular 
mu cle o  Data are mean ± SEM.  Stat i st i cal comparison were performed u ing 
i ndependent ample He t .  Ti ue amples are from 9- 1 0  heart . Arb = Arbitrary. 
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Figure 3 .2 :  Expre ion of gene encoding i nterce l lu lar protein . The relative quant i t ies 
ver u Gapdh of gene encod ing variou i ntercel lular protein i n  ventricular mu cleo  
Data are mean ± SEM.  Stati t ical compari ons were perfom1ed u i ng i ndependent 
ample He t. Ti ue amples are from 9- 1 0  hearts .  Arb = Arbitrary. 
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Figure 3 . 3 :  Expression of gene encoding membrane pump and exchanger prote in . The 
relative quant i  t ie  ver u Gapdh of gene encoding various membrane pump and 
exchanger protein i n  entri cular mu cle.  Data are mean ± SEM. Stat istical compari sons 
were performed us ing i ndependent ample He t. Ti s ue ample are from 9- 1 0  hearts. 
* p < 0 .05 , ** P < 0.0 ] .  Arb = Arbi trary. 
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Figure 3 .4 :  Expre ion of genes encoding calc ium channel proteins .  The relative 
quanti t ie ver u Gapdh of gene encoding variou calc ium channel prote i n  i n  
ventricu lar mu cleo  Data are mean ± SEM . S tati t ical compruisons were perfolll1ed 
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Figure 3 . 5 :  Expre ion of genes encoding odium channel protein . The relat ive 
quanti t ie  \ 'er u Gapdh of gene encoding ariou odium channel proteins i n  
ventricu lar mu cleo  Data are mean ± S E M .  Stati t ical compari o n  were performed 
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Figure 3 .6 :  Express ion of genes encod i n g  potassi u m  chan nel  prote i ns .  The re lat i ve q uant i t i es versus Capdh of genes encod i ng 
various potass i u m  channel  protei ns i n  ventr icu l ar m usc le .  Della are mean ± S E M .  Stat i st ical  compari sons were performed us ing 
i n depe ndent samples t- tesl .  Ti ssue samples are from 9- 1 0  hearts .  * P < 0.05, **  P < 0.0 J .  Arb = Arbi trary . 
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Figure 3 . 7 :  Expre ion of gene encod ing i ntracel l u lar calc ium regulatory protei n . The 
relative quant i t ie er u Gapdh of gene encod ing variou i ntrace l l u lar transport 
protei n  i n  ventr icular m uscle.  Data are mean ± SEM . Stati t ical compari son were 
performed u i ng i ndependent ample He t. Tis ue ample are from 9- 1 0  heart . Arb = 
Arbi trary. 
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3. 1 .2.3 Ven t ri u lar myocyte hortening and i n t rac l lu lar Ca2+ 
entricular m ocyte were i solated from oung animals ( 8- 1 0  week of age ) u. 1 l1g 
enzymat ic and mechanical d i  persal technique a de cribed in ection 2A. l .  enlricular 
myocy te horten ing  and i ntracel lu lar Ca2+ concentration were mea ured b video-edge 
detection and flore cence photometry a de cribed in sect ion 2AA and 2 ..+ .5 .  
re pect ively .  Re t i ng cel l length ( Figure 3 . 8a) .  THALF relaxation (Figure 3 . 8c )  and 
ampl i tude of 'hortening ( Figure 3 . 8d)  were not ignificantly (P > 0.05 ) al tered : 
however. TPK h rtening ( Figure 3 .8b )  wa significantly (P  < 0.05 )  prolonged i n  GK 
( 1 25 . 3 ± 3 .3  m )  compared \: i th  control myocyte ( 1 1 5 .03 ± 3 .32 m ) .  Re t ing fura-2 
rat io (Fi gure 3 .9a),  TPK Ca2+ tran ient (Figure 3 .9b) and ampli tude of the Ca
2+ tran ient 
(Fi gure 3 .9d) were unal tered. wherea THALF decay of the Ca
2+ tran ient (Figure 3 .9c ) 
\'" as ign ificantly (P  < 0.0 1 )  reduced i n  GK ( 1 48 .32 ± 4 . 88 m ) compared wi th control 





1 40 Ii) 1 40 
E E. * 2: 1 20 Ol 1 20 ..r::. c: 
Ol 100 c: c: Q) 1 00 � 1:: 0 
60 ..r::. 60 (ij (/l 
(.) � Ol 60 (I) 60 c: Q) 
- a. (/l 40 £ Q) 40 a: Q) 
20 E i= 20 
0 
0 
Control  GK Control GK 
c d 
Ii) 1 00 
E. 1 0  
Ol ::::; c: 




� ..r::. Q) (/l 4 ... Q) 
::: "0 (I) ::l ..r::. 20 ::: 
£ a. 2 E Q) � E 
i= 0 "-0 
C ontro l  G K  
Control G K  
Figure 3 . 8 :  Ventricu lar myocyte shorten i ng. Record ings of  ventricu lar myocyte 
horten ing i n  e lectrical l y  t imulated ( 1  Hz) cel l s .  (a) Mean rest ing cel l  length, (b )  Time 
to peak hortening,  (c) Time to half relaxation of horten ing and (d) Ampl i tude of 
hortening, expre ed a a percentage of re t ing cel l  length ( RCL). Data are mean ± 
S .E .M .  Stati t ical com pari on were performed u ing i ndependent samples t-test .  n = 
33-37 cel l s  from 5 heart . * P < 0.05 
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Figure 3 .9 :  Ventricular myocyte i ntracel l u lar Ca2+ . Recordings of i ntracel lu lar Ca2+ in 
e lectrical ly  t imulated ( 1  Hz)  ventricular myocytes. (a) Mean re t ing fura-2 rat io.  (b) 
Time to peak Ca2+ tran ient ,  (c )  Time to half decay of the Ca
2+ tran ient and (d) 
Ampl i tude of the Ca
:!+ tran ient .  Data are mean ± S .E .M.  Stati t ical compalisons were 
performed u i ng  unpaired tudent t test . n = 37-4 1 cel l s  from 5 hearts .  **  P < 0.0 ] 
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3. 1 .3 D i  ell ion 
The major fi nding of the tudy were a fol low : ( i )  upregu lation of gene encoding 
A lp /a3. Caella /h .  5c11 1h. and Hcn2 i n  GK compared with control left entri c le; ( i i )  
downregulation o f  genes encoding 51c9a 1 .  Hcn4. Kcna2, Kcna4 and KCI1j2 i n  G K  
compared with c ntrol left vent ric le :  and ( i i i )  unal tered amplitude of horten ing and 
i nt race l lu lar a2+ tran" ient and prolonged TPK hortening and shortened THALF decay 
of the Ca2+ tran" ient in ventricular myocyte from young (8- 1 0  week of age) GK 
ompared with control rat . 
Expre �ion of gene' encoding n ine of the 67 mea ured cardiac mu cle protein were 
ignificantl al tered: A/p i a3. Cacna 1h .  5cn i b  and HCll2 were upregulated. whi l  t 
Ic9a i .  HCIl4. Kcna2. Kcna4 and KCllj2 were downregulated in GK compared with 
control ventric le .  
The Na+-K+-ATPase i found i n  v irtual l y  al l  animal cel l s  and ha major regulatory 
function . i nc l ud ing the main tenance of in tra- to extrace l lular Na+ and K+ concentrat ion 
gradient . membrane e c i tabi l i ty and contract i l i ty. as well as secondary tran port 
proce e .  It compri e a catalytic a subunit  ( 1 00- 1 1 2  kDa) and a glyco ylated �-
ubuni t  (-+0-60 kDa). The expre ion of the a3 ubuni t  in humans is confined to adul t  
brain and heart [ 292-29-1-] .  Al though the pecific role  of A lpia3 i n  heart i s t i l l  not 
under tood. upregulation of Atp i a3 might have an effect on catalytic act iv i ty of the 
a�- K+-ATPa e .  which might in turn alter the i ntracel lu lar Na
+-K+ balance and have 
impl ication for exci tation-contraction coupl i ng. The � ubunit play an essential role in 
regulati ng cardiac contract i l i ty, and it loss as ociated wi th significant 
1 09 
pathoph iolg) of the heart [ 295 J .  The gene Atp l b l ,  which encode the � 1  ubunit  wa 
unal tered [ 295 J .  
I n  the myocard ium,  the a+- H+ exchanger i oform l (Slc90 1 )  i a pia ma membrane 
protein that regulate i ntra e l lu lar pH.  Activation of the e changer lead to the 
e tru�ion of one i ntracel lu lar proton in exchange for one e tracel l u lar odium [ 296 ] .  
Slc90 1 was downregu lated i n  GK entric le .  A pre iou tudy in the Zucker diabetic 
fatty rat ha abo reported downregulation of Slc90 1 [ 284 ] .  Downregulation of SIc90 1, i f  
accompanied by a reduction i n  exchange prote i n .  would be expected to  reduce act ivi ty 
of the ex hanger. which perhap in tum might lead to an accumulation of i ntracel l u lar 
proton '. Acidifi cation of the in trace l lu lar environment would be expected to have a 
variety of effects on e ci tat ion-contraction coupl ing, i ncluding al tered myofi lament 
en i t iv i t  to Ca
2+ : a feature that ha been previously demonstrated in ventricu lar 
myocyte from ageing GK rat and i n  treptozotocin- i nduced diabetic rat [ 203, 280, 
297 ] .  
The voltage-gated T-t pe Ca
2+ channel Cav3 . 2  (a I H ) ubunit re ponsible for T-type 
Ca2+ current ,  is e pre ed in d ifferent t i  ues, i nc luding cardiac muscle, and 
part ic ipate i n  pacemaker act iv i ty [ 298 ] .  The gene Cacl1o 1 II encode the a l H ubunit  of 
the T-type Ca
2+ chan nel . and upregulation m ight be expected to modify T-type Ca
2+ 
current .  Changing expre ion of Cacna 1 h might be a compen atory re pon e to the 
reduction i n  H R  that ha been previou ly reported i n  young GK rat [ 203 ] .  L-type Ca
2+ 
channel are formed by heteromul timeric complexe of a, � and y ubuni ts [ 299 ] .  The 
major L-type voltage-gated calc ium channel i n  the heart con i st of an a l e (Cav 1 .2. )  
ubuni t. usual ly a sociated with an  aux i l iary � subunit  (Cav�2) [ 300 ] .  I n  young GK 
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\ entric 1e ,  aena / c. Cacnb /  and Cacnb2. which encode a l e, � J  and �2 ubuni t  and 
play an important role in the regu lation of Ca:!+ current. were unal tered [ 30 1 ] .  
Vol tage-gated aT channel are heteromeric prote in  that function in the generation and 
propagat ion of action potentials in mu c le  and neuronal cell and are compo ed of one a 
and two � ubuni t . where the a ubunit  provide channel act iv i ty. Type 5 a prote in ,  
encoded b cn5a, i s  re pon ible for the i n i tial up troke of the action potential .  and type 
J � prote in .  encoded b Sen /b, contribute to the modulation of the kinet ics of channel 
inacti vati n. E pre ' ion of n5a wa unaltered and SCll / b wa upregulated i n  GK 
ventric le .  In terest i ngly,  previous studie have hown that mutations i n  Sen ] b are 
a ociated wi th Brugada syndrome and defect i n  card iac conduct ion [ 302 ] .  
Hyperpo]arizat ion-acti ated cyclic nucleotide-gated (HCN) channel s  contribute t o  the 
i n i tiat ion and regulation of cardiac rhythm.  The pacemaker current ( I r) i encoded by the 
HC fami l . HC i oform . i nc l uding HCI12 and Hen-/., are present in ventric lu lar t i s  ue 
of the heart [ 303. 30-+]. Previou tudie have demon trated that Hen2 and Hen4 
channel protein can a ociate with each other i n  rat ventricle and that d ifferent rat io of 
Hen2 and Hcn4 tran cript overlappi ng i n  d ifferent  t i  ue might contribute to t is  ue-
pecific propert i e  of Ir [ 305 ] .  Upregulation of Hcn2 and downregulation of Hcn4 might 
be compensatory re pon e to the reductions i n  HR  that have been previously reported 
i n  young G K  rat [ 203 ] .  
I n  contrast to the c Ia  ica l  I Kr and IKs• i t  has become evident that many cardiac t i  sue 
e pre delayed rect ifier current with faster ki netics. im i l ar to those found in nerve 
and m u  cleo and the e currents have been de ignated as I Kur. A variety of I Kur channel 
compri i ng d ifferent shaker-related clone . i nc luding Kv 1 .2 ,  Kv 1 . 3 and Kv 1 .6 have 
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been identi fied in d ifferent pecie and to different e tent in  different regjons of the 
heart [ 306, 307. 76 ] . Oo� nregulation of Kcna2. if accompanied by a reduction in 
expre��ion of Kv J . 2 channel protei n .  might alter the t ime course of repolari zation and 
contribute t the reduced HR pre iou I reported i n  the GK rat [ 203 ] .  
Rapidly acti ati ng and i nacti at ing cardiac Ito are expre,sed in mo t mammal ian 
cardiomyocyte' and contribute to the early pha e of action potential repolari zation and 
to plateau potent ial . The I [o.f and I to., are different ial l y  expre ed in the myocardium, 
and di t i nct pore-forming (a )  subuni t  underl i e  the two IlO component . Kena4 encode 
I to., channel�, and downregulat ion of Ke11a4 prote in might alter the t ime cour e of 
repolari zation and contribute to the reduced H R  previou ly reported i n  the GK rat [ 203 ] .  
Various K+ channel are involved i n  pha e 3 repolarization of  the cardiac action 
potent ia! ,  and the e channel i nc l ude K I L l (hEROl ). Kv7 . 1 (Kenq l )  and Kir2. 1 
(Ken}2) .  which are the a ubunit  that conduct I Kr, I K, and I K J .  re pectively [ 308 ] .  
Reduced Kir2 . 1  would be l i kely to prolong the tenn i nal pha e of the cardiac action 
potent ial [309 ] .  00\ n-regulation of Kcna4. if accompan ied by a reduction in ex pres ion 
of Kv l ...l channel prote in .  m ight alter the t ime cour e of repolarization and might also 
contribute to reduced H R  [ 203 ] .  
Cardiac mu d e  function wa a e sed to investigate whether the changing pattern of 
gene might be a ociated with change in the anlpl i tude and/or t ime cour e of 
ventricu lar myocyte horten ing .  Whi l  t re ting cell length. fura-2 rat io, THALF 
relaxation and ampli tude of horten ing and TPK and ampl i tude of the Ca
2+ tran ient 
were unal tered, the TPK horten ing was prolonged and THALF decay of the Ca
2+ 
tran ient  was hortened i n  GK myocyte compared wi th control myocytes .  Alteration 
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I n  the kinet ic of L-type Ca2+ current and/or SR  Ca2+ relea e might contribute to the 
prolonged TPK shorteni ng. whi lst al terations in the kinetic of Ca2+ extru ion. primari ly 
i n  the a+/Ca2+ e change and/or SR Ca2+ uptake. might contribute to the hortened 
THALF de ay of the Ca:!+ tran ient in GK myocyte . Consi tent wi th the pre ent rudy. 
El Omar et al C WO-l) reported unaltered ampl i tude of hortening and Ca2+ tran ient in 
GK myocyte [ 205 ] .  nal tered ampl i tude of hortening accompanied by unal tered TPK 
and decrea ed THALF rela ation of hortening and increa ed ampli tude of the Ca2+ 
tran. ient accompanied by unal tered TPK and THALF decay of the Ca2+ tran ient have 
been previou Iy reported i n  entricu lar myocyte from elderly GK rat ( 1 8  month of 
age) [ 1 92 ] .  A l tered expre sion of certain genes, i ncluding tho e that encode Atp l a3 and 
S 1c9a l .  might have impl icat ions for intrace l lu lar Na+ and H+ balance, which in rum 
might ha e effect on the proces of exci tation-contraction coupl ing .  Gene expression 
e 'peri ment were perfornled on entricular mu cle t i  ue, which contains not only 
mu. cle but al 0 va cular and connect ive t i  sue . In  the future, more exten ive 
e peri ment might be conducted to i nve t igate whether any of the reported change i n  
gene e x  pre ion might be attributed partly  to changes occurri ng i n  t issue other than 
cardiac mu cleo 
3 . 1 .4 Conclusion 
The pattern of 67 gene encoding cardiac muscle, i ntercel lular. membrane pump and 
exchanger. calc ium,  odi um and pota s ium channel and i ntrace l lu lar Ca
2+ and Ca2+ 
regulatory prote ins  have been characterized i n  the cardiac ventricle of young G K  rat . 
Even at thi  early tage of diabete . the expres ion of gene encoding some membrane 
pump . exchanger and calc ium.  odium and potas i um channel protei n s  were al tered . 
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Further under tanding of the change that occur i n  the heart during the earl tage of 
diabete-. may provide opportuni t ie!:. to de elop i ntervention and treatment trategie 
that might prevent or delay the on el of eriou functional di order a the di ease 
progre e .  
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3.2 E ffec of e erci e trai n i ng on the excitat ion-contraction cou pl i n g, e 'pre ion of 
genes encod i ng cardiac muscle p rotein L-type Ca2+ current,  card iac mu de 
p rotein expre ion and entricular morphology i n  the aging Goto-Kakizaki  type 2 
d iabetic rat 
3.2. 1 I nt roduction 
OM has reached pandemic proport ion worldwide.  I n  the UAB OM i a senou and 
worsen ing medical problem.  In 2005 the reported prevalence of OM in UAE ci tizen 
\\  a ' 25% ri s ing to -+0% after the age of 55 [97 ] .  Cardiova cular di sease i the major 
cam,e of morbidi t  and mortal ity i n  diabetic pat ient and heart of diabet ic patient are 
frequently i n  a compromi ed condi t ion [29 1 ] . A variety of dia tol ic  and y tol ic 
dy function ha e been reported i n  T20M patient and the everi ty of the abnormal i t ie 
depend on the pat ients '  age and the durat ion of diabete [ 1 52 . 1 55 ,  ] 6 1 .  1 63 ,  1 64-, 3 1 0-
3 1 2 ] .  Al though, e eral novel foml of i ntervention aiming at newly identi fied 
therapeutic target are current ly bei ng developed for T20M.  i t  i well  estab l i  hed that 
phy i cal exerci e conti nues to be one of the most valuable forms of non­
pharmacological therapy.  An abundance of evidence exi ts for pre cri bing exerci e 
therapy i n  the treatment of a variety of di ea e i nc luding metabol ic yndrome-related 
di order ( i n  u l i n  re i stance, T20M.  dy l ipidemia, hyperten ion,  obe i ty) ,  heart and 
pu lmonary di  ea es .  mu cle, bone and joint  di ea es and cancer, depression and asthma 
[ 3 1 3 ] .  Phy ical act iv i ty ha been reported to i nfluence several sign and ymptom of 
OM,  inc luding blood glucose concentrat ion, i nsu l in  action and cardiovascular risk 
factor and long-term exerci e ha been repeatedly as ociated with lower occurrence 
rate of T20M [ 3 1 '+] . 
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I n  thi ..,tud) , the effect of DM and e erci e trai n ing a a form of non-pharmacological 
therapy [or DM on the expre �ion of gene encoding cardiac mu cle prote i n  and on 
ventricu lar m yocyte horten ing and i ntrace l l u lar Ca�+ in the aging ( 1 0- 1 1 month) GK rat 
ha. been 1J1ve t igated . 
3.2.2 Re u l t  
3.2.2. 1 Genera l  characteri t ic  of the  a n i mal  
Thirty male  GK and th irty male Wi  tar control rat aged 8 months were divided i nto -+ 
ubgroup�. ea h contai n ing I S  animal . T\ 0 ubgroup of GK and control rat received 
exerci e trai n ing performed as descri bed in Section 2'-+.2 .  whi l  t the other 2 ubgroups 
of GK and control rat cont i nued a edentary l i fe tyle. A gluco e tolerance te t wa 
performed in the re t ing tate 2 month i nto the exerci e trai n i ng program . After 2 
months of exerci e tra in ing, b lood gluco e concentration J 20 min fol lowing a gluco e 
chal lenge i n  edentary G K  rat (236 .27 ± 1 5 . 1 2  mg/dl ) wa ign ifi cant ly (P < 0.0 1 )  
h igher than blood g luco e i n  edentary control (93 .93 ± 2.32 mg/dl ) .  Exerci e trai n ing 
mode t ly  reduced blood gluco e in  GK (207.36 ± 1 2 . 1 3  mg/d l )  and i n  control 
( 89 .60 ± 2 .78  mg/dl )  rat however. the reductions in blood glucose wi th exerc ise did not 
reach i gn ificance (P > 0.05 ) .  
Body weight .  heart weight and non-fast ing blood gluco e .  mea ured i mmediately before 
experiments, were ignificantly (P  < 0.0 1 )  i ncrea ed i n  edentary GK compared to 
edentary control rats .  Exerci e train i ng modestly reduced body weight, blood gluco e 
and increa ed heart weight to body weight ratio i n  both GK and control rat although 
the difference d id not reach s ignifi cance (P > 0.05 ) (Table 3 .2 ) .  
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Table 3 .2 :  General characteri t ic of the ani mal 
Control Control + GK + 






Body weight ( g )  4-00.33 ± 37 1 .73 ± ] 1 . 80 4-4-3 .64 ± 7 .94- 4- ]  8 .93 ± 6.80 
1 2 . 1 7  
Heart weight ( g )  1 . 37 ± 0.05 1 .34- ± 0.04 1 .60 ± 0.04- 1 .64 ± 0.05 
Heart weight  / 3 .43 ± 0.07 3 .62 ± 0.09 3 .6 1 ± 0.08 3 .92 ± 0. 1 3  
Bod weight 
( mg/g) 
Non-fast ing 9 1 .67 ± 1 .74- 89.67 ± 1 .58  1 6 1 .29 ± 1 33 .07 ± 9.79 
blood gluco e 1 2 .77 
(mg/dl )  
Data are mean ± S .E .M .  Stati t ical compari on were perfol111ed usmg one-way 
A OVA fol lowed by Bonferroni .  1 5  animals i n  each group. 
Body weight: CS v . GKS and CEX s .  G KEX P < 0.05 ; CEX V S .  GKS P < 0.0 1 
Heart weight :  CS \, ' .  GKS,  CS vs .  G KEX. CEX v . GKS and CEX v . GKEX P < 0.0 1  
Heart weightlbody weight :  CS  s .  GKEX P < 0.0 1 
Non-fa r ing blood glucose : CS v . GKS.  CS v . GKEX. CEX vs .  GKS and CEX vs .  
GKEX P < 0.0 1 
] 1 7  
3.2.2.2 Ventricular myocyte horteni ng 
fter 2 month, of exerc i e train i ng, ventricu lar m ocyte from exerci e trained animal 
and edentar rat were i olated u ing enzymat ic and mechanical di per al technique 
a, de ribed i n  Se t ion 2 .4 . ] .  Ventri ular myocyte hortening was mea ured by a ideo 
edge detect ion y tem a d 'cribed in Section 2AA.  Characterist ic of ventricular 
m 'ocyte 'hortening  are hown in  Figure 3 . 1 0 . Myocyte re  t i ng  cell length wa 
ign i fi cant ly  (p < 0.05) longer in edentary GK compared to edentary control myocyte 
and \\ as not addi t ionally al tered by e erci e trai n ing in GK or control myocyte ( Figure 
3 . 1 0a) .  TPK horten ing wa not ignificant ly ( P > 0.05 ) d ifferent i n  myocyte from 
sedentary GK compared to edentary control rat . E erc ise train ing ignificantly 
(P  < 0.05) reduced TPK 1 11 myocyte from control rats compared to those from 
edentary control rat ( Fi gure 3 . 1 0b ) .  THALF relaxation of hortening wa not 
ign ificant ly (P > 0.05 ) d ifferent in myocyte from sedentary GK compared to edentary 
control rat and wa not addi t ional ly al tered by exerc ise train ing ( Figure 3 . 1 0c ) .  
Ampli tude of  hortening  wa not ign ifi cant ly (P > 0.05 ) al tered i n  myocytes from 
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Figure 3 , 1 0: Ventricu lar myocyte horteni ng .  Recording of ventricu lar myocyte 
shortening in e lectrical l y  t imulated ( 1  Hz)  cel ls .  (a )  Mean re r ing cel l  length, (b )  Time 
to peak hortening.  ( c )  Ti me to half relaxation relaxation of hortening and (d )  
Ampl i tude of  shorten ing expres ed  as  a percentage of  rest ing cel l length ( RCL) .  Data 
are mean ± S .E . M .  S tatistical compari ons were performed u ing one-way A OVA 
fol lowed by Bonferron i .  n = 4-+-67 cell from 5-6 heart' .  Line above bars i ndicate 
ignificance (P < 0,05 ) .  
1 1 9 
3.2.2.3 Ventr icular  myoc te i n t rac l lu lar  Ca2+ 
Intracel l u lar a2+ concentration was mea ured by flore cence photometry. a de cri bed 
i n  ection 2 .-+ .5 .  u i ng ventricular myocyte i olated from edentary and exerci e 
trai ned group .. Characleri tic of ventricular myocyte i ntracel lu lar Ca2+ are hown in  
Figure 3 . 1 1 . Re  t ing fura Ca2+ wa  not ignificantly ( P  > 0.05 ) different between 
edentar OK and :edentar control myocyte however. exerci e trai n ing ignificantly 
(p < 0.05 ) i ncrea ed re ting fura Ca2+ i n  exerci se trai ned OK compared to edentary 
GK myoC) te ( Figure 3 .  I I a). TPK Ca2+ tran ient wa not ignificantly (P > 0.05 )  
d ifferent i n  m ocyte from edentary GK compared to edentary control rat and wa 
not addit ional ly  al tered by exerci e train ing in myocyte from GK and control rats 
( Figure 3 . 1 1  b). THALF decay of the Ca2+ tran ient was not ignificant ly ( P > 0.05 ) 
al tered i n  myocyte from sedentary O K  compared to edentary control rats or by 
exerci e train ing  ( Figure 3 . 1 1  c). Ampli tude of the Ca
2+ tran ient wa not s ignificantly 
(P > 0.05 ) al tered in myocyte from ei ther edentary OK compared to edentary control 
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Figure 3 . 1 1 :  Ventricu lar myocyte i ntracel lu lar Ca
2+ . Recording of ventricu lar myocyte 
i n trace l lu lar Ca
2+ i n  electrical ly t imulated ( I  Hz)  cel l s .  (a )  Mean re t ing fura-2 ratio 
(3-+0/380 nm).  (b)  Time to peak Ca
2+ tran ient ,  (c )  Time to half decay of Ca
2+ tran ient 
and (d) Ampl i tude of Ca
2+ transient .  Data are mean ± S .E .M . ,  tati t ical compari son 
were performed u i ng one-way A NOVA fol lowed by Bonferron i ,  n = 40-46 cel l s  from 
5-6 heart . Line above bar indicate s ignificance P < 0.05 . 
1 2 1  
3.2.2.4 a rcopJa rnic ret icu l u m  Ca2+ t ran port 
' +  
R a- lran">port a mea ured in entricular myocyte loaded with fl uore cence fura-
a de cribed i n  ection 2A.6 .  entricular m ocytes were obtained from the heart 
of edentary and exerci e trai ned rat heart . 
t pica! re ording, in a control myocyte, i l l u  trating the e perimental protocol i 
�hown in  Figure . 1 2a. The ampl itude of e lectri cal ly-evoked Ca2+ tran ient were not 
� ignificant l (P > 0.05 ) al tered in myocytes from GK rat compared to contro ls .  
In tere. t ingly.  e lectrical l -evoked Ca2+ tran ient were ignifi cantly (P < 0.05) i ncreased 
i n  myocyte from exerci e trai ned G K  compared to edentary G K  rats ( Figure 3 . 1 2b) .  
Caffeine-evoked Ca2+ tran ient were not signifi cant ly  (P > 0.05 ) al tered in myocyte 
from GK rat ompared to control or by exerci e train ing (Figure 3 . 1 2c) .  Fract ional 
relea e of Ca2+ (fract ion of caffeine-evoked Ca2+ tran ient that i released duri ng 
electrical ly-evoked t imulation) wa not s ignificant ly  (P > 0.05 ) altered i n  myocyte 
from G K  rat compared to controls .  however. it was ignificant ly ( P  < 0.05) i ncrea ed 
i n  m locyte from exerci e trained control compared to edentary control rat (Figure 
3 . 1 2d) .  Recovery of the Ca
2+ tran ient  fol lowing appl ication of caffeine and resumption 
of electrical t imulat ion wa not ignificant ly  (P > 0.05) al tered i n  myocytes from GK 
rat compared to control or by exerc ise train i  ng ( Figure 3 . 1 2e) .  
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Figure 3 . 1 2 : S arcopla mic ret icu lum Ca2+ . (a )  Typical record i l l ustrat ing the effects of 
1 Hz electri cal t imulat ion (ES )  and rapid appl ication of caffeine on fura-2 ratio i n  a 
myocyte from a edentary control rat . (b )  Mean ampli tude of e lectri cally-evoked and (c )  
1 23 
affeine-evoked Ca2+ tran ient . Cd ) 1ean ampl i tude of ,arcopla mic ret icu lum 
fract ional Ca2+ relea e and (e)  Recovery of the electrical ! -evoked in tracel lu lar Ca�+ 
after appl ication of caffe ine .  Data are mean ± S .E .M.  Stati t ical compari on were 
performed u" ing one-way A OVA fol lowed by Bonferroni .  n = 27-52 cell from 5-6 
heart . Line abo\ e bar i nd icate ignificance (P < 0.05 ) .  
1 2.+ 
3.2.2.5 :\ 1 .  ofi lament en i t i v i t  to Ca2+ 
Myofi lament _en�i t i \ ' i ty to Ca1+ wa a e ed from pha e-plane diagram of fura-2 rat io 
\er�u e l l  length by l11ea�uri ng the gradient of the fura-2-cel 1 length trajectory duri ng 
the late re la. ation of the twi tch contraction a de cribed in ection 2 .4- .7 .  The po i t ion 
f the trajectory reflect the relati e myofi lament respon e to Ca2+ and hence, can be 
used a� a measure of myofi lament sen i t iv i ty to Ca2+ ( Spurgeon et a l . .  1 992) .  A typical 
record ing of ,horteni ng and Ca2+ tran ient with t ime in a myocyte from a control rat i 
�ho\\'n i n  Figure 3 . 1 3a .  A pha e-plane diagram of fura-2 ratio versu cel l length i 
shown in  Figure 3 . l 3b .  The mean gradient during the period 500-800, 500-700 and 
500-600 m . are hown in  Figure 3 . 1 3c-e, re pecti ely .  Gradients were not ignificant ly 
(p > 0.05) altered i n  myocyte from GK rat compared to control or by e erci e 
train ing .  It \ a i ntere t ing to note a difference i n  gradient between myocyte from 
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Figure 3 . 1 3 : M yofi lament sen i t iv i ty to Ca2+ . (a) Typical record of horten ing and fura-
2 rat io un i t  ( RU )  i n  a myocyte from a sedentary control rat. (b)  Typical pha e plane 
diagram of Fura-2 rat io un i t  (RU) ver u . Cell length in electrical ly  t imulated ( 1  Hz)  
myocyte from a edentary control rat . The sol id  alTOW in  (b) i ndicate where the 
gradient wa mea ured. Mean gradient of the fura-2-cell length trajectory during late 
re laxat ion of the twitch contraction during  the periods (c)  500-800 ms, (d)  500-700 m 
and (e)  500-600 ms.  Data are mean ± S .E. M .  S tati stical compari sons were performed 
us ing one-way A OVA fol lowed by BonfelToni .  n = 6-24 cell from 5-6 heart . Line 
above bar indicate ignifi cance (P < 0.05 ) .  
3.2.2.6 L-t.  pe a2+ cu rrent 
1 26 
entricu lar myocyte from edentary and e erci e trai ned animal were j olated u ina � 
enzymatic and mechanical di per al technique a de cribed i n  Section 2.-+. J .  L-type 
Ca2+ current wa mea ured u ing whole cell patch-clamp technique a de cribed i n  
ection 2.-1-. .  Typical recording of  L-type Ca2+ current i n  edentary control m ocytes 
during acti vation, i nacti vation and re 't i tut ion e periment are hown in Figure 2 . 1 4a-c, 
respect ively .  Ampl i tude of L-type Ca2+ current at te t ol tages ranging between -60 and 
+ 70 were not s ignificanr l  ( P > 0.05) al tered in myocytes from ei ther edentary GK 
ompared to . edentary control rat or  wi th  exerci e train ing ( Figure 3 .  1 4d ) .  Al though 
the urrents were not ign ifi cantly different. i t  was i ntere ting to note that the largest 
ampl i tude of L-type Ca2+ current generated at a te t potential of 0 mY wa ob erved i n  
exerci  e trained control , fol lowed by  edentary control . exerc ise trained GK and 
mal le t i n edentary G K  myocyte . I nactivation of L-type Ca2+ current at pre-pul e te t 
vol tage ranging between -50 and +30 were not ignifi cantly (P > 0.05) al tered i n  
myocyte from ei ther sedentary G K  compared to edentary control rats or by exerci e 
trai n ing ( Fi gure 3 . 1 4e ) .  Re t i tut ion of L-type Ca
2+ current  with i nter-pul e t imes ranging 
between 20 and 700 m were not ign ificant ly (P > 0.05) al tered in myocyte from 
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Figure 3 . 1 -+ : L-type Ca�+ current .  Typical recording (a) Activation. (b)  Inacti vat ion and 
(c )  Re t i tut ion of L-type Ca2+ current in a ventricu lar myocyte from a sedentary control 
rat, (d )  Mean act ivation current  at vol tage ranging from -60 to +70 mY, (e )  Mean 
i nact ivation curve at pre-pul e vol tages ranging from -50 to +30 mY and (f) Mean 
re t i tu t ion curve at i nter-pul e t iming ranging from 20 to 700 ms i n .  Data are 
mean ± SEM.  S tati t ical compari son were performed u i ng one-way ANOYA 
fol lowed by Bonferroni ,  n = 9-20 cel l s  from 5 to 6 hearts .  Sedentary GK (GKS) ,  
edentary control (CS) ,  exerci ed  trai ned GK (GKEX) and exerci e trai ned control 
(CEX) rat . 
3.2. 2.7 E 'pr  ion of ca rd iac mu de m R N A  
1 2  
E pre sion of mR A encoding a variety of cardiac mu cle o  i ntercel lu lar. i ntracel l u lar 
2+ Ca transport and regulator . cel l  membrane tran port. odi um. calcium and pota JUm 
channel prot In  In  ventricu lar mu cle wa a e ed u Ing real t ime RT-PCR a 
de,>cribed i n  ection 2 .-+ .3 .  The re u l t  obtained from edentary and exerci e trained 
gr uP' are 'hown in  Figure  3 . 1 5-3 .2 1 .  The re ul t  how that expre ion of mR A 
encoding cardiac mu cle prote i n  Myh617, Mybpc3, MylJ/3, AClcl , TI111i3. Tl1l1t2, 
Tpm lN and Dbi were not ignificant l y  (P > 0.05 ) al tered in ventricular mu cle from 
. dentary OK compared to edentary control rat or by exerci e trai n i ng (Figure 3 . 1 5 ) .  
Expre ion o f  m R N A  encoding Tpm2 w a  signifi cantly ( P  < 0.05 ) upregulated i n  
ventricu lar m uscle from edentary OK compared to  sedentary control rats ( Figure 3 . 1 5 ) .  
E pre ion of m R  A encoding i ntercel l ular proteins  Gja5/7 and Cav l  were not 
ignifi cantl (P > 0.05 ) al tered in ventricular mu cle from edentary OK compared to 
edentary control rat or by exerci e train ing ( Figure 3 . 1 6) .  Gja J was ign i ficantly 
( P  < 0.05) downregulated and Gja4 was ign ificantly (P < 0.05) upregulated i n  
ventricular mu cle from edentary OK compared to  edentary control rats ( Figure 3 . 1 6 ). 
Gja J and Cad were ign ifi cant ly (P < 0.05 ) upregulated in ventricular mu cle from 
exerci e trained O K  compared to edentary OK rat ( Figure 3 . 1 6) .  Expression of mR A 
encoding  i ntrace l lu lar Ca
2+ tran port and regulatory protein Atp2a J ,  A fp2a2, Ryr2, 
Casq2, PIn and Calm2 were not ign ifi cantly (P  > 0.05 ) altered i n  ventricular muscle 
from edentary O K  compared to edentary control rats or by exerci e train ing ( Figure 
3 .  1 7) .  Expre ion of mR A encoding cel l  membrane transport protei n  Afp l a l/2/3. 
Slc8a l/3 and Slc9a J were not s ignificant ly (P  > 0.05) altered i n  ventricular muscle from 
1 29 
,>edentary GK compared to eden tar control rat or by e erci e train ing ( Figure 3. 1 ). 
Ho\\ e\ er, Alp l  bl wa ignificantly (P < 0.05 ) upregulated in ventri cular muscle from 
edentary GK rat compared to edentary control ( Fi gure 3 . 1 8 ) .  Expre ion of mR A 
encod ing a�+ channel prote ins Cacna lc, Cacna2dll2. Cacnb 1l3 and Cacnb4 were not 
ignifi cantl (P > 0.05 ) al tered i n  entricu Jar mu cle from edentary GK compared to 
edentar control rat' or by e erci e train ing ( Figure 3 . 1 9) .  Cacna l g and Cacnb2 were 
ign ifi ant ly (P < 0.05 ) upregu lated in ventricu lar muscle from edentary GK rats 
compared to edentary control (Figure 3 . ] 9) .  Expre ion of mR A encoding a+ 
channel prote ins  Scn5a, Sen l b and Scn3b were not s ignificantly (P > 0.05 ) al tered i n  
ventricu lar mu c le  from eden tar GK compared to sedentary control rats (Figure 3 . 20). 
Expre ion of mRNA encoding Na+ channel protein Scn3b wa significantly (P < 0.05 ) 
upregulated i n  exerci e trained GK compared to exercise trai ned control rats (Figure 
3 .20) .  Figure 3 . 2 1 a & b how the expre ion of mRNA encoding K+ channel proteins 
HCIl4. Kcn a 2141517, Kcnj315181l 1l1 2. Kchip2, Kcnab l ,  Kcnbl .  Kcndll213, Kcne213, 
Keng2, Kenlz2 and Kenn2 were not ignificantly (p  > 0.05 ) al tered i n  ventricular mu cle 
from edentary GK compared to sedentary control rats or by exerc ise trai n i ng, Hcn2, 
Kena3. Kenel were ign ificantly (P  < 0.05 ) upregulated and Ke17j2 and Kenk3 were 
downreguJated in ventricu lar mu c le  from edentary GK rat compared to edentary 
control . Hcn2 wa significant ly (P < 0.05 ) downregulated ( Fi gure 3 .2 I a) and Kenk3 
wa ignificantly (P  < 0.05) upregulated ( Figure 3 . 2 1 b )  in ventricu lar mu cle from 
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Figure 3 . 1 5 : Express ion or mRNA encod ing various cardiac muscle prote ins .  The re lative quantit ies versus Capdll or genes 
encoding various card iac muscle prote ins  in ventricular muscle. Data are mean ± S .E. M .  Stati stical compari�ons were 
perrormed using one-way ANOYA rol lowed by BonfelToni , n = 7- 1 0  hearts .  Lines above bars indicate sign i ricance ( P  < 
0.05 ) .  Arb = Arbitrary . 
w o 
2 I D CON 


















0 I..r) '" .,... � .,... 0') 
.� .� .� .� :::. :::. cu cu � � � � () () 
Figure 3 . 1 6 : Expression of mRNA encoding various in tercel lu lar prote ins .  The re lative quant i t ies versus 
Gapdh of genes encodi ng various intercel lu lar prote ins  in ventri cu lar muscle. Data are mcan ± S .E .M .  
S tat istical compari sons were performed using one-way ANOV A followed by Bonferroni ,  n = 7- 1 0  heart s .  
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Figure 3 . 1 7 : Expression of mRNA encod ing various i ntracel lu lar Ca2+ transport prote ins .  The relative quantit ies 
versus Capdh of genes encod ing various intracel l u lar Ca2+ transport protei ns in ventricu lar muscle.  Data are mean 
± S.E .M . Stati s t ical comparisons were performed us ing one-way ANOYA followed by Bonferroni ,  n = 7- 1 0  hearli-> .  
Li nes above bars indi cate sign i ficance (P < O.OS ) .  Arb = Arbi trary. 
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Figure 3 . 1 8 : E xprcssi o n  of m R N A  encod i n g  various ce l l mcmbrane t ransport protci ns .  Thc rclat i ve quan t i t ie� ver�u� 
Capdh of genes encod i n g  cc l l  mcmbrane transport protc i ns in ventr icu lar  m usc le .  Data are mean ± S . E . M .  Stat i st ical 
compar isons were performed usi ng one-way ANOV A fol lowed by Bon ferro n i .  n = 7- 1 0  hearts .  Li nes above har� 
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Figure 3 . 1 9 : Express ion of m R N A  encod i n g  various Ca2+ channel  prote i ns. The re l at i ve q uant i t ies versus Gapdh or 
genes encod i n g  various Ca2+ channel  prote i ns in  ventr icu lar  m usc le .  Data are mean ± S . E. M .  Stat ist ical comparisons 
were performed u s i n g  one-way A NO Y A  fo l lowed by B o n ferron i ,  n = 7- 1 0  hearts .  L i nes above bars i nd icate 
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Fi gure 3 .20: Expression of m R N A  encod i n g  various Na+ chan nel  prote i ns. The re lat i ve q uan t i t i es versus Copdh of genes 
encod i n g  various Na+ channel  protei ns i n  ventri c u l ar m uscle.  Data are mean ± S . E. M .  Stat i st ical comparisons were performed 
u s i n g  one-way A N O Y A  fol lowed by Bonferron i ,  n = 7- 1 0  hearts .  Li nes above bars i n d icate s ign i ficance ( P  < 0.05 ) .  Arb = 
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Figure 3 .2 1 :  Express ion of m R N A  e ncod i n g  vari ous K+ channel  prot e i n s .  ( a )  & ( b )  The re l a l i ve quan t i t ies versus Copdll 
of genes encod i n g  various K+ channel  protei ns i n  venlr icu lar m usc le .  Data are mean ± S . E . M .  Stat i s t ical compari sons 
were performed us i ng one-way A NOV A fol lowed by Bonferro n i ,  n = 7- 1 0  hearts .  Li nes above bars i nd icate s i g n i  ficancc 
(P < 0.05 ) . Arb = Arbi t rary . 
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3.2.2.8 E pre ion of ven t ricular mu de protei n 
1 3  
The re u l t  from real t ime RT-PCR howed al teration 1 n the expre ' ion of gene 
enc d ing a number of cardiac mu cle prote in , To in e t igate. if the e al teration� of 
gene have been tran lated into expre ion of corre ponding protein , immunoblot 
experiment!:> were conducted. E periment · were performed u ing ti ue acquired from 
the !:>ame animal. that were u ed in the real t ime RT-PCR experiment . The re u l t  of 
real t ime RT-PCR 'howed that. the expre sion of mRNA encoding Gaj ] ,  Gaj4, Cacnb2 
and Tp1Il2. were al tered i n  edentary GK compared to edentary control therefore. the 
evaluation of the e pre ion these prote ins  were i nve t igated. 
Expre. ion of connexin 37 (CX37) ,  connexi n  .+3 (CX43) ,  L-type Ca2+-beta 1 subuni t  
and tropom 0 i n  2 (beta) edentary and exerci e trained GK and control rat were 
evaluated b immunoblot a a a de cribed in Section 2 .4 .9 
Figure 3 . 22a how immunoblot of the proteins and �-ct in  as an i n ternal control .  
Quant i tative den i tometric data cOlTected to �-acti n  and normal ized to control edentary 
for CX 37,  CX .. +3, L-type Ca
2+ and tropomyo i n  are hown in  Figure 3 . 22b to 3 .22e, 
re pecti  e ly .  0 ign ificant (P > 0.05)  a l terations were observed in  CX43, CX37,  L­
type Ca2.j. and tropomyo i n  protei n  i n  sedentary G K  rat compared t o  sedentary control 
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Figure 3 ,22 :  Expres ion of cardiac mu cle prote in ,  (a) Immunoblots of cardiac protein 
Quantitative den i tometric corrected to p-act in and normal ized to control rats for (b) 
Connex in  37 ,  (c) Connexin  '+3, Cd) L-type Ca�+. and (e) Tropomyo in. The average data 
wa obtai ned from three separate experi ments. Resul ts are expres ed as mean ± S .E .M.  
1 -1-0 
tat I t i  al compari son were performed u i ng one-way A 0 A fol lowed b) 
Bonferron i .  edentary control ( Sed-cont) ,  exerci e trained control (E t-cont) .  edentary 
GK ( ed-GK and exerc i se trai ned GK (Ext-G K) .  
1 4 1 
3.2.2.9 lorphoJogicaJ tud  
The u l tra tructural morphology of left ventricle in edentary and exerci e trained 
animal \\ a a<; e sed u' ing tran mi ion electron micro copy a" de cribed in Section 
2 .4 . 1 2 . At a magn ification of X I  000, no ub tant ial change were ob erved in 
ventricular t i,sue from edentary GK compared to edentary control rats or in  exerci e 
trai ned compared to edentary rat . LV myocyte structure wa intact and pre erved i n  
a l l  group of rat' ( Fi gure 3 .23 ) .  
M i tochondria were den e ly packed bet\veen the m ofibri l . The quantitative re u l ts  are 
shown in  Figure 3 .24. The number of mi tochondria wa modestly but not ignificantly 
(p > 0.05) reduced i n  edentary GK ( 8 .0 ± 0 .7)  compared to edentary control rats (9 .0 
± O. ) howe er ,  exerc i  e trai n ing i gn i fi cantly P < 0.05) i ncreased the mitochondria 
number in exerci e trained GK ( 1 1  ± 0 .8)  compared to edentary GK rat , with no 
ignificant ( P  > 0.05 ) changes obser ed in control . Sarcomere organization was regular 
i n  arrangement and c lear striation were een i n  al l  groups. Sarcomere length was 
mea ured a the di tance between two Z-bands and resu lts are shown i n  Figure 3 .25a. 
o ign ificant (P > 0.05) al teration wa ob erved in sarcomere length between 
edentary GK (3 .07 ± 0.02) and edentary control ( 2 .95 ± 0.05 ) .  Exerci e trai n ing 
ignificant ly  ( P  < 0.05 ) reduced arcomere length in exerci  e trai ned GK (2 .67 ± 0.09) 
and i n  exerci  e trained control ( 2 .73 ± 0.02) rat compared to sedentary GK and control 
rats, re pectively .  Sarcomere width was also measured and re ul t  are shown in Figure 
3 . 25b .  S arcomere width i n  sedentary G K  ( 1 . 88  ± .0.09 ) was signifi cantly ( P  < 0.0 1 )  
wider compared to sedentary control ( l .47 ± 0.07 ) rat . Exerc ise train i ng ignificantly 
l ·n 
( P  < 0.0 1 ) increa ed arcomere width i n  e erci e trained GK (2 .73 ± O. l � ) and exerci e 
trai ned control ( 2 .3 1 ± 0.0 ) rats .  
The TeO were evaluated from electron micrograph under a magnification of X7000 
( Figure 3 .26a). Random field of many longitudi nal ection howed pre erved tructure 
of JeD i n  a l l  experimental group . Vi  ual 1y .  more leO were observed i n  GK edentary 
compared to the other group . The convolut ion per given length of leO membrane 
\\ ere measured ( Figure 3 .26b) .  There wa no ignificant (P > 0.05 ) d ifference i n  the 
a\ erage number of convol ution between edentary GK and edentary control rat . 
Exerci e trai n i ng i gn ificantly (P  < 0.0 1 ) i ncrea ed the number of convolution in  
exerci e trai ned GK compared to  edentary GK rat . 
1 -B 
Figure 3 .23 :  Electron micrograph of longitudinal sections of rat left ventricular 
myocytel .  Sedentary control ( Sed-cont ) ,  exerci e trained control (Ext-cont). sedentary 
G K  ( Sed-GK)  and exerci e trai ned G K  ( Ext-GK) .  Sarcomere Length ( SL). Sarcomere 
width ( SW) ,  M i tochondria ( M )  and Z-l ine (Z) .  Magnification X l 8000. 
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Figure 3 . 2'+:  Average numbers of mitochondria. Re ul ts are expres ed a mean ± S .E .M .  
Stati t ical compari on were performed u i ng one-way ANOV A fol lowed by 
Bonferron i .  2 1 -24 e lectron m icrograph were analyzed from 4- rats .  Li ne above bar 
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Figure 3 . 25 :  Cardiac myoc te arcomere . ( a) Sarcomere length and (b )  Sarcomere 
width.  Re u l t  are expre ed a mean ± S .E .M .  Stati t ical compari ons were performed 
u i ng one-way ANOV A fol lowed by BonfelToni .  36-5..+ electron micrographs were 




Figure 3 . 26 :  I n tercalated d isc. (a) Electron micrograph of in tercalated disc of left 
ventricu lar t i s  ue and (b)  Relat ive convolut ion number of intercalated d isc membrane. 
Re ults are expre sed as mean ± S .E .M .  Statist ical compari on were performed u i ng 
one-way A OVA fol lowed by Bonferroni .  1 1 -22 e lectron micrograph were analyzed 
from 3 rat . Line above bar i ndicate s ignifi cance (p < 0.05 ) .  Sedentary Control (Sed­
cont), Exerci se trained control (Ext-cont) ,  Sedentary GK (Sed-GK )  and Exerci e trai ned 
G K  ( Ext-GK) .  I ntercalated d i sc ( ICD) .  Magnifi cation X7000. 
1 -l-7 
3.2.3 Oi cu ion 
Thi<:.  tudy i m  eMi gated the effects of exerci e tra in ing on exci tation-contraction 
coupl ing and e pre ion of mR A encoding cardiac mu cle prote in  in the adult  GK 
type 2 d iabet i c  compared to age-matched Wi tar control rat . The major fi ndi ngs were : 
( i ) ampl i tude of horten ing wa not al tered i n  entricular myocyte from edentary GK 
compared to sedentary control rat or  by e erci e tra in i ng. ( i i )  ampl i tude of  Ca"+ 
[ran' ient wa not al tered in ventricu lar myocyte from edentary GK compared to 
. edentar contr I rat or by exerc i  e trai n i ng. ( i i i )  SR Ca"+ content and myofi l ament 
�en i t iv i ty  to Ca2+ were not al tered. ( i  ) L-type Ca2+ current ( acti vat ion, i nacti vation and 
re t i tu t ion ) wa not al tered in ventricular myocyte from sedentary GK compared to 
edentary control rat or by e erc i se tra in i ng. (v) expre ion of mR A encoding Tp1112. 
Gja-t. A rp J b J ,  CacnaJg,  Cacnb2, Hcn2, Kcna3 and KcneJ were upregulated and GjaJ ,  
Kcnj2 and Kcnk3 were downregulated i n  edentary GK compared to  sedentary control 
rat and Gja J .  Cad and Kcnk3 were upregulated and Hen2 wa downregulated i n  
exerci e trai ned G K  compared to edentary G K .  ( i )  expre ion of variou cardiac 
protei n  inc lud ing CX 37.  CX -D, L-type Ca2+ channel and tropomyosi n  were not al tered 
i n  edentary G K  compared to edentary control or by exercise trai n i ng and (vi i )  
morphological l y. m i tochondria number was i ncreased i n  exerc ise trai ned GK compared 
to edentary GK .  The arcomere length wa shorter i n  exerci e trai ned GK and control 
compared to edentary GK and control rats. respect i vely .  In contrast, the arcomere 
w idth wa longer i n  exerci e trai ned GK and control compared to sedentary G K  and 
control rat , respect ively .  ICD membrane convol ution were i ncrea ed in exerc i sed 
trained GK compared to sedentary G K  ventricle . 
1 .+  
fter 2 month. of exerci e trai n ing a gluco e tolerance te t wa appl ied fol lowing an 
overnight fa t i n  all four group of rat . The re u l t howed that 1 20 min  fol lowi ng an 
i ntraperi toneal i njection of gluco e ( 2  g/kg body weight ) ,  blood gluco e level were 
ign i ficant ly ( P  < 0.05 ) e levated in edentary GK rat compared to edentary control 
demonstrat ing impaired gluco e uptake in GK rat . Exerci e train ing reduced blood 
gluco�e to a mall e tent in control and to a larger e tent in GK rat . however, the 
d ifference d id not reach tati tical ignificance ( P  > 0.05) .  on-fa t ing blood gluco e 
measured immediate ly before experi ment wa signifi cantly (P  < 0.05 ) elevated i n  GK 
edentar. compared to control edentary rat . Exerci e train ing reduced blood gluco e 
to a mal l e tent i n  control and to a l arger extent i n  GK rat however, the difference did 
not reach tat i  · t ical ign ificance (P > 0.05) .  Previou tudies have hown that long term 
(2 .  and 1 .+  month of age ) non-fa t ing erum i n  u l in  i reduced i n  the GK rat 
compared to age-matched control whi l  t fa t i ng- in  u l in  is reduced at 2 months and 
i ncrea ed at 8 and 1 .+  month of age in GK rat compared to age-matched control 
[ 3 1 5 ] .  I t  ha al 0 been shown that exerc ise train ing for 9 week reduced the level of 
fa t ing in u l i n  i n  exerci e trai ned G K  rats compared to age-matched controls and 
calculation of the i n  u l i n  en i t i  vi ty i ndex determined that train ing ignificantly 
increa ed in u l i n  en  i t iv i ty [ 3 1 6 ] .  
Body weight and heart weight were s ignificantly i ncreased i n  edentary G K  rat 
compared to edentary contro ls .  Col lecti vely, these characteri t ic are typical of feature 
widely di played i n  T2D M  [ 203 ] .  
Ventricu lar myocyte shortening and Ca
2+ transport were general l y  well preserved i n  
edentary G K  rat compared t o  sedentary control and after exerci se train i ng. The t ime 
1 .+9 
courc..,e of shorten ing and Ca2+ tran ient were al tered by exerci e train ing. The TPK 
c..,hortening was unaltered by exerci e trai n ing in GK compared to edentary GK rat and 
reduced by e erci e trai n ing in control compared to edentary control rat ' .  
Despi te genera i l  well pre erved myocyte horten ing there were a variety of  change 1 11 
expre . ion of ntric le mR A in edentary diabetic compared to control heart and as a 
re u l t  of exerci.e trai ni ng. 
Expre ion of mR A encoding cardiac mu cle protein in young ( 8- 1 0  week ) [ 3 1 7 ]  
and i n  adul t  ( 1 0- 1 1 month ) G K  rat [ 3 1 8 ]  are compared i n  Table 3 . 3  It i i ntere t ing to 
note the changing profi le of mR A expre sion a the GK rat aged. E pres ions of 
Tpm2. Cja.:/., Atp l b i .  Cacnalg.  Cacnb2. Kena3 and Kcne l were upregu lated wherea 
Cja I and KCIlk3 were downregulated wi th age . Downregulation of Sle9al .  HCI14, 
KCl1a2. and Kcna4 in young animal normali zed with age .  Upregu lation of Cac/w i h 
nonnal ized with age .  Hcn2 wa upregulated and Kcnj2 wa downregulated i n  edentary 
G K  rats from an early age. 
The effect of exerci e tra in ing on expressJOn of mR A encoding cardiac mu cle 
protein in adult  GK and control rat are ummarized i n  Table  3 .4 .  Intere t ingly mRNA 
expre s ion of Cja i .  Cav3 and Kcnk3 were upregulated and Hcn2 wa downregu lated by 
exerci  e train ing  in GK but was unal tered by exerc ise train ing in control rats .  
E pre ion of mRNA encoding Tpm2 wa upregulated i n  aging sedentary GK rat . 
Tropomyo i n  control mu cle contraction by inhib i t ing act in-myosi n i n teraction i n  a 
calc ium- ensi t ive manner and mutations i n  the Tpm2 gene may lead to change i n  the 
affi ni ty  for act in  resul t ing i n  e i ther muscle weakne s or defective Ca
2+ act ivation of 
contracti l i ty [ 3 1 9 ] .  
I SO 
Expre��ion of mR encoding Gja } wa downregulated and Gja4 wa upregulated in  
agi ng �edentar GK compared to  sedentary control ral .  I n  contra t Gja ]  wa 
upregulated i n  GK \ entricle by e erci e trai ni ng. eonnexi n  are the pore forming 
ubuni ts  of gap junct ion channel and the e channel regulate membrane pemleabi l i ty 
i n  i nd i \  idual cel l  or couple between adjacent cel l  to form gap junction and thereby 
prO\ id ing a pathway f r regu lated i ntercel lu lar commun icat ion. ex .. +] which i encoded 
by Gja } .  i a major prote in  of gap junction i n  the heart and i v i tal to the ynchronici ty 
of contract ion i n  the heart . M utat ion in ariou connex i n  protei n including eX-1-3 are 
kno\\ n to be a ,ociated with cardiac arrhythmias 1 320 ] .  Al tered expression of the gene 
encod ing  Gia ] .  if accompanied by a reduction in CX-1-3 prote i n .  might partly underl ie 
the low heart rate which ha e been previou ly  reported in GK rat heart [ 203 ] .  
In tere t i ngly. the pre ent re u l t  how that exerc i e trai n ing appeared to upregulate the 
expre sion of Gia ]  in exerc i se trai ned GK rat ventric le .  Multiple epidemiological 
tudie have a ociated a i ngle nucleotide polymorphi m i n  the Gia4 gene. coding for 
e 37 .  with i ncreased ri k for athero clero i s  and myocardial  i nfarct ion and 
athero clero i i frequently i nvolved i n  the pathophy iology of DM [ 32 1 ] . 
A tp J  b ]  was upregulated i n  aging edentary GK compared to edentary control rat 
ventric le .  The a+/K+ .. ATPa e is re ponsible for maintain i ng the e lectrochemical 
gradient of Na+ and K+ ion acro the pIa ma membrane and i s  compo ed of two 
e entia l  u- and B subuni t . both of which have mul t ip le i soform . The B subun i t  
regulate the a embly of alB heterodi mer and translocation of odium pump protein to 
the plasma membrane .  Upregu]at ion of Alp ]  h l ,  i f  accompanied by an i ncrea e i n  B 
ubuni t  protein .  m igh t  be expected to i ncrea e acti v i ty of the pump. Lo of a
+/K+- B l  
i a�"ociated \\ I th  ign i ficant pathophysiolog of the heart [ 295 ] .  The pre ent re u l t  
. how that (lcna ) g and Cacllb2 were upregulated in ventricle of aging edentary GK 
compared to edent ary control . T-type Ca2+ channel current i invol ed i n  the 
generat ion of the pacemaker potential in SA nodal cell . Prev ious tudie have hown 
that di �ruption of the gene encoding Cacllal  g abol i  he T-type Ca2+ current in i olated 
cell from the A node and the A V node wi thout affecting L-type Ca2+ current [ 322 ] .  
acnb_ encod , the P2 subuni t  of the L-type Ca2+ channel . Previous tudie have 
demon trated that in embryonic cardiomyocyte al tered expres ion of the P2 subun i t  ha 
a large effect on L-type Ca2+ current however, in adult  cardiomyocyte the effect are 
\\ e l l  tolerated [ 300] .  The re u l t  have hown that Caenb2 was upregulated i n  edentary 
GK ventric le  however. Ca2+ ignal ing including ampli tude of the Ca2+ transient and L­
type Ca2+ current ,  the pri mary trigger for SR Ca2+ release, were not s ignificantly al tered 
i n  myocyte from agi ng edentary GK rat .  
The pre ent tudy ha hown that Hcn2. Kena3, Kcnel were upregulated and Kcnj2 and 
Kcnk3 were downregulated in aging edentary GK compared to edentary control rat 
ventric le .  Hcn2 wa downregulated and Kcnk3 wa upregulated i n  GK entricle after 
exerci  e train i ng .  H yperpolarization-activated cyclic nucleotide-gated ( HC ) channels 
contribute to the i ni t iation and regulation of cardiac rhythm. The pacemaker current ( Ir) 
i encoded by the HCN famj ly .  HCN i oforms i ncl uding Hcn2 and Hen4 have been 
identified i n  ventricle t i  ue [ 303,  30-+ ] .  Hcn2 was downregulated by exerci e train ing in 
GK ventricle bri ngi ng Hcn2 towards edentary control leve l .  Previou 1y, i t  was reported 
that Kena3 encodes the voltage-gated Kl'l . 3  channel which is expre ed in d ifferent 
region of guinea p ig  and ferret heart [ 306, 307 ] .  In the heart Kvl . 3  channels contribute 
1 52 
to repolari zation and membrane potential . The phy iological effect of upregulation of 
KCI1a3 in ventri cle ti ' ue remain to be c lari fied. Cardiac repolarization i control led by 
the 1 Kr and I K, .  The human ether-ago-go-related gene (hERG) encode I Kr• wherea 
K Q I and KC El together encode I K, .  Decrease i n  I Kr or I K, can cau e long QT 
'>yndrome. a cardiac di order with a h igh ri k of udden death [ 323. 324- ] .  Upregulation 
r Kcne I  might be a ociated with changed kinetic of cardiac repolari zat ion. Variou 
K+ channel are involved in pha e 3 repolari zat ion of the cardiac action potential and 
the.e channel i nclude Kv l 1 . 1  (hERGI). Kv7 . 1 (Kcnq I )  and Kir2 . 1 (Kcnj2) which are 
the a- ubuni t  that conduct I Kr• I K, and I K I  [ 308 ] .  Reduced Kir2 . 1 might prolong the 
teml inal pha e of the cardiac action potential which in tum may lead to a reduction in 
HR [ 309 ] .  Two pore domain K+ channels mediate background K+ currents, tab i l i z ing 
re, t ing membrane potent ial and expedi t ing action potent ial repolarization . In the heart . 
two pore domain K+ KCI1k3 (Ta k- l )  channel are impl icated i n  the cardiac plateau 
current [ 3 25 ] .  Ta k- l  carries a background or " leak" current and its i nhibi t ion i 
uffic ient  to delay repolari zation,  cau i ng prolongat ion of the act ion potent ial durat ion.  
and in orne ca es, early after depolarizations [ 326 ] .  In tere t i ngly, exerc ise train ing 
normal ized OK ventri cl e  Kcnk3 towards sedentary control level. 
Immunoblot a ay wa done to evaluate whether the al teration of mRNA encoding 
cardiac protei n  wa tran lated i nto al terat ion of prote in  expression. Despite The real ­
t ime RT-PCR resul ts  howing downregulat ion i n  the expre sion of Gja l  and 
upregulation of Gja4, Cacnb2 and Tpm2 in sedentary O K  compared to sedentary 
control and upregulat ion of Gja J  i n  exerci  e trained OK compared to sedentary OK rat , 
the expre ion of corre ponding protein  encoded by the e gene were not ignificantly 
1 53 
( P  > 0.05 ) al tered i n  sedentary GK compared to edentary control or b exerci e 
trai n i ng. Previou, tudie comparing the mR A and protein level concluded that the 
c nelation i poor [ 327.  32 ) . A tudy by Schwanhau er ha hown that mRNA Ie el 
explain on ly around 409'c of the variabi l i ty  in prote in level [ 329 ] .  
The lack of  change of  protein . d pite change i n  mRNA. may partl y  explain the 
pre, erved funct ion in myocyte hoTtening and Ca2+ tran port i n  GK compared to control 
rats .  
Thi tudy ha al 0 hown the effect of diabete and exercise train ing on myocardial 
u l tra tructure .  The ul tra tucture wa general ly well pre er ed in al l  groups. The 
mito hondria are important determinant of myocyte function and urvival. CIa sical ly. 
approximatel 40% of cardiomyocyte olume i mitochondria. The mj tochondria are 
e ential for upply ing the heart with ATP to u tain heart function. lmpaimlent of 
m i tochondrial function and energy metaboli  m in diabet ic heart has been reported i n  
n umerou c l in ical [ 330. 33 1 ]  and experimental tudies [ 332.  333 ] .  Resu lt from the 
pre ent tudy howed mitochondrial number were not ignificant ly al tered in edentary 
GK compared to sedentary control rats .  Exerci e train ing significantly i ncreased 
nli tochondrial number in exerci e trained GK compared to sedentary OK rats and to a 
i nl i l ar extent i n  exerci e trained control compared to edentary control rats .  Whi l  t the 
number of nutochondria wa not ign ificantly al tered, the biochemical acti vi t ie might 
change. A previou tudy has reported that mi tochondrial function of chron ical l y  
diabetic rat and i n  part icular A TP  and pho phocreati ne Ie  el were al tered and 
endurance train ing wa able to reverse th is  al terat ion [ 334 ] .  Exerc ise train ing i ncreased 
cardiac output to meet the enhanced demand of the mu culo 'keletal and pulmonary 
1 5.+ 
')y tem,> .  Enhanced mi tochondrial number and generation of A TP can great ly benefi t  
card iac fun t ion  during exerci se train ing [ 207. 335 .  336 ] .  
I t  i wel l  known that cardiac hypertrophy i an  adapti e re pon e to  tre on the heart 
[ 337-339 ] .  ardiac hypertrophy i broadly  c Ia  ifi ed i nto pathologic hypertrophy a 
ob,>erved i n  diabete ' .  and ph iologic hypertrophy a a con equence for example of 
regular exer i se .  In exercise trai n i ng. the myocardial mas i increa ed in order to 
i n  rea�e performance of the heart and the hypertrophy i reversible [ 340] . In contra t. i n  
d iabetes i n  rea ed myocardial ma i i n-ever ib ly a ociated wi th increa ed in ter t i t ial 
fibro i s .  cel l death and cardiac dy function. At the cel lu lar level ignificant 
morphologi al change contribute to the hypertrophic proce i ncluding i ncrea e of 
myocyte ' ize .  enhanced protei n ynthes i s  and remodel ing of 'arcomere organizat ion.  
The pre ent tudy revealed that edentary GK heart were heavier compared to 
edentary control rats. whi le the impact of exerci e train i ng on heart weight wa not 
ign ificant .  Cardiac hypertrophy fac i l i tate the i ncrea ed workload by i ncrea ing 
contracti l e  capacity .  The contract i le funct ion of the heart rel ie on the sarcomere . 
S arcomere length wa reduced i n  exerci e trai ned G K  and exerCI e trained control 
compared to edemary GK and sedentary control rat , re pect ively .  However. 
hypertrophic  remode l ing produced by exerc i se train i ng was accompanied by an i ncrea e 
i n  arcomere width i n  exerci e trained GK and exerci e trained control rats .  
CIa i ca] ]y, the ICD are described a i n-egularly-spaced dark band between myocytes. 
and contain different tructures inc luding desmo omes that are re ponsible for 
mechan ical coup l ing  and gap junction that are re ponsible for electrical coupl i ng of the 
myocyte . In the current  study, ICD morphology was evaluated. to i nve t igate cardiac 
1 5.+ 
.,tem,>. Enhanced mi tochondrial number and generation of ATP can greatly  benefi t  
cardiac function duri ng exerc i se trai ni ng [ 207, 335 .  336 ] .  
I t  I .,  well  k.nown that cardiac h pertrophy i an adaptive respon e to tre on the heart 
[ 3  7-339 J .  Cardiac hypertrophy i broadly  clas i fied i nto pathologic hypertrophy as 
ob,erved in diabete . and phy iologic hypertrophy a a consequence for example of 
regular exerci e .  In e erc i se trai ni ng. the myocard ial mas i i ncrea ed in order to 
i ncrea 'e pelfonnance of the heart and the h pertrophy i rever ib le [ 3'+0] .  In  contra t, i n  
d iabetes i ncrea ed myocardial ma ' i i rrever ibly a sociated with i ncreased i nter t i t ial 
fibro i . .  ce l l  death and cardiac d y  function. A t  the cel lu lar level ignifi cant 
morphological hanges contribute to the hypertrophic proce i ncluding increa e of 
myocyte ize ,  enhanced prote in  ynthe i and remodel ing of sarcomere organizat ion. 
The pre ent rudy revealed that edentary GK healt were hea ier compared to 
,edentary control rat . wh i le the impact of exerci e train ing on heart weight was not 
s ign ificant. Cardiac hypertrophy fac i l i tate the i ncrea ed workload by i ncreasing 
contracti l e  capaci ty .  The contract i le function of the heart rel ies on the arcomere . 
Sarcomere length was reduced i n  exerc i  e trained G K  and exercise trained control 
compared to sedentary GK and edentary control rat , re pect ive ly .  However. 
hypertrophic  remode l ing  produced by exerci se train ing was accompanied by an i ncrea e 
i n  sarcomere width i n  exerci se trained G K  and exerci e trained control rats. 
CIa ical ly .  the ICDs are de cribed as i rregularly-spaced dark bands between myocytes ,  
and contain d i fferent  tructure including de mosome that are respon ible for 
mechan ical coup l i ng and gap j unction that are responsible for e lectrical coupl i ng of the 
myocyte . I n  the current  study, ICD morphology was evaluated, to i nve t igate cardiac 
cel l - to-cel l  j unction remodel ing 1 0  diabete and exerci e train ing .  ICD membrane 
c nvolution was mea�ured per length uni t .  A ignificant i nc rea e i n  membrane 
convolut ions was observed i n  e erc i,  e trained GK compared to edentary GK and to a 
lesser e tent i n  exerci e trai ned control compared to ,edentary control rat . 
General ly, a flattened con olut ion lead to 100 ening of attachments and may explain  
poor conduction i n  the  m ocardium.  On the  other hand a h igh degree of  membrane 
convolut ion may be a ociated with greater electrical and mechanical attachment and 
enhanced myocardial conduction. 
3.2A Conclusion 
In  the previou ect ion ( 3 . 1 . 2 )  employing hearts from 8 to 1 0  week old GK and age-
matched control rat 67 gene encoding cardiac muscle proteins and ventricular 
myocyte hortening and i ntrace l lu lar Ca1+ concentrat ions were investigated. The re ul t  
showed that even in the e young animal there were al teration in the pattern of mRNA. 
I n  adul t  GK rat a conti nuation i n  the changjng  pattern of mRNA which in some ca e 
wa modified by e erci e tra in ing was ob erved . However. the e change were not 
a sociated w i th s ign i ficant alterat ion in the expression of some cardiac mu cle prote in 
or i n  ei ther entricu lar myocyte horten jng or ci+ transport . 
")+ I n  T2DM a derangement i n  cardiac muscle contraction and cel lu lar Ca- tran port 
u ual ly  occur later i n  l i fe and it i s  po sible that ome of the changes in mRNA are 
tiling place to protect cardiac mu cle function and exerci e train i ng may have a 
beneficial therapeut ic role as the animals develop chronic diabetes later i n  l i fe .  
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Table 3 . 3 :  E pre ion of gene encoding cardiac mu cle prote in I n  ventricle from 
) oung and aging GK rat 
Gene Young (8- 1 0  week ) Aging ( l  0- 1 1 month ) 
GK . Control GK . Control 
Card iac mu ele  protein 
Tpl1l2 No change Upregulation 
I nterce l lu lar p rot i n  
Gja l  o change Downregulation 
Gja4 No change Upregulated 
Cell  membrane t ran port 
Slc9a I Downregulation o change 
Alp ]  hI  No change Upregulat ion 
Calci u m  chan nel 
Cacna l g No change Upregulat ion 
Caclw ] h Upregulat ion No change 
CacIlb2 No change Upregulat ion 
Sod i u m  chan nel 
Sen 1 b Upregulation o change 
Potassiu m  channel 
Hcn2 Upregulation Upregulat ion 
HCI14 Downregu lation No change 
Kena2 Downregulation No change 
Kcna3 No change Upregulation 
Kcna4 Downregu lation No change 
Kcnj2 Downregulation Downregu lation 
Kellel No change Upregulation 
Kenk3 No change Downregu]ation 
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Table 3 ..+ :  Effect of exerci e trai n ing on e 'pre ion of gene encoding cardiac mu cle 
protein  i n  ventricle from aging  GK and control rat 
Gene Aging ( 1 0- 1 1 month ) Aging ( 1 0- 1 1 
GK E ercise \' . GK month ) 
Sedentary Control E erci e v 
Control Sedentary 
I ntercel lu lar protei ns 
Gja J Upregu lation No change 
CQl'3 Upregulation No change 
Pota s i u m  chan nel 
HC172 Downregu lation No change 
KcnU Upregulation No change 
] 5  
3.3 E ffect  of piogli tazone on e 'ci tat ion-contraction cou pl ing L-t pe Ca2+ cu rren t 
and elect rica l conduction i n  the G oto- Kakizaki  ty pe 2 d iabetic rat heart 
3.3. 1 I n t roduct ion 
PlOgli tazone (PIO) belong to the th iazolidi nedione group of oral antid iabetic agent 
and i an agoni t of peroxi ome proli  ferator-acti ated receptor gamma ( PPARy) [ 253 ,  
3-+ 1 ] . It can be admin i s tered a a monotherapy or  i n  combination with metfol1n in ,  
"u l fon ) l urea . exenatide, dipeptidyl pept ida e -I- i nh ibi tor or in 'u l in  [ 25-+ ]  for the 
treatment of T2D M .  PIO in combi nation with any in u l in  contain ing regimen l i ghtly 
i n  rea. es the ri k of hypoglycaemic epi odes. cau e weight gai n  and oedema, due to 
fl u id retent ion,  and i ncrease the ri k for the development and/or exacerbation of beart 
fai lure [ 3-1-2 ,  3-+3 ] .  PIO i mpro es fast ing and po tprandial levels of i nsul i n  en i t iv i ty, 
pIa, rna gluco e and l ip id Ie el and al 0 decrea e ystol ic and mean arterial pressure i n  
pontaneou ly  obe e, i n  u l i n-re i tant rhe u monkey [ 257 ] .  High oral do  e of  PIO 
(500- 1 000 mglkg) admin i  tered to mice produce hypertrophy of the heart and mi ld  
congestion of the l iver and kidneys [ 34-1- ] .  PIO attenuate conge t i  e heart fai l ure­
i nduced atrial structural remode l ing and atri al fibri l lation in rabbit heart [ 270] . Major 
ide effects of PIO incl ude sodium and water retent ion, which can provoke oedema. 
anemia  and even aggra ate or reveal healt fai l ure , hepatotoxici ty and increa e i n  
edema and  weight gai n  [ 263,  26-1- ] .  In  addit ion to  an  i ncrea ed  risk of  heart attack and 
troke. cardi ac electrical conduction abnormal i t ie  are frequently observed in diabetic 
pat ient [ 3-1-5-3-+7 ] .  The e i nc lude variou arrhythmias [ 3-+5-347 ] .  atrioventricular block 
[ 3-+8] .  prolonged QT i n terval and udden death [ 3-+6. 3-+7. 3-+9 ] .  Hyperglycaemia ha 
been l i nked to a prolonged QT i ntervaL and the pre ence of QT abnormal i t ie are 
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common ly u ed as indicator of mortal i ty i n  diabetic pat ient [ 349. 350] .  It i al 0 
notable that the i ncidence of Bundle branch block. brad arrhythmia and 
atno\entricular block are ignificantl higher i n  diabet ic pat ient than in the general 
popu lation [ 34 ] .  PIO ha been hown to improve LV remodel ing and function i n  mice 
with po, t-myocardial i nfarction hean fai l ure and reduce i nfarct ize by 5 1  % in PPAR-y 
knockout mice [ 27 1 .  35 J ] . Precondit ioning with n idcorandi l  and PIO reduced lactate 
accumulation, counteracted 0 idati e tre , improved energy production and reduced 
ventricular arrhythmia in myocardial i chemiaJreperfu ion inj ury in rats [ 35 2 ] .  PIO 
reduced angioten i n  I I -i nduced card iac hypertrophy in 1 'itro and in l 'iI'D in rat [ 272 ] .  
yocardial h pertrophy i nduced b y  gluco e and insu l in  was inh ibi ted directly by PIO 
in pri mary cul tured rat cardiac myocyte [ 3 5 3 ] .  PIO amel iorated left ventricular 
hypertrophy and fibrosi i n  the heart of hypertensive rats and attenuated cardiac 
hypertrophy and fibro i i n  angioten in I I - i nduced cardiac hypertrophy in m ice [ 273 .  
27-1- ] .  L !body weight rat io wa i ncrea ed and myocyte ize and atrial natri uretic factor 
v,'ere i ncrea ed in PIO treated aortic banded rat [ 354 ] .  PIO ameliorated the hi tological 
( reduced area of cardiac fibrosi ) and funct ional cardiac damage ( improved sy tol ic  and 
d ia  tol ic cardi ac performance ) i nduced by angiotens in  I I  hyperten i ve rat by a 
mechani m that might be related to it antioxidat ive action [ 3 5 5 ] .  PIO also protected 
against i schemiaJreperfusion i nj ury when admin i  tered prior to ischemia i n  isolated 
perfused rat heart [ 275 ] and i nhibited cardiomyocyte apoptosis and reduced 
m itochondrial u ltrastructure i njury and membrane potential 10 s in i chemic/reperfused 
rat heart [ 35 6 ] .  I nfarct s ize i nduced i n  rat heart wa mal ler in PIO treated animal and 
the l imi t ing effect were dependent on acti vation of mitochondrial lKATP [ 3 57 ] .  In 
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can i ne ventri u lar myoc) te act ion potential durat ion wa hortened by PlO at 
concentration 2: 1 0  f..l M and th is  '.va accompanied by i nhibi tion of everal tran -
membrane ion current� inc lud ing L-type Ca:!+ current .  the rapid and low component of 
delayed rect ifi er K+ current  and the tTan ient outward K+ current  [ 3 5 8 ] .  PIO attenuated 
angioten in  I I - i nduced connect ive t i  ue growth factor e pre ion and prol iferation i n  
atrial fibrobla t and a l  0 suppre ed Ang I I- induced L-type Ca2+ current remodel ing i n  
H L- J cel l '  [ 35 9 ] .  The a ims  of  the current tudy were to i n  e t igate the acute effect of 
PIO on " entricular myocyte horten ing and Ca2+ transport. and the effect of PIO on 
cardiac elec trical conduct ion i n  type 2 diabetic GK rat .  
3.3.2 Re u l ts 
3.3.2. 1 Acute effects of piogl i tazone on ventricular myocyte shortening and Ca2+ 
t ransport 
3.3.2. 1 . 1  General  characterist ics of the a n i mal 
Experiment were perfomled in cardiac myocyte i olated from GK rats.  aged 8- 1 0  
month . and age-matched control . Body weight, heart weight  and non-fa t ing blood 
gluco e were mea ured immediate ly before experiment . The results are shown i n  Table 
3 . 5 .  Body wei ght and heart weight were s ignificantly ( P  < 0.0 1 )  higher in GK compared 
to control rat . on-fa t ina  blood alucose was ign ifi cant ly (P  < 0.0 1 )  elevated i n  GK b b � 
compared to control rat . Heart weight to body weight rat io was not ign ificant ly (P  > 
0.05 ) altered i n  G K  compared to control rat . 
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Table 3 . 5 :  General characteri l i c  of Goto-Kakizaki rat 
Control G K  P value 
Bod weight(g) 352 .  ± 1 1 .6 4 1 7 .83 ± 5 . 1  0 .00 
Heart weight (g)  1 .2 ± 0.03 1 .4 ± 0.02 0.00 
Heart weightlbody weight (mg/g) 3 .4  ± 0.07 3 . 2  ± 0.03 0.057 
Blood gluco e (mg/dJ )  96.9 ± 2 . ] 1 3 1 .5 ± 3 .6  0.00 
Data are mean ± S .E .M .  S tati stical compari ons were perfonl1ed u ing i ndependent 
ample He t. n = 1 1 - 1 2 . 
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3.3.2. 1 .2 E ffects of acute p iogJ i tazone on ventricular myocyte horteni n g  
Experi ments were conducted n ventricular myoc te. i olated from - 1 0  month GK and 
age-matched control rats. 1 yoc le were i olated u ing enzymatic-mechanical di per al 
te hnique a '  de  cribed i n  eCl ion 2A. l .  M ocyte 'horten ing wa mea ured u ing a 
video edge detect ion tem ( eCl ion 2 "+ "+) .  Myoc te were expo ed to 10 min T 
contain ing d i fferent concentrat ion of PIO di  01 ed i n  DMSO. The fi nal concentration 
of DM 0 in al l PIO and T solu tions a 0.02%, a ment ioned in the drug  preparat ion 
t ection 2A . l 0) .  
Figure 3 .27 _ hO\ the effect of 1 0  min PIO 0. 1 - 1 0  !-1 M )  on the ampl i tude of myocyte 
bortening. Ampl i tude of bortening wa ign ificantly ( P  < 0.05 ) and progre sively 
reduced i n  GK myocyte fol lowing treatment with 1 and ] 0 !-1M PlO and i n  control 
myocyte fol lowing treatment with 0. 1 .  1 and 1 0  fl M  PlO. 
Re t ing cel l  length and the kinetic of myocyte hortening were mea ured in myocyte 
expo ed to 1 J-I ffi PlO. A typical recording  of hortening in a control myocyte 
uperfu ed wi th T or NT + 1 !-1M PlO for 1 0  m in  i shown in  Figure 3 .28a. Re r ing 
cel l length i n  GK and control myocyte was unaltered by PlO (Figure 3 .28b) .  TPK 
horten ing wa ign ificantly (P < 0.05) prolonged in GK and control myocyte and 
THALF rel axation of horten ing was ign ifi cantly (P < 0.05 ) prolonged only in GK 
myocyte w i t h  1 f..1.M P lO  ( Figure 3 .28c-d) .  Ampli tude of hartening was unal tered i n  
GK (7 .37 ± 0..+4) compared to  control ( 8 . 5  ± 0 .38 )  moycyte . P lO s ign ificantly ( P  < 
0.05 ) reduced the ampl i tude of hortening i n  GK (5 .9  ± 0.39) and control ( 6.94 ± 0.34) 
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Figure 3 . 2 7 :  Effects of different concentrations of piogli tazone ( PIO) 0. 1 - 1 0  Il M  on 
ventri cular myocyte hortening .  Recording of ventlicular myocyte horten ing were 
perfomled i n  e lectrical ly t imu lated ( l Hz)  myocyte . Data are mean ± S .E .M .  
Stati t ical compari on  were performed u i ng paired ample t-test ( wi th in the ame 
m ocyte analy i ) and independent amples He l ( for analy is of data from different 
group ) .  n = J.+- ] 9 cel l  from 9- 1 0  heart . Horizontal l i ne above graph bar i ndicate 
ignifi cance (P < 0.05 ) .  
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Figure 3 . 28 :  Effect of piogl i tazone ( PIO) on shorteni ng. Recording were performend 
in e lectri cal l y  t imulated ( 1  Hz )  myocytes .  (a) Typical records of shorten ing in a control 
myocyte uperfu ed with ei ther normal Tyrode ( T) or NT + ] 11 M  PIO, (b)  Re t i ng 
ce l l  length ( RC L). ( c )  Time to peak hortening.  (d )  Time to half rel axation of 
hortening, and (e )  Ampli tude of shorten ing. Data are mean ± S . E. M .  S tat i tical 
compari on were performed u i ng paired sample t-te t (wi th in the arne cel l  analy i s) 
and i ndependent ample He t (for analysi of data from different groups). n = 22-24-
cel l s  from 8 heart . Horizontal l i nes above graph bar i l l ustrate ign ificant difference ( P  
< 0.05 ) .  
3.3.2 . 1 .3 E ffects of acute piogl i tazone on ventricular myocyte i n t racel lu lar Ca2+ 
concentrat ion 
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I n  the, e e perimem". the effect f 1 0  min  bath appl ication of PIO ( 1 11 M )  on the reL t ing 
i ntra e l lu lar Ca2+ le\ el and on the ampl i tude and kinetic of Ca:!+ tran ient were 
im e"tigated u ing nu  re cence photometry a de cribed in Section 2 .-1- .5 .  The effect of 
1 0  min  bath appl ication of 1 11 M PIO on i ntracel lu lar Ca:!+ is hown in Figure 3 .29 .  A 
t pical record ing of Ca:!+ tran ient i n  a control myocyte uperfu ed with NT or 1 0  min 
T + 1 11M P IO i hown in Figure 3 . 29a. Rest ing fura-2 rat io wa not s ignificantly (P 
> 0.05 ) altered i n  GK or control myocyte or  by PIO ( Figure 3 . 29b) .  TPK Ca:!+ transient 
\\ a, not altered in GK c mpared to control myocyte and wa ignifi cantly prolonged 
by PlO in GK and control myoc te (Figure 3 .29c) .  THALF decay of the Ca:!+ transient 
wa ' ignifi cantly (p  < 0.05 ) hortened in GK compared to control myocytes (Figure 
3 .29d) .  Ampli tude of the Ca:!+ tran ient wa ignificantly (P < 0.05 )  reduced in GK and 
control myocyte by PIO ( Figure 3 .2ge) . 
I 0.8 � 
�-_ 0.6 .12 
e 




N T  
� I  o 
200 ms 
Control G K  
Control GK 
1 66 
N T+ l � M  PIO 
C 
1 00 D NT 
o NT + 1 1lM PIO 
I 80 
C .91 I/) c � 60 
�a .>< 40 '" 8. 
g 





E i  0.4 .91 _ � �  
!:: I/) 0.3 . ." 
"a § / � �  0.2 / l �  If 0.1  
0 
Control G K  
Figure 3 .29 : Effect of piogl i tazone ( PIO) on i ntrace l lu lar Ca2+ concentration . 
Recordi ng III e lectri cal ly t imulated ( 1  Hz)  myocyte . (a )  Typical records of Ca2+ 
tran ient i n  a contro l  myocyte uperfu ed with ei ther normal Tyrode ( NT) or T + 1 � M  
PIO, (b)  Re t ing fura-2 ratio, ( c )  Time to peak Ca2+ transient, (d )  Time to half rel axation 
of Ca2+ tran ient .  and ( e )  Ampl i tude of Ca2+ tran ient. Data are mean ± SEM. Stati t ical 
compari on were performed us ing paired sample t-test (wi th in  the arne cell analy i s )  
and i ndependent ample He t ( for analysis of  data from different groups), n = 20-24-
cel l from 8 hearts .  Horizontal l i ne above graph bar i ndicate s ignificance (P  < 0.05 ) .  
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3.3.2. 1 .4 Effects of p iogL i tazone on myofi lament en i t i v i ty to Ca2+ 
In  some e periment myocyte ,>hortening and intracel l u lar Ca2+ transient were re orded 
s imul taneou ly (Section 2 .4 .7 ) before and after 1 0  min appl ication of I 11 m PIO. 
T) pl al re ord of myocyte horteni ng and fura-2 ratio in T and a typical pha e plane 
diagram of fura-2 ratio cel l  length i n  NT are hown in  Figure 3 .30a & 3 .30b. 
re�pect i \'ely.  The gradient of the fura-2-cel l  length trajectory during late relaxation of 
the twit  h contraction wa not ign ifi cant l y  (P > 0.05 ) altered in GK compared to 
ontrol III oc te or by PIO ( 1  )J m)  during the period 500-800 m (Figure 3 . 30c ) ,  500-
700 m ( Figure 3 . 30d) and 500-600 m (Figure 3 . 30e) .  
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Figure 3 . 30: Effect of piog l i tazone ( PlO) on myofi lament en I t lY l ty  to Ca2+ . 
( a)Typical records of horten ing and Ca2+ tran ient recorded s imul taneously i n  a control 
myocyte uperfu ed wi th  e i ther nonnal Tyrode ( T) or NT + 1 fl M  PIO. (b)  Typical 
phase plane d iagram of fura-2 rat io un i t  (RU)  v . cell length in a control myocyte. The 
o l id  arrow and bar in (b )  indicates where the gradient was mea ured. Gradient of the 
fura-2-cell length trajectory during l ate relaxation of twitch contraction duri ng the 
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Figure 3 .30:  Effect of piogli tazone (PIO) on myofi lament sens l t lv J ty to Ca:!+ . 
(a )Typical records of horten ing and Ca2+ transient recorded i mul taneously i n  a control 
myocyte uperfused with ei ther nonnal Tyrode ( T) or NT + 1 11M PIO. (b )  Typical 
phase plane diagram of fura-2 ratio unit ( RU)  v . cel l  length in a control myocyte. The 
ol id  arrow and bar in (b )  indicate where the gradient was measured. Gradient of the 
fura-2-ce l l  length trajectory during l ate relaxation of twi tch contraction during the 
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period ( c )  500- 00 TIl . ( d )  500-700 m and ( e )  500-600 m . Data are mean ± SEM . 
Stat i� t ical compari ons \ ere perfomled u jng paired ample He t (wi th in  the ame cel l 
analy j ,»  and i ndependent sample He t ( for anal si of data from different group ). n = 
2 1 -26 cel l s  from 8 heart. . 
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3.3.2. 1 .5 E ffects of p iog L i tazone on arcoplasmi c reticu l u m  Ca2+ t ran port 
The effects of J a min  appl ication of PIO ( 1  � 01 ) on �+ . R Ca- were a e ed I n  fura-2 
loaded myocyte� from GK and control rat ( ection 2 .4-.6) .  A typical record of the 
experi mental protocol in a control myocyte i hown i n  Fi gure 3 . 3 1 a. Ampli tude of the 
caffeine evoked Ca2+ transient wa not ignificant 1y ( P  > 0.05) altered in GK compared 
t control m ocyte or by PIO ( Fi gure 3 .3 1 b) .  SR fractional relea e of Ca2+. mea ured 
as the re lation h ip between electri cal ly evoked and caffe ine evoked Ca�+ tran ient. wa 
ignificant ly ( P  < 0.05 ) i ncrea ed in GK compared to control myocyte and wa further 
i ncreased by PIO ( Figure 3 . 3 1  c ) .  Recovery of the Ca
�+ tran ient fol lowi ng appl ication 
of caffeine wa not - ignifi cant ly (P > 0.05) altered in GK compared to control myocytes 
or by PIO ( Figure 3 . 3 1 d) .  
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Figure 3 . 3 1 :  Effect of piogli tazone ( PIO) on sarcopla mic ret iculum (SR)  Ca2+ 
tran port. ( a) Typical record of experimental protocol i n  control myocyte. (b)  
Ampl i tude of caffeine-evoked Ca2+ transient .  ( c )  Fractional relea e of Ca2+. and (d)  
Recovery of the  Ca2+ transient fol lowing rapid appl ication of  caffeine.  Data are mean ± 
S .E .M .  Statistical compari ons were performed u ing paired ample t-test (wi th in the 
arne cell anal y is) and i ndependent ample He t (for analysi of data from different 
group ) ,  n = 25-36 cell from 1 0  hearts .  Horizontal l i nes above graph bars i ndi cate 
tati t ical ignifi cance ( P  < 0.05 ) .  
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3.3.2. 1 .6 E ffects of piogl i tazone on L-type Ca2+ cu rrent 
The effect. of 1 0  min PIO ( I  /J m) on myocyte L-t pe Ca2T current wa al 0 
I \lve t igated. u i ng whole cell patch clamp a de cribed in Section � "+ .8 .  
The electrophy iological protocol ( upper panel that were u ed and t pical current 
record of Ca2+ current i n  a control myocyte ( lower panel ) duri ng act ivat ion. 
i nact ivation and re l i tut ion experiment are hown i n  Figure 3 .32a, b and c, 
re�p c l ive ly .  Over a range of te t potent ial the ampl i tude of L-type Ca2+ current wa 
mode�tl} reduced i n  GK compared to control myocytes and was further reduced by PIO 
( Fi gure 3 .32d) .  At a te t potential of 0 mY the ampl itude of L-type Cac+ current wa 
large t i n  control myocyte (7.-+ ± 1 .3 pAJpF). then control myocyte treated with I /Jm 
PIO (6 . 1 ± 1 .-+ pAJpF) , then GK myocyte ( 5 . 8  ± 0.9 pAJpF) and smal 1e t i n  GK 
myocyte treated wi th I , . .lITI PIO ( 5 .0 ± 0.7 pA/pF) ( Figure 3 .32e) .  I nacti vat ion of L-type 
Ca2+ current .  wa not ign i ficant ly ( P  > 0.05 ) al tered i n  GK compared to control 
myoc te or by 1 0  m in  appl ication of 1 )J m PIO ( Figure 3 . 32f). S im i larly, the t ime 
cour e of recovery from inact i vat ion wa not ign ificantly ( P  > 0.05 ) al tered i n  GK 
compared to  control myocyte or by PIO ( Figure 3 . 32g) .  
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Figure 3 _ 32 :  Effect of piogli tazone (PIO) on ampli tude of L-type Ca:!+ current Voltage 
protocol ( upper panel ) and typical record ( lower pane l )  of ( a) Activation. (b)  
I nac6vation . and (c) Re t i tut ion of L-type Ca2+ current i n  a control myocyte. c)  
Activation current at vol tage ranging from -60 to +70 mY. (e) Mean L-type Ca2+ 
current  evoked by te t potential to 0 mY,  (f)  Inactivat ion curve at pre-pul e vol tage 
rangi ng from -60 to +30 mV.  (g)  Re t i tut ion curve at i nter-pul e t iming ranging  from 25 
to 70 m . Data are mean ± SEM . Stati t ical compari ons were perfomled using paired 
ample He t (wi th in  the arne cel l  analysi ) and i ndependent ample He t (for anaIysi 
of data from different group ) ,  n = 9- 1 1 cells from 4-6 heart . 
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3.3.2.2 The effects of piogl i tazone on card iac electrical conduction 
The effect of oral PIO on e lectrical conduction of the heart in 1 'i1 'o wa al 0 i nve, ti gated 
in GK and control rats. Biotelemetry technique were u ed (Section 2 A. 1 1 )  to monitor 
the ECG i n  GK and control rat . The urgical procedure were performed i n  7 GK and 7 
controb at 7 month of age ( ection 2 A. 1 1 . 1 ) . HR ,  H RV, QRS comple , QT. cQT and 
PQ were evaluated after PIO treatment. Animal recei ed 2 .5  to 20 mglkg body weight 
of PIO accord ing to the protocol de cribed in Section 2.4 . 1 1 . 3 .  PIO wa prepared a 
des ribed i n  Section 2 . ... L J I A. 
3.3.2.2 . 1  General  characteri t i c  of the a n i mal  
Prior to i mplantation of the tran mi tter device . the fa t ing blood gl uco e wa 
ignifi cantl (P < 0.05 ) h igher in GK rat ( 1 0 1 . 3 ± 5 .6 mg/d J )  compared to age matched 
control s (73 .9  ± 5 .6 mg/dl ) .  B lood glueo e at 1 20 m in  after glueo e i njection (2 glkg 
body weight.  i .p )  wa 283 .7 ± 24-.5 mg/dJ in GK rat compared to 9 1 .9 ± 4-.0 mgldJ i n  
control . Average body weight, fa t i ng blood gluco e and blood glueo e at 1 20 min 
fol 1o\v ing g lueo e admin i  tration were al l  s ignificant ly (P  < 0.05 ) higher in  GK rat 
compared to control (Table 3 .6 ) .  
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Table 3 .6 :  General characteri t ic of experimental animal prior to implantation of 
tran<;m i tter. 
Control ( n  = 7 )  GK ( n  = 7 )  
Body \>, eight ( g )  3'+5 . 3  ± 1 0 .5  407 .7 ± 7 .4* 
Fa�t i ng blood gluco e (mg/dl )  73 . 9 ± 5 . 6  1 0 1 . 3 ± 5 .6* 
Gluco e to lerance (mgld l )  at 9 1 .9 ± .+ 283.7 ± 24.5* 
1 20 min 
Data are mean ± SEM.  Stati t ical compan ons were performed using i ndependent 
ample He t. *p < 0.0 1 
3.3.2.2.2 E ffec of piogL i tazone on body weight and blood gJ uco e 
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The effects of PIO on body weight and blood gluco e of GK rat and control were 
mea. ured periodical l at different  tage of the tudy. The re ul t  are hown i n  Figure 
3 .33 .  Bod) weight of GK rat were ign ificant ly (P  < 0.05 ) h igher than control at aJ ]  
, tage� of the experiment .  PIO had no ignificant (P > 0.05 ) effects on body weight i n  
ei ther GK rat o r  control on-fast i ng  blood glucose in GK rat and control mea ured 
at d ifferent tages of the tudy are shown in Figure 3 . 3'+ .  At the tart of the experiment 
blood g luco e wa ' ign i ficant ly  ( P  < 0.05 ) h igher i n  GK rats compared to  control . Wi th 
i n  rea ing concentrat ions of PIO blood gluco e i n  GK rat was reduced toward contro l  
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Figure 3 . 33 :  Effect of piogli tazone ( PIO) on body weight .  Data are mean + S .E .M .  
tati � t icaJ compari on  were performed u j ng one-way A OVA fol lowed by 
Bonferroni ,  n = 7. Number on the X-axi repre ent the do e in mg/kg/day. Line above 
bar i ndicate ign ificance ( P  < 0.05 ) .  
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Figure 3 . 3-1-: Effect of piogli tazone ( PIO) on non-fa t ing blood gluco e. Data are mean 
+ . E .M .  Stati t ical compari on were performed u ing one-way A OVA fol lowed by 
Bonferroni .  n = 7. umber on the X -axi repre ent the do e in mg/kg/day. Lines above 
bar i ndicate i gn i ficance ( P  < 0.05 ) .  
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3.3.2.2.3 EITects of piogl i tazone on heart rate and heart rate variabi l i ty 
Biotelemetry data wa" col lected for 5 mi nfhrlanima1l2-t hr/da and analyzed u i ng one­
way TOY fol lowed b Bonferroni .  HR wa mode ' t ly lower i n  GK rat compared to 
control. ( Figure 3 . 3 - ) . PIO had no ignificant ( P  > 0.05 ) effect on H R  in  ei ther GK or 
control rat. .  HR  wa  m de  t l y  elevated i n  GK compared to  control rat (Figure 3 .36) .  
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Figure 3 . 35 :  Effect of piogl i tazone (PIO) on heart rate. (a) Typical record of heart 
rate. and (b)  Mean heart rate during admi ni stration of d ifferent concentrations of PIO. 
Data are mean + S .E .M .  Stati t ical compari ons were perfomled u i ng one-way 
A OVA fol lowed by Bonferroni n = 7. umber on the X-axi repre ent the dose i n  
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Figure 3 . 36:  Effects of piogl i tazone (PIO) on heart rate variabi l i ty. (a)  Typical recording 
of heart rate variabi l i ty, and (b )  Mean heart rate variabi l i ty during admin i  tration of 
different  concentrat ion of PIO. Data are mean ± S .E .M.  Stati st ical comparison were 
performed using  one-way A OVA fol lowed by Bonferroni ,  n = 7 .  Number on the X­
ax l repre ent  the  do e i n  mglkglday. 
3.3.2.2A E ffects of piogl i tazone on the elect roca rd iogram 
The QR complex.  QT. cQT and PQ inter al were analyzed during  the study . QR 
complex duration wa mode tl but not ignificantl ( P  > 0.05 ) reduced in GK 
compared to  control rat and was not altered by PIa (Figure 3 .37) .  QT interval ( Figure 
3 . -+  ) wa<, modest ly  but not s ignificant ly (P  > 0.05 ) prolonged and QT in terval corrected 
for HR ( Figure 3 .-+9) \ as not d ifferent in GK compared to control rat and were not 
al tered b PIa. I ntere t ingly .  the PQ inter al wa s ignificantly ( P  < 0.05) prolonged i n  
GK ompared to  control rat a t  t he  tart of  the  study ( Figure 3 .40 ) .  P Ia had no 
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Figure 3 . 37 : Effect of Piogl i tazone ( PIO) on QRS complex duration .  ( a) Typical 
records of QRS in terval . and (b )  Mean QRS interval duri ng admin i stration of d ifferent 
concentrat ion of PIO.  Data are mean ± S .E .M .  Statist ical compari ons were performed 
u i ng one-way A OVA fol lowed by Bonferroni ,  n = 7 .  Number on the X-axi 
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Figure 3 . 38 :  Effect of p iogli tazone (PIO) on QT in terval . (a )  Typical recording of QT 
i n terval .  and (b )  Mean QT in terval duri ng admin i stration of different concentrat ions of 
PIO.  Data are means ± S .E .M .  S tat i st ical compari on were performed us ing one-way 
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Figure 3 .39 :  Effect of piogli tazone ( PIO)  on cQT i nterval . (a)  Typical recording of 
corrected QT i nterval ,  and (b) Mean corrected QT in terval duri ng admin i  trat ion of 
differen t  concentration of P IO. Data are mean ± S .E .M .  Stati tical compari sons were 
perfon11ed u ing  one-way ANOYA fol lowed by Bonfenoni ,  n = 7. Number on the X­
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Figure 3 .40: Effect of piogJ i tazone (P IO) on PQ i nterva1 . ( a) Typical recordi ng of PQ 
i n tervaL and (b)  M ean PQ i n tervaJ duri ng admin i  trat ion of d ifferent concentrat ion of 
PIO. Data are mean ± S .E .M .  Stati t ical comp31ison were performed us ing one-way 
A OVA fol lowed by Bonferroni .  n = 7 .  Numbers on the X-ax i s  repre ent the do e i n  
mglkglday. L i ne  above bar i nd icate s ign ificance ( P  < 0.05 ) .  
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3.3.3 Di cu ion 
In  recent year much of the re. earch ha focu ed on the general effects of PIO on 
cardio\ a 'cu lar function. In th i s  'tud the effect of PIO on ventricu lar myocyte 
. hortenmg and Ca2+ tran port and on the e lectrical conduction ystem of the diabet ic 
heart were i nvestigated. 
Ex.periment. were performed in GK rat . 8- 1 0  month of age. and age-matched control 
Diabetes status wa confi rmed by elevated blood g luco e .  
The major fi nding of th is  tudy were a fol low : ( i )  PIO i n  the range 0. 1 - 1 0 � M  
reduced the ampJi tude of hortening to im i lar extents in GK and control myocytes. ( i i )  
PIO ( I  � M )  reduced the ampl i tude o f  the Ca2+ transient t o  im i lar extents i n  GK and 
control myocyte . ( i i i )  M ofi lament  en i t iv i ty to Ca2+ wa not al tered in GK compared 
to control myocyte or by P IO. ( i v )  SR  Ca2+ fractional rel ease was i ncreased i n  GK 
compared to control myocytes and wa addi t ional l y  i ncrea ed by P IO. ( v )  L-type Ca2+ 
current wa mode t ly decreased i n  GK compared to control myocyte and further 
decrea ed by PIO. 
I t  ha  been reported that blood gluco e i e levated i n  GK rats a young a 1 month old 
[ 360 ] .  Body weight wa h igher in GK compared to control rat. A previous tudy 
reported no ign ificant d ifference at 2 month and ignificantly lower gain in weight at 
7 months in GK compared to control rats [ 203 ] .  PIO beJong to the TZD group of oral 
antid iabetic agents. and i an agoni  t of PPARy [ 36 1 ] which i s  as ociated with al tered 
gluco e homeo tasi [ 362-364 ] .  umerous experimental and c l i n ical studie have 
demonstrated the favorable effects of PIO to modulate cardiovascular risk factors 
related to T2DM [ 255 ,  266. 365-367 ] .  Furthennore. pre iou tudie have hown that 
the effects of pro on the cardiova cular sy tern are in i tiated at the pre-diabete tage in 
t) pe 2 diabet ic rat [ 36 ] .  In thi tudy PIO ( I  fl M )  ignificantly reduced the ampl itude 
of .,horrening and prol nged the TPK horten ing i n  GK and control myocyte to im i lar 
e tent�. Re�t ing cel l  length \ as unal tered i n  GK compared to control rat or by PIO. In  a 
pre iou ' . tudy PIO treatment reduc d cardiac cel l  length in myocytes from tran genic 
rats o\ er ex pre i ng ren in  compared to non-tran genic  l i t temlate [ 369 ] .  To i nve t igate 
the po ib le  mechanism underly ing the effe t of PIO on myocyte horten ing, further 
experi ment · were conducted. PIO decrea ed the ampl i tude and prolonged the TPK of 
the Ca2+ tran ient in GK and control myocyte , sugge t ing that the negati e i notropic 
effect of PIO might be part ly  attributed to al tered mechani m of Ca2+ tran port . The 
effect of PIO on myofi l ament en i t iv i ty to Ca2+ wa al a i nve t igated. Myofi l ament 
en i t iv i ty to Ca2+ wa not al tered by PIO ugge t ing that the negative i notropic effect 
of PIO could not be attributed to altered myofi lament en i t iv i ty to Ca2+ . Relea 'e of 
Ca2+ from the S R  duri ng the proce of E-C coup l ing contribute great ly to the 
generation of the Ca
"-r tran ient i n  cardiac myocytes [ 33 ] .  Therefore, SR Ca
"+ tran port 
wa a e ed before and after P lO treatment .  Caffeine-e oked SR Ca
"+ relea e wa not 
al tered in G K  compared to control myocyte or by PIO. However, the fractional relea e 
of Ca2+ wa i ncrea ed i n  GK compared to control myocyte and wa addit ional ly 
i ncrea ed by PIO. The e re u l t  may ugge t that the SR  Ca
"+ release channel i n  
diabet ic heart and during P IO treatment i more sen i t ive to e lectrical t imulation. The 
recovery of the Ca
2+ tran ient was not al tered in GK compared to control or PIO treated 
myocyte . During  the recovery proce s Ca
2+ i taken back i nto the SR via the SERCA 
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pump and ex truded from the cel l  primari ly v ia  the a"'/Ca�- exchanger [ 33 ] .  Further 
..,tudJe� \ I I I  be requ i red La in e t igate the effect of PIO on the e mechani m . L-type 
Ca2+ current i the primary tri gger for SR Ca2+ relea e. mpl i tude of Ca2+ current wa 
mode t l  reduced in  GK compared to control myocyte ' and wa further mode t ly 
reduced by PIO. I nacLi aL ion and the t ime course of recovery from inacti ation were not 
al tered i n  ei ther GK or con tro l  myocyte' or PIO treated myocyte . Previou tudie i n  
anine \ entricu lar m ocyte hawed that everal tran -membrane ion currents i ncluding 
L-t) pe Ca2+ curr nt were i nh ibited by 2: 1 0  11 M  PIO [ 35 8 ] .  
The maw fi nding o f  the biotelemetry e periment a fol lows: ( i )  Body weight wa 
h igher i n  GK compared to control rat and PIO treatment in the range 2 .5  to 20 mg/kg 
d id  not ign ificant ly alter body weight i n  e i ther G K  or control rat , ( i i ) on-fast ing 
blood g]uco e wa ign ifi cant ly  elevated i n  G K  compared to contra] rat and wi th 
i ncrea ing concentration of PIO treatment blood gluco e i n  GK wa progres i vely 
normal i zed towards control rat value . ( i i i )  HR  was mode t ly lower i n  GK compared to 
contro l  rat and wa not al tered by PIO. ( i v )  HRV wa mode t ly h igher i n  GK compared 
to control rat and wa not altered by PlO, ( v )  QRS complex durat ion and QT i nterval 
were not ign ificant ly different i n  G K  compared to control rats and were not al tered by 
P IO and (v i ) PQ i n terval wa prolonged in GK compared to control rat and wa not 
a ltered by PIO.  
Body weight wa h igher in G K  rat compared to controls a fi nding that i con i stent 
w i th ome previou tudies [ 1 92 .  203, 3 1 7 , 3 1 8 ] .  TZD are typical ly associated with 
weight gain and i ncreased ri k of oedema [370]  so i t  was i ntere t ing to note that PIO. in 
the range of concentration used in th is study, had l i tt le effect on body weight i n  e i ther 
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GK rat" or control s .  Con i tent v.. i rh  previou tudie . the non-fa r ing blood gluco e \.\.'a  
ele\ aled i n  GK rats compared to control [ 203. 3 1 7 . 3 1 8 ] and treatment with i ncrea ing 
concentrat ion. of PIO gradual ly  improved blood gluco e in GK toward control rat 
value:.. 
HR v.. a<., modest ly reduced i n  GK compared to control rat and wa not addit ional ly 
al tered by PIO. Pre, iou ill 1 'i\'O biotelemetry tudie have al 0 reported reduction In 
HR in  GK aged between 2 and 1 5  mont hs compared to control ral [ 203 ] .  Reduction m 
H R  might be attributed to al tered autonomic nerve control and/or altered i ntri nsic 
contr I of the heart. Action potent ial experiment i n  spontaneou ly beat ing i olated 
heart have 'hO\ n reduction i n  HR ugge t ing that i ntr in ic  mechani m at lea t part ly 
underl ie  the reduced HR in  GK rat [ 1 92 ] .  HRV was mode t ly i ncreased in GK 
compared to control rat and was not addit ional l y  altered by PIO.  Al teration i n  H RY. 
a lbei t  mode t ,  might sugge t changes i n  ympathovagal control of  the  heart [ 37 1 ,  372 ] .  
The ECG provide valuable mea ures of e lectrical conduction i n  the heart . The QRS 
complex.  which represent ventricu lar depolari zat ion.  was mode t ly but not 
ignificantl y  reduced i n  GK compared to control rat and wa not addit ional ly  al tered 
by PIO.  In tere t ingly .  previou studies have demon trated prolonged QRS complex 
duration i n  GK compared to control rat . however. the difference were only ignificant 
in young 2 month old rat and, con i tent with the current study, were no longer 
s ignifi cant in older animals aged 7 and 1 5  month [ 203 ] .  Prolonged QT i n tervaL which 
repre ent the t ime from ventricular depolalization to repolarization, i s  a frequently 
reported fi nding in diabetic pat ients [373 ] .  In the curren t  study QT interval wa 
modestly but not s ignifi cantly prolonged and QT when corrected for HR wa not al tered 
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i n  GK compared to control rat and vv a  not addit ional l al tered by PIO. Thi fi nding i 
conc.,l c.,tent wi th prev ious , tudie� where mal l prolongation of QT interyal were reported 
i n  GK raL aged 2. 7 and 1 5  month [ 203 ] .  The PQ intervaL t ime between atrial 
depolarizat ion and the , tan of entricular depolari zat ion,  wa prolonged in GK 
compared to  control rat and appeared to be mode t ly reduced i n  GK toward control 
ral with i ncrea ing  concen trat ion of PIO. Thi fi nding may uggest prolonged 
conduct ion t ime between the atria and ventric le which might be attributed to 
atriov entricular node dy funct ion.  Reduced H R  and prolonged i noatrial node 
conduct ion t ime have been previou ly demon trated in the streptozotoci n-i nduced 
diabetic rat heart [ 373,  37'+ ] .  
3.3-"' Conclu ion 
Col l ect ively,  the re ult have hown that PIO ha negat ive i notropic  effects on GK and 
control myocyte which might be partl y  attributed to al tered mechani ms of Ca
2+ 
tran port . The biotelemetry tudy ha hown thaL PIO in the range 2 .5-20 mg/kg 
admin i  tered oral l y  during a period of 1 .+  week had favorable effect on blood gluco e 
and l i tt le or no effect on HR .  H RV and QRS complex durat ion. QT and PQ in terval . 
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Chapter 4 :  Summa ry 
The e pre�"ion pattern of 67 gene encoding cardiac mu cle ,  i n tercel 1u lar. membrane 
pump and exchanger. calc ium. sod ium and pota i um channel and intrace l lu lar Ca:!+ and 
Ca�+ regulatory prote i n" were characterized i n  cardiac ventri c le of young GK rat . Even 
at thi earl tage of diabete , the expre ion of mR A encoding orne membrane pump 
and ex hange prote in  were ei ther upregulated CA rpJo3) or downregu lated (Slc9o l ) .  
Expre ion of mR A encoding ome calc ium and pota ium channel prote in  were 
upregulated (Cacnolh .  Scn Jb. Hcn2) or downregulated (Hcn4, Kcno214. Kcnj2) .  
Although ampli tude of ventricular myocyte hOrlening and i n trace l lu lar Ca2+ tran i ent 
were unaltered. TPK shorten ing was prolonged and THALF decay of the Ca2+ tran i ent 
wa shortened in  GK m ocyte compared to control . Further understanding of the 
change that occur in the heart duri ng the early tages of diabete may provide 
opportun i t ie  to develop in ter ention and treatment trategie that might prevent or 
delay the on et  of evere functional d i  order a the d i  ea e progres es. 
I n  T2D M  a derangement in cardiac muscle contract ion and cel l u l ar Ca2+ tran port 
u ual ly  occur later i n  l i fe and it i s  po ib le that ome of the change i n  mRNA are 
tak i ng place to protect cardi ac mu c1e funct ion. 
I t  i well  e tabl i  hed that physical exerci e cont i nue to be one of the mo t aluable 
form of non-pharmacological therapy.  Experiment were performed in GK and control 
rat aged 1 0- 1 1 month fol 1owing 2-3 month of treadmi l l  exerc ise tra in ing .  
Expre ion of mRNA encodi ng TPIll2, Gjo4. A lp l  b l ,  Cocno l g, Coenb2. Hen2, Keno3 
and Kenel were upregulated and Gjo J ,  Kenj2 and Kenk3 were downregulated i n  hearts 
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of <,edemary G K rat compared to edentary control . Cja } .  Cad and Kcnk3 were 
upregulated and Hcn2 wa downregulated in heart of e erc i e trai ned GK compared to 
edentary GK control . However. ampl i tude of hortening, Ca�+ tran ient and L-type 
Ca�+ current vv ere not , i gn i ficantly al tered i n  ventri cular myocyte from edentary GK 
rat� compared t sedentary control or by exerci e trai n ing. Although. the expre ion of 
mR A encodi ng Cja } .  Cja4. Cacnb2 and Tpm2 were al tered in  edentary GK 
compared to  edentar control and Cja }  were upregulated i n  exerci se trained GK 
compared to  edentary GK rat . the  expre ions of corre ponding protei n encoded by 
the e genes were not al tered in edentary GK compared to edentary control or by 
exerc i se lrai ni ng. 
The u l tra tucture of ventricu lar myocyte wa general ly wel l  preserved i n  al l  group . 
The number of m itochondria was not s ign ificant ly al tered i n  edentary GK compared to 
sedentary control rat . Exerc i  e trai n i ng ign ificant ly increa ed mi tochondrial number i n  
e erci e trained G K  compared to  edentary GK rats and to  a i rn i l ar extent i n  exerc i se 
trai ned control compared to edentary control rat . Sarcomere organization wa regular 
i n  arrangement and clear triat ion were seen i n  al l  group . Sarcomere length wa 
mea ured. no al teration wa ob erved i n  arcomere length between edentary GK and 
edentary contro l .  Exerci e trai n i ng reduced arcomere length in exerci e trai ned GK 
and in exerci e trai ned control rats compared to sedentary GK and control rat . 
re pect ively.  Sarcomere width i n  edentary G K  wa wider compared to sedentary 
control rat . Exerci e trai n i ng increa ed acromere width in exerc i se trai ned GK and 
exerc i se trai ned control rats . 
] 9-+ 
Despite \\ idespread therapeut ic u e ' of PIO for the treatment of T �DM, the effect of 
PIO on the hean remain unclear, I t ' . \>. e l l  known that d iabet ic pat ient uffer from an 
increa ed risk of heart attack and , troke and cardiac electrical conduction abnormal i t ie . 
Ther fore the effect of PIO wa incorporated i nto the current tud to i nve t igate the 
benefi t  and ri h of PIO treatment. 
Experiment ", ere performed in ventricular myocytes from GK and control rat aged 8-
1 0  month . PIO ( I ).l ) reduced the arnpli tude and prolonged t ime to peak hortening 
and reduced the  ampl i tude and prolonged the  TPK Ca:>'+ tran ien t  to  s imi lar extents i n  
GK and control myocyte , Sarcopla m ic  ret icu lum fractional relea e o f  Ca2+ wa 
i ncrea oed in GK compared to control myocyte and wa addi t ional ly i ncreased by PIO. 
Acti vat ion of L-type Ca:>'+ current wa mode t ly reduced in myocyte from GK 
compared to  control rat and wa further reduced by  PIO treatment .  Inact i vation and 
re t i tut ion of L-type Ca2+ current were unal tered i n  GK compared to control myocytes 
or by PIO treatment .  
Collect ive ly, PIO had negat ive i notropic  effect in GK and control myocyte and the 
effect may part ly  be attribu ted to al tered mechanism of Ca
2+ transport . 
The biotelemetry tudy ha hown that P IO i n  the  range 2 .5 -20 mg/kg admin i  tered 
oral ly  during a peliod of 1 4  week had favorable  effect on blood g luco e and l i t t le or 
no effect on HR ,  HRV and QRS complex duration, QT and PQ i n tervals .  
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C h a pter 5 :  L i mitat ion of the study and fut u re d i rection 
• mR expres ion wa perfomled i n  ven tricle t i  ue which.  i n  addit ion to 
ven tricu lar myoc te . a lso contain other type of cell . Al though technical l y  
d i ffi cu l t  i t  might be  i ntere t ing t o  repeat the mRNA tudie i n  i ndi idual 
ventricular m oc te and to in e't igate whether change in mR A expre ion 
tran late int change in protein e pre ion. 
• entri cular myocyte e periment were performed at 1 Hz. It might be 
intere, t ing to in e t igate the effect of d i fferent t imulation freguencie on E-C 
coupl i ng. 
• Heart function of G K  rat wa only s l ight ly  compromi ed. It might be i nterest ing 
to i nve t igate the effect of PIO i n  everely compromi ed diabet ic heart . 
• I t  m ight be i ntere t ing to i nve l igate the effect of h igher doses of PIO (> 20 
mg/kg body weight) and longer durat ion of treatment on the ECG. 
• AP recorded i n  i olated perfu ed heart ( not i nc luded i n  th is  tudy) howed 
prolongat ion at 50% and 70% repolarizat ion and reduced HR i n  GK compared 
to control rat . It m ight be i nterest ing to i nve t igate the effect of PIO on the ion 
channel current that are re pon ible for AP repolarizat ion .  
• PIO undergoes hepat ic  metabol i  m i nto act ive and i nacti ve metaboli tes.  It m ight 
be i n tere t i ng to i nve t igate the effects of the various metabol i tes of PIO i n  
myocyte from diabet ic heart . 
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